<SEC-DOCUMENT>0001558370-25-004996.txt : 20250418
<SEC-HEADER>0001558370-25-004996.hdr.sgml : 20250418
<ACCEPTANCE-DATETIME>20250418093019
ACCESSION NUMBER:		0001558370-25-004996
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20250610
FILED AS OF DATE:		20250418
DATE AS OF CHANGE:		20250418

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Xilio Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001840233
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				851623397
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40925
		FILM NUMBER:		25849321

	BUSINESS ADDRESS:	
		STREET 1:		828 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
		BUSINESS PHONE:		617-833-1027

	MAIL ADDRESS:	
		STREET 1:		828 WINTER STREET
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02451
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>xlo-20250610xpre14a.htm
<DESCRIPTION>PRE 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.9.0.3 -->
<!-- Based on: iXBRL 1.1 -->
<!-- Created on: 4/17/2025 3:35:09 PM -->
<!-- iXBRL Library version: 1.0.9062.16423 -->
<!-- iXBRL Service Job ID: b68f8e49-bb1d-44cc-b291-6b109eb1ff1b -->
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlo="http://www.xiliotx.com/20250610" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16"><head><meta content="text/html" http-equiv="content-type"/><title>XILIO THERAPEUTICS,&#160;INC.</title></head><body><div style="margin-top:30pt;"></div> <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" name="dei:AmendmentFlag" id="Narr_3Yutd_6FCkS7NNSivtrbww">false</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" name="dei:EntityCentralIndexKey" id="Tc_UcyDYk1GOkKHyXitK5FEvg_2_1">0001840233</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" name="dei:DocumentType" id="Hidden_DHvk5juwyUegKGfLvHvz8A">PRE 14A</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="xlo-20250610.xsd"/></ix:references><ix:resources><xbrli:context id="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-08-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001840233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="Unit_Divide_USD_shares_c9xUV7cLfUGdKvEEazKsrg"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="Unit_Standard_USD_OLynBvCv7kGDid3dGGWBgw"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Unit_Standard_pure_99kf4M5Iyk-m5QIB71yB2A"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit></ix:resources></ix:header></div><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 30pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:10.35pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1px solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_ba15a16c_630f_44e0_9300_78a35943255f"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-size:17pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Washington, D.C. 20549</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:12pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:100%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:17pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><span style="-sec-ix-hidden:Hidden_DHvk5juwyUegKGfLvHvz8A;"><b style="font-family:'Times New Roman','Times','serif';font-size:17pt;font-style:normal;font-weight:bold;">SCHEDULE 14A</b></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Proxy Statement Pursuant to Section&#160;14(a)&#160;of the</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Securities Exchange Act of 1934</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(Amendment No.&#160;&#160;)</b></p><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:12pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:100%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 0pt;">Filed by the Registrant&#160;<span style="font-family:'Segoe UI Symbol';">&#9746;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 6pt 0pt;">Filed by a Party other than the Registrant&#160;<span style="font-family:'Segoe UI Symbol';">&#9744;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Check the appropriate box:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9746;</span></p></td><td style="vertical-align:bottom;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Preliminary Proxy Statement</p></td></tr><tr><td style="vertical-align:bottom;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:bottom;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><b style="font-weight:bold;">Confidential, for Use of the Commission Only (as permitted by Rule&#160;14a-6(e)(2))</b></p></td></tr><tr><td style="vertical-align:bottom;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:bottom;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Definitive Proxy Statement</p></td></tr><tr><td style="vertical-align:bottom;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:bottom;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Definitive Additional Materials</p></td></tr><tr><td style="vertical-align:bottom;width:4.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:bottom;width:95.36%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Soliciting Material under &#167;240.14a-12</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:19pt;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" name="dei:EntityRegistrantName" id="Narr_fllLZWSAGEWlK0dYeHzy0Q"><b style="font-weight:bold;">XILIO THERAPEUTICS,&#160;INC.</b></ix:nonNumeric></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">(Name of registrant as specified in its charter)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:7pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><b style="font-weight:bold;">(Name of person(s)&#160;filing proxy statement, if other than the registrant)</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Payment of Filing Fee (Check the appropriate box):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:bottom;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9746;</span></p></td><td style="vertical-align:top;width:92.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">No fee required.</p></td></tr><tr><td style="vertical-align:bottom;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:top;width:92.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fee paid previously with preliminary materials.</p></td></tr><tr><td style="vertical-align:top;width:7.41%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Segoe UI Symbol';">&#9744;</span></p></td><td style="vertical-align:top;width:92.58%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Fee computed on table in exhibit required by Item&#160;25(b)&#160;per Exchange Act Rules&#160;14a&#8211;6(i)(1)&#160;and 0&#8211;11</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1pt;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:3.0pt solid #000000;border-top:1px solid #000000;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:72pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_015da338_4759_4132_9a08_564cdb228803"></a><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:6pt 0pt 0pt 0pt;"><b style="color:#ff0000;font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">PRELIMINARY PROXY STATEMENT SUBJECT TO COMPLETION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 4pt 0pt;"><img src="xlo-20250610xpre14a_a003.jpg" alt="Graphic" style="display:inline-block;height:72pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:115.17pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 4pt 0pt;"><b style="font-weight:bold;">828 Winter Street, Suite&#160;300</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Waltham, Massachusetts 02451</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><a id="_Toc193222791"></a><a id="_Toc193224622"></a><a id="_Toc193225835"></a><a id="_Toc193708058"></a><a id="_Toc193805339"></a><a id="_Toc194480999"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 4pt 0pt;">NOTICE OF 2025 ANNUAL MEETING OF STOCKHOLDERS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">To Be Held on June 10</b><b style="font-weight:bold;">, 2025</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10pt;text-align:justify;margin:0pt 0pt 4pt 0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">Dear Stockholders:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">You are cordially invited to attend the 2025 annual meeting of stockholders of Xilio Therapeutics,&#160;Inc. to be held on June 10, 2025 at 11:00 a.m., Eastern Daylight Time, virtually at www.virtualshareholdermeeting.com/XLO2025. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">At the annual meeting, stockholders will consider and vote on the following matters:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The election of three Class I directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her successor has been duly elected and qualified;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The approval of an amendment to our restated certificate of incorporation to increase the number of authorized shares of our common stock from 200,000,000 to 600,000,000;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The approval of an amendment to our restated certificate of incorporation to reflect Delaware law provisions regarding officer exculpation;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The ratification of the selection of Ernst&#160;&amp; Young LLP as our independent registered public accounting firm for the fiscal&#160;year ending December&#160;31, 2025; and</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">5.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The transaction of any other business that may properly come before the annual meeting or any adjournment or postponement thereof.</span></td></tr></table><div style="margin-top:8pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">We have elected to provide access to our proxy materials over the internet under the U.S. Securities and Exchange Commission&#8217;s, or the SEC&#8217;s, &#8220;notice and access&#8221; rules. We believe that providing our proxy materials over the internet expedites stockholders&#8217; receipt of proxy materials, lowers costs and reduces the environmental impact of our annual meeting. Accordingly, on or about __________, we are sending to our stockholders a notice of internet availability of proxy materials, or the notice of availability, instead of a paper copy of our proxy materials. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">Only stockholders of record at the close of business on April 11, 2025, the record date for the annual meeting, are entitled to notice of and to vote at the annual meeting or any adjournment or postponement thereof. As noted above, our annual meeting will be a virtual meeting of stockholders, which will be conducted exclusively via the internet as a virtual web conference. You will be able to attend the annual meeting online, vote your shares during the annual meeting and submit questions for consideration during the annual meeting through <i style="font-style:italic;">www.virtualshareholdermeeting.com/XLO2025</i>. Please carefully review the enclosed proxy statement and the notice of availability for additional details.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:22.5pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 8pt 0pt;">Your vote is important, and we encourage all stockholders to attend the annual meeting online. Whether or not you plan to attend the annual meeting online, we encourage you to read this proxy statement and submit your proxy or voting instructions as soon as possible by following the instructions in the notice of availability and submitting your proxy by the internet, telephone, or by signing, dating and returning your proxy card or voting instruction form. Please review the instructions on each of your voting options described in the attached proxy statement. Further information about how to register for and attend the annual meeting online, vote your shares and submit questions for consideration at the meeting is included in the accompanying proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Thank you for your ongoing support and continued interest in Xilio Therapeutics, Inc.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt 0pt 12pt 0pt;">By Order of the Board of Directors,&#160;</p></td></tr><tr style="height:4.15pt;"><td style="vertical-align:middle;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:4pt;visibility:hidden;background:#00ff00;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:4pt;visibility:hidden;background:#00ff00;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><span style="font-size:9pt;font-style:italic;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><i style="font-style:italic;"><img src="xlo-20250610xpre14a_a004.jpg" alt="Graphic" style="display:inline-block;height:21.75pt;left:0%;padding-bottom:0.75pt;position:relative;top:0pt;width:94.5pt;"/></i></p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;">Ren&#233; Russo, Pharm.D.</p></td></tr><tr><td style="vertical-align:bottom;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:50%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:10pt;text-indent:-10pt;margin:0pt;"><i style="font-style:italic;">President and Chief Executive Officer</i></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:5pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Waltham, Massachusetts</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">___________, 2025</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:3pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p><a id="_Toc193708059"></a><a id="_Toc193222792"></a><a id="_005e3814_b723_464d_abfe_f58c38c76858"></a><a id="TOC"></a><a id="_Toc193805340"></a><a id="_Toc193708060"></a><a id="_Toc193224623"></a><a id="_Toc193225836"></a><a id="_Toc194481000"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">TABLE OF CONTENTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481003">INFORMATION CONCERNING SOLICITATION AND VOTING</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481003"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481003">1</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481004">IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481004"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481004">2</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481021">PROPOSAL NO.&#160;1&#8212;ELECTION OF DIRECTORS</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481021"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481021">8</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481024">PROPOSAL NO. 2&#8212;AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481024"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481024">12</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481025">PROPOSAL NO. 3&#8212;AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO REFLECT DELAWARE LAW PROVISIONS REGARDING OFFICER EXCULPATION</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481025"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481025">15</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481026">PROPOSAL NO. 4&#8212;RATIFICATION OF THE SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481026"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481026">18</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481027">CORPORATE GOVERNANCE</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481027"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481027">19</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481040">EXECUTIVE OFFICERS</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481040"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481040">26</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;text-transform:uppercase;"><a href="#_Toc194481042">Executive Compensation</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481042"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481042">27</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481056">DIRECTOR COMPENSATION</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481056"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481056">34</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481058">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481058"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481058">36</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#SECURITIESAUTHORIZED_517448">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#SECURITIESAUTHORIZED_517448"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#SECURITIESAUTHORIZED_517448">37</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481061">CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481061"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481061">38</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481068">STOCK OWNERSHIP AND REPORTING</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481068"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481068">41</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481069">DELINQUENT SECTION 16(a) REPORTS</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481069"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481069">43</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481070">STOCKHOLDERS SHARING THE SAME ADDRESS</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481070"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481070">43</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481071">STOCKHOLDER PROPOSALS FOR OUR 2026 ANNUAL MEETING</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481071"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481071">43</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481072">OTHER MATTERS</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481072"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481072">44</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481073">APPENDIX A</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481073"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481073">45</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:5pt;margin-left:0pt;margin-top:0pt;overflow:hidden;position:relative;"><span style="padding-bottom:2.0pt;padding-right:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481074">APPENDIX B</a></span></span><span style="bottom:2.663086pt;display:block;height:1em;left:0pt;position:absolute;width:100%;z-index:0;border-bottom:1.0px dotted #000000;">&#8204;</span><span style="float:right;padding-left:2.0pt;position:relative;text-indent:0pt;z-index:1;background:white;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481074"></a></span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"><a href="#_Toc194481074">46</a></span></span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="display:none;font-family:'Times New Roman','Times','serif';line-height:0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:72pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_0e0da679_06a6_404c_9b14_454ac636cc95"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 6pt 0pt;"><img src="xlo-20250610xpre14a_a003.jpg" alt="Graphic" style="display:inline-block;height:72pt;left:0%;padding-bottom:0pt;position:relative;top:0pt;width:115.17pt;"/></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">828 Winter Street, Suite&#160;300</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Waltham, Massachusetts 02451</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 9pt 0pt;"><b style="font-weight:bold;">(857) 524-2466</b></p><a id="_Toc193222793"></a><a id="_Toc193224624"></a><a id="_Toc193225837"></a><a id="_Toc193708061"></a><a id="_Toc193805341"></a><a id="_Toc194481001"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">PROXY STATEMENT</p><a id="_Toc193222794"></a><a id="_Toc193224625"></a><a id="_Toc193225838"></a><a id="_Toc193708062"></a><a id="_Toc193805342"></a><a id="_Toc194481002"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt;">2025 ANNUAL MEETING OF STOCKHOLDERS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 9pt 0pt;"><b style="font-weight:bold;">To Be Held on June&#160;10, 2025</b></p><a id="_Toc193222795"></a><a id="_Toc194481003"></a><a id="INFORMATIONCONCERNINGSOLICITATIONANDVOTI"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 9pt 0pt;">INFORMATION CONCERNING SOLICITATION AND VOTING</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">This proxy statement and the enclosed proxy card are being furnished in connection with the solicitation of proxies by the board of directors of Xilio Therapeutics, Inc., or Xilio, for use at the annual meeting of stockholders, or annual meeting, to be held virtually on June&#160;10, 2025 at 11:00 a.m., Eastern Daylight Time, and at any adjournment thereof. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">The annual meeting will be held exclusively online as a virtual meeting at <i style="font-style:italic;">www.virtualshareholdermeeting.com/XLO2025</i>. There will not be a physical meeting location, and stockholders will not be able to attend the annual meeting in person. Further information about how to attend the annual meeting online, vote your shares and submit questions during the meeting is included in this proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">In this proxy statement, unless expressly stated or the context otherwise requires, references to &#8220;Xilio,&#8221; &#8220;the company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar terms refer to Xilio Therapeutics,&#160;Inc. References to our website are inactive textual references only, and the contents of our website are not incorporated by reference into this proxy statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">We are making this proxy statement, the related proxy card and our 2024 annual report to stockholders available to stockholders on or about __________, 2025. All properly submitted proxies will be voted in accordance with the instructions contained in those proxies. If no instructions are specified, the shares represented by the proxies will be voted in accordance with the recommendation of our board of directors. If you are a stockholder of record, you may change your vote or revoke your proxy at any time before it is exercised at the meeting by following the instructions set forth in this proxy statement. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">Important Notice Regarding the Availability of Proxy Materials </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;text-transform:uppercase;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">This proxy statement and our Annual Report on Form&#160;10-K for the fiscal&#160;year ended December&#160;31, 2024, as filed with the SEC, are available for viewing, printing and downloading at </b><span style="font-style:italic;font-weight:bold;">www.proxyvote.com</span><b style="font-weight:bold;">. In addition, this proxy statement and our Annual Report on Form&#160;10-K are available on the SEC&#8217;s website at </b><span style="font-style:italic;font-weight:bold;">www.sec.gov</span><span style="font-style:italic;font-weight:bold;"> </span><b style="font-weight:bold;">and the &#8220;Investors &amp; Media &#8212; Financials &amp; Filings &#8212; SEC Filings&#8221; section of our website, which is located at </b><span style="font-style:italic;font-weight:bold;">https://ir.xiliotx.com</span><b style="font-weight:bold;">. A printed copy of our Annual Report on Form 10-K, excluding exhibits, will be furnished without charge to any stockholder upon written request to Xilio Therapeutics,&#160;Inc., 828 Winter Street, Suite&#160;300, Waltham, Massachusetts 02451 o</b><b style="font-weight:bold;">r by calling 1-800-579-1639, e-mailing </b><span style="font-style:italic;font-weight:bold;">sendmaterial@proxyvote.com</span><b style="font-weight:bold;"> and including your control number in the subject line, or by submitting a request at </b><span style="font-style:italic;font-weight:bold;">www.proxyvote.com</span><b style="font-weight:bold;">. </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-1-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc193222796"></a><a id="_Toc194481004"></a><a id="_aa259a4f_5ddc_47d5_8fdc_b75dccab9bc4"></a><a id="IMPORTANTINFORMATIONABOUTTHEANNUALMEETIN"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 10pt 0pt;">IMPORTANT INFORMATION ABOUT THE ANNUAL MEETING AND VOTING</p><a id="_Toc193224628"></a><a id="_Toc193225841"></a><a id="_Toc193708065"></a><a id="_Toc193805345"></a><a id="_Toc194481005"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Why Did I Receive These Proxy Materials?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We have made these materials available to you on the internet in connection with the solicitation of proxies for use at our 2025 annual meeting of stockholders to be held online on Tuesday, June 10, 2025 at 11:00 a.m., Eastern Daylight Time, at <i style="font-style:italic;">www.virtualshareholdermeeting.com/XLO2025</i>. As a holder of common stock, you are invited to attend the annual meeting online and are requested to vote on the items of business described in this proxy statement. This proxy statement includes information that we are required to provide to you under applicable SEC rules and regulations and that is designed to assist you in voting your shares.</p><a id="_Toc193224629"></a><a id="_Toc193225842"></a><a id="_Toc193708066"></a><a id="_Toc193805346"></a><a id="_Toc194481006"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Purpose of the Annual Meeting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">At the annual meeting, our stockholders will consider and vote on the following matters:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">1.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the election of three Class&#160;I directors nominated by our board of directors, each to serve for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her successor has been duly elected and qualified (Proposal 1);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">2.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the approval of an amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 200,000,000 to 600,000,000 (Proposal 2);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">3.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the approval of an amendment to our certificate of incorporation to reflect Delaware law provisions regarding officer exculpation (Proposal 3);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">4.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the ratification of the selection of Ernst&#160;&amp; Young LLP as our independent registered public accounting firm for the fiscal&#160;year ending December&#160;31, 2025 (Proposal 4); and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">5.</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the transaction of any other business that may properly come before the annual meeting or any adjournment or postponement thereof.</span></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">As of the date of this proxy statement, we are not aware of any business to come before the meeting other than the first four items noted above. Should any other business come before the annual meeting, the persons named on the company&#8217;s proxy card will have discretionary authority to vote the shares represented by such proxies. If you hold shares through a broker, bank or other nominee as described below, we expect that they will not be able to vote your shares on any other business that comes before the annual meeting unless they receive instructions from you with respect to such matter.</p><a id="_Toc193224630"></a><a id="_Toc193225843"></a><a id="_Toc193708067"></a><a id="_Toc193805347"></a><a id="_Toc194481007"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Board of Directors Recommendation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Our board of directors unanimously recommends that you vote:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> the election of all three director nominees to serve as Class&#160;I directors, each for a three-year term expiring at the 2028 annual meeting of stockholders or until his or her successor has been duly elected and qualified; </span></td></tr></table><div style="margin-top:10pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.85pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;"> </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the approval of an amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 200,000,000 to 600,000,000;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.85pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> the approval of an amendment to our certificate of incorporation to reflect Delaware law provisions regarding officer exculpation; and</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">FOR</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> the ratification of the selection of Ernst&#160;&amp; Young LLP as our independent registered public accounting firm for the fiscal&#160;year ending December&#160;31, 2025.</span></td></tr></table><div style="margin-top:10pt;"><a id="_Toc193224631"></a><a id="_Toc193225844"></a><a id="_Toc193708068"></a><a id="_Toc193805348"></a><a id="_Toc194481008"></a></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Availability of Proxy Materials</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The proxy materials, including this proxy statement, a proxy card and our 2024 Annual Report on Form 10-K are available for viewing, printing and downloading at <i style="font-style:italic;">www.proxyvote.com</i>. On or about ________, 2025, we will mail the notice of availability to stockholders, unless they have requested a printed copy of proxy materials. If you would like to receive a </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-2-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">paper copy of our proxy materials, you should follow the instructions for requesting paper materials in the notice of availability. To facilitate delivery prior to the annual meeting, please make your request prior to ________, 2025.</p><a id="_Toc193224632"></a><a id="_Toc193225845"></a><a id="_Toc193708069"></a><a id="_Toc193805349"></a><a id="_Toc194481009"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Who Can Vote at the Annual Meeting?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Only stockholders of record at the close of business on April 11, 2025, the record date for the annual meeting, are entitled to notice of and to vote at the annual meeting or any adjournment or postponement thereof. As of the record date, there were 51,775,395 shares of our common stock outstanding and entitled to vote at the annual meeting. Each share of common stock that you own as of the record date is entitled to one vote on each matter properly brought before the annual meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Difference Between a &#8220;Stockholder of Record&#8221; and a Beneficial Owner of Shares Held in &#8220;Street Name&#8221;</b></p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Stockholder of Record</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">. </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If your shares are registered directly in your name with our transfer agent, Computershare Trust Company, then you are considered the &#8220;stockholder of record&#8221; of those shares. In this case, your notice of availability has been sent to you directly by us. You may vote your shares by proxy prior to the annual meeting by following the instructions contained in the notice of availability and in the section titled &#8220;How to Vote and Voting Deadlines&#8221; below.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Beneficial Owner of Shares Held in Street Name</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">. </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If your shares are held by a bank, broker or other nominee, then you are considered the beneficial owner of those shares, which are held in &#8220;street name.&#8221; In this case, your notice of availability will be sent to you by that organization. The organization holding your shares is considered the stockholder of record for purposes of voting at the annual meeting. As the beneficial owner, you have the right to instruct that organization as to how to vote the shares held in your account by following the instructions contained on the voting instruction card provided to you by that organization.</span></td></tr></table><div style="margin-top:12pt;"><a id="_Toc193224633"></a><a id="_Toc193225846"></a><a id="_Toc193708070"></a><a id="_Toc193805350"></a><a id="_Toc194481010"></a></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">How to Virtually Attend the Annual Meeting</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The annual meeting will start at 11:00 a.m., Eastern Daylight Time, on June&#160;10, 2025 and will be a virtual meeting of stockholders where stockholders will participate by accessing a website using the internet. There will not be a physical meeting location. We believe that hosting a virtual meeting will facilitate stockholder attendance and participation at our annual meeting by enabling stockholders to participate from any location around the world. We have designed the virtual annual meeting to provide the same rights and opportunities to participate as stockholders would have at an in-person meeting, including the right to vote and ask questions during the meeting through the virtual meeting platform.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Stockholders of record as of April 11, 2025 will be able to attend and participate in the annual meeting by accessing <i style="font-style:italic;">www.virtualshareholdermeeting.com/XLO2025</i>. You may log into the virtual meeting starting at 10:45 a.m., Eastern Daylight Time, on the day of the meeting. To join the annual meeting, you will need to have your 16-digit control number, which is included on your notice of availability and your proxy card. In the event that you do not have a control number, please contact your broker, bank, or other nominee as soon as possible so that you can be provided with a control number and gain access to the annual meeting. Stockholders will also have the opportunity to submit questions during the annual meeting through <i style="font-style:italic;">www.virtualshareholdermeeting.com/XLO2025</i>. A technical support telephone number will be posted on the log-in page that you can call if you encounter any difficulties accessing the virtual meeting during the check-in or during the meeting.</p><a id="_Toc193224634"></a><a id="_Toc193225847"></a><a id="_Toc193708071"></a><a id="_Toc193805351"></a><a id="_Toc194481011"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">How to Vote and Voting Deadlines</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">If you are the stockholder of record of your shares</b>, meaning that your shares are registered in your name in the records of our transfer agent, Computershare Trust Company, N.A., and not in the name of a bank, brokerage firm or other nominee, you can vote your shares by proxy prior to the annual meeting or online during the annual meeting as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">By internet prior to the annual meeting</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">. </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">You may transmit your proxy and vote via the internet by following the instructions provided in the notice of availability and on the proxy card. You will need to have your notice of availability or proxy card in hand when you access the website. The website for voting is available at </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">www.proxyvote.com</i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">. Proxies submitted via the internet must be received by 11:59 p.m., Eastern Daylight Time, on June 9, 2025, the day before the annual meeting, for your proxy to be valid and your vote to count.</span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-3-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">By telephone prior to the annual meeting</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">. </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">You may transmit your proxy and vote over the phone by calling 1-800-690-6903 and following the instructions provided in the notice of availability and on the proxy card. You will need to have your notice of availability or proxy card in hand when you call. Proxies submitted by telephone must be received by 11:59 p.m., Eastern Daylight Time, on June 9, 2025, the day before the annual meeting, for your proxy to be valid and your vote to count.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">By mail prior to the annual meeting</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">. </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">If you requested printed copies of our proxy materials, you can vote by mail by marking, signing, and dating the proxy card and then mailing the proxy card in accordance with the instructions on the proxy card. If you vote by mail, you do not need to vote over the internet or by telephone. Proxies submitted by mail must be received by Broadridge Financial Solutions, Inc. no later than June 9, 2025, the day before the annual meeting, for the proxy to be valid and your vote to count. If you return your proxy card but do not specify how you want your shares voted on any particular matter, they will be voted in accordance with the recommendations of our board of directors.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Online during the annual meeting</span><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:bold;">. </b><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">You may vote your shares during the annual meeting by going to </span><i style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:normal;">www.virtualshareholdermeeting.com/XLO2025 </i><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">and following the instructions on that website for submitting your vote. You will need the 16-digit control number included on your notice of availability. If you vote by proxy prior to the annual meeting and choose to attend the annual meeting online, there is no need to vote again during the annual meeting unless you wish to change your vote.</span></td></tr></table><div style="margin-top:10pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">If the annual meeting is adjourned or postponed, the foregoing deadlines may be extended. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">If your shares are held in &#8220;street name,&#8221;</b> meaning your shares are held for your account by an intermediary, such as a bank, brokerage firm or other nominee, then you are deemed to be the beneficial owner of your shares, and the bank, brokerage firm or other nominee that actually holds the shares for you is the record holder and is required to vote the shares it holds on your behalf according to your instructions. The proxy materials, as well as voting and revocation instructions, should have been forwarded to you by the bank, broker or other nominee that holds your shares. In order to have your broker or other nominee vote your shares, you will need to follow the instructions that your bank, broker or other nominee provides you. The voting deadlines and availability of telephone and internet voting for beneficial owners of shares held in &#8220;street name&#8221; will depend on the voting processes of the bank, broker or other nominee that holds your shares. Therefore, we urge you to carefully review and follow the voting instruction card and any other materials that you receive from that organization. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Under applicable stock exchange rules, banks, brokerage firms and other nominees may use their discretion to vote &#8220;uninstructed&#8221; shares (i.e., shares of record held by banks, brokers or other nominees, but with respect to which the beneficial owner of such shares has not provided instructions on how to vote on a particular proposal) with respect to matters that are considered to be &#8220;discretionary,&#8221; but not with respect to &#8220;non-discretionary&#8221; matters. With respect to non-discretionary items for which you do not give your broker voting instructions, your shares will be treated as broker non-votes. A &#8220;broker non-vote&#8221; occurs when shares held by a bank, brokerage firm or other nominee are not voted with respect to a particular proposal because the bank, brokerage firm or other nominee does not have or did not exercise discretionary authority to vote on the matter and has not received voting instructions from its client. For a discussion of how broker non-votes will be treated, see the discussion under &#8220;Votes Required to Approve Each Proposal.&#8221;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Regardless of whether your shares are held in street name, you are welcome to attend the annual meeting online.&#160;To do so, you will need your control number included on your notice of availability, proxy card or voting instruction form in order to demonstrate proof of beneficial ownership. However, you may not vote shares held in street name at the annual meeting, unless you obtain a legal proxy from your bank, brokerage firm or other nominee issued in your name giving you the right to vote your shares.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-style:italic;font-weight:bold;">Even if you plan to attend the annual meeting online, we urge you to vote your shares by proxy in advance of the annual meeting so that if you become unable to attend the annual meeting, your shares will be voted as directed by you.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><b style="font-weight:bold;">Can I Vote My Shares by Filling Out and Returning the Notice of Internet Availability of Proxy Materials?</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">No.&#160;The notice of availability and proxy card contain instructions on how to vote by proxy via the internet, by telephone, by requesting and returning a paper proxy card, or by voting online while virtually attending the annual meeting.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-4-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc193224635"></a><a id="_Toc193225848"></a><a id="_Toc193708072"></a><a id="_Toc193805352"></a><a id="_Toc194481012"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">How Do I Submit a Question at the Annual Meeting?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">If you wish to submit a question during the annual meeting, beginning at 10:45 a.m., Eastern Daylight Time, on June 10, 2025, you may log into the virtual meeting platform using the unique link provided to you via e-mail following the completion of your registration at <i style="font-style:italic;">www.virtualshareholdermeeting.com/XLO2025 </i>and follow the instructions there. Our virtual meeting will be governed by our Rules&#160;of Conduct and Procedures which will be posted at <i style="font-style:italic;">www.virtualshareholdermeeting.com/XLO2025 </i>during the annual meeting. The Rules&#160;of Conduct and Procedures will address the ability of stockholders to ask questions during the meeting, including rules&#160;on permissible topics and rules&#160;for how questions and comments will be recognized and disclosed to meeting participants.</p><a id="_Toc193224636"></a><a id="_Toc193225849"></a><a id="_Toc193708073"></a><a id="_Toc193805353"></a><a id="_Toc194481013"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">May&#160;I See a List of Stockholders Entitled to Vote as of the Record Date?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">A complete list of registered stockholders as of the close of business on the record date will be available for inspection by our stockholders of record at least 10 days prior to the annual meeting during normal business hours at our headquarters at 828 Winter Street, Suite 300, Waltham, MA 02451. If you are unable to inspect this list in person, please contact our Corporate Secretary by mail at Xilio Therapeutics,&#160;Inc., 828 Winter Street, Suite&#160;300, Waltham, Massachusetts 02451, Attention: Corporate Secretary, or by e-mail at <i style="font-style:italic;">investors@xiliotx.com</i> to request such list. When making such request, please ensure that you have your notice of availability or proxy card available so that you can prove that you are a registered stockholder. </p><a id="_Toc193224637"></a><a id="_Toc193225850"></a><a id="_Toc193708074"></a><a id="_Toc193805354"></a><a id="_Toc194481014"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Quorum</p><a id="_Toc193224638"></a><a id="_Toc193225851"></a><a id="_Toc193708075"></a><a id="_Toc193805355"></a><a id="_Toc194481015"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-weight:normal;">A majority of our shares of common stock outstanding as of the record date must be present or represented by proxy to constitute a quorum and hold the annual meeting. For purposes of determining whether a quorum exists, we count as present any shares that are voted over the internet, by telephone, by mail or that are represented at the virtual annual meeting. Further, for purposes of establishing a quorum, we will count as present shares that a stockholder holds even if the stockholder votes to abstain or only votes on one of the proposals. In addition, because we expect that brokers, banks or other nominees will be able to vote on at least one proposal, we expect that the shares held by these entities will be counted for purposes of determining whether a quorum is present. If a quorum is not present, we expect to adjourn the annual meeting until we obtain a quorum. Votes cast by proxy will be tabulated by the inspector of election appointed for the annual meeting, who will also determine whether a quorum is present.</span></p><a id="_Toc193224639"></a><a id="_Toc193225852"></a><a id="_Toc193708076"></a><a id="_Toc193805356"></a><a id="_Toc194481016"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Votes Required to Approve Each Proposal </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:26.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Proposal 1&#8212;Election of Class I Directors: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">The three nominees for director to receive the highest number of votes FOR election will be elected as directors, which is called a plurality vote. Proposal 1 is expected to be considered a non-discretionary matter under applicable rules. If your shares are held by your brokerage firm in street name and you do not timely provide voting instructions with respect to your shares, your bank or brokerage firm will not vote with respect to Proposal 1 and those votes will be counted as &#8220;broker non-votes.&#8221; Broker non-votes will have no effect on the outcome of the voting on Proposal 1. You may either: (i) vote FOR all nominees; (ii) vote FOR one or more of the nominees and WITHHOLD your vote from the other nominee or nominees; or (iii) WITHHOLD your vote from all nominees. Votes that are withheld will not be included in the vote tally for the election of directors and will not affect the results of the vote.</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:26.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Proposal 2</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">&#8212;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Amendment to Our Certificate of Incorporation to Increase the Number of Authorized Shares of Our Common Stock: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To approve the amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 200,000,000 to 600,000,000, holders of a majority of the votes cast on the matter must vote FOR the proposal. Proposal 2 is expected to be considered a discretionary matter under applicable rules. If your shares are held by your bank or brokerage firm in street name and you do not provide voting instructions with respect to your shares, your brokerage firm may vote your unvoted shares on Proposal 2. Abstentions and broker non-votes, if any, will have no effect on the outcome of Proposal 2.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:26.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Proposal 3</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">&#8212;</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Amendment to Our Certificate of Incorporation to Reflect Delaware Law Provisions Regarding Officer Exculpation: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To approve the amendment to our certificate of incorporation to reflect Delaware law provisions regarding officer exculpation, holders of a majority of the outstanding shares of our common stock entitled to vote thereon must vote FOR the proposal. Proposal 3 is expected to be considered a non-discretionary matter under applicable rules. If your shares are held by your brokerage firm in street name and you do not </span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-5-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:26.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">timely provide voting instructions with respect to your shares, your bank or brokerage firm will not vote with respect to Proposal 3 and those votes will be counted as broker non-votes. Abstentions and broker non-votes will have the effect of a vote AGAINST Proposal 3</span></td></tr></table><div style="margin-top:12pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:26.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;">Proposal 4&#8212;Ratification of Selection of Independent Registered Public Accounting Firm: </span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">To approve the ratification of the selection of Ernst&#160;&amp; Young LLP as our independent registered public accounting firm for the fiscal&#160;year ending December&#160;31, 2025, holders of a majority of the votes cast on the matter must vote FOR the proposal. Proposal 4 is expected to be considered a discretionary matter under applicable rules. If your shares are held by your bank or brokerage firm in street name and you do not provide voting instructions with respect to your shares, your brokerage firm may vote your unvoted shares on Proposal 4. Abstentions and broker non-votes, if any, will have no effect on the outcome of Proposal 4.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 44.4pt;">Although stockholder approval of our audit committee&#8217;s selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025 is not required, we believe that it is advisable to give stockholders an opportunity to ratify this selection. If this proposal is not approved at the annual meeting, our audit committee will reconsider its selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the year ending December 31, 2025.</p><a id="_Toc193224640"></a><a id="_Toc193225853"></a><a id="_Toc193708077"></a><a id="_Toc193805357"></a><a id="_Toc194481017"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Revoking a Proxy; Changing Your Vote</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">If you are a stockholder of record,</b> you may revoke your proxy and change your vote at any time before the vote is taken at the annual meeting. To do so, you must do one of the following:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Submit a new proxy with a later date before the applicable deadline either signed and returned by mail or transmitted using the telephone or internet voting procedures described in the &#8220;How to Vote and Voting Deadlines&#8221; section above;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Attend the annual meeting online and vote using the procedures described in the &#8220;How to Vote and Voting Deadlines&#8221; section above; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">File a written revocation with our corporate secretary before or at the annual meeting.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">If your shares are held in &#8220;street name,&#8221; </b>you may submit new voting instructions by contacting your bank, broker or other nominee holding your shares. You may also vote online during the annual meeting, which will have the effect of revoking any previously submitted voting instructions, if you obtain a legal proxy from the organization that holds your shares and follow the procedures described in the &#8220;How to Vote and Voting Deadlines&#8221; section above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Your virtual attendance at the annual meeting, without voting online during the annual meeting, will not automatically revoke your proxy.</span></p><a id="_Toc193224641"></a><a id="_Toc193225854"></a><a id="_Toc193708078"></a><a id="_Toc193805358"></a><a id="_Toc194481018"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Costs of Proxy Solicitation</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">We will bear the costs of soliciting proxies and tabulating your votes. In addition to solicitation by mail, our directors, officers and employees may solicit proxies personally, by telephone, e-mail or in person without additional compensation for the solicitation, but these directors, officers and employees may be reimbursed for out-of-pocket expenses incurred in connection with the solicitation. Copies of solicitation materials will be furnished to brokerage firms, fiduciaries, and other custodians who hold shares of our common stock of record for beneficial owners for forwarding to such beneficial owners. We may reimburse banks, brokers and other holders of record for their reasonable, out-of-pocket expenses for forwarding these proxy materials to beneficial owners.</p><a id="_Toc193224642"></a><a id="_Toc193225855"></a><a id="_Toc193708079"></a><a id="_Toc193805359"></a><a id="_Toc194481019"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Voting Results</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">We plan to announce preliminary voting results at the annual meeting and expect to report final voting results in a Current Report on Form&#160;8-K to be filed with the SEC within four business&#160;days following the annual meeting.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-6-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc193224643"></a><a id="_Toc193225856"></a><a id="_Toc193708080"></a><a id="_Toc193805360"></a><a id="_Toc194481020"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 10pt 0pt;">Whom Should I Contact With Any Additional Questions?</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">If you hold your shares directly or have additional questions about the annual meeting, please contact us at Xilio Therapeutics, Inc., 828 Winter Street, Suite 300, Waltham, Massachusetts 02451, Attn: Investor Relations, or by e-mail at <i style="font-style:italic;">investors@xiliotx.com</i>.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">If your shares are held in street name, please call the telephone number provided on your voting instruction form or contact your bank, brokerage firm or other nominee directly.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-7-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:10.35pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc194481021"></a><a id="_Toc193222797"></a><a id="_d4b95ce1_b3db_4126_a8ed_60d7fc9ae2eb"></a><a id="PROPOSALNO1ELECTIONOFTHREECLASSIDIRECTOR"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PROPOSAL NO.&#160;1&#8212;ELECTION OF DIRECTORS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In accordance with the terms of our certificate of incorporation, our board of directors is divided into three classes (Class&#160;I, Class&#160;II and Class&#160;III), with members of each class serving staggered three-year terms. Directors in each class are elected at the annual meeting of stockholders held in the year in which the term for their class expires and hold office for a three-year term and until their resignation or removal or their successors are duly elected and qualified. In accordance with our certificate of incorporation and our second amended and restated bylaws, or our bylaws, our directors may fill existing vacancies on the board of directors. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The term of office of our Class I directors, Ren&#233; Russo, Pharm.D., Sara M. Bonstein and James Shannon, M.D., will expire at the 2025 annual meeting of stockholders. Our board of directors has nominated Ren&#233; Russo, Sara M. Bonstein and James Shannon for election as Class&#160;I directors at the annual meeting. Dr. Russo, Ms. Bonstein and Dr. Shannon have indicated a willingness to continue to serve as directors, if elected. If Dr. Russo, Ms. Bonstein or Dr. Shannon is elected at the 2025 annual meeting of stockholders, such individual will be elected to serve for a three-year term that will expire at our 2028 annual meeting of stockholders and until such individual&#8217;s successor is elected and qualified. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">If no contrary indication is made, proxies in the accompanying form will be voted for Dr. Russo, Ms. Bonstein and Dr. Shannon, or, in the event that any of Dr. Russo, Ms. Bonstein or Dr. Shannon is not a candidate or is unable to serve as a director at the time of the election (which is not currently expected), for any nominee who is designated by our board of directors to fill the vacancy.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Information Regarding Directors</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Set forth below are the names and certain information for each member of our board of directors as of April 15, 2025, including the nominees for election as Class I directors. The information presented includes each director&#8217;s and nominee&#8217;s principal occupation and business experience for the past five years, and the names of other public companies of which he or she has served as a director during the past five years. The information presented below regarding the specific experience, qualifications, attributes and skills of each director and nominee led our board of directors to conclude that he or she should serve as a director. In addition, we believe that all of our directors and nominees possess the attributes or characteristics described in &#8220;&#8212;Director Nomination Process&#8221; that the nominating and corporate governance committee expects of each director. There is no arrangement or understanding between any of our directors and any other person or persons pursuant to which he or she was or is to be selected as a director.</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Position(s)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Class I Directors</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Ren&#233; Russo, Pharm.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">50</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">President, Chief Executive Officer and Director</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Sara M. Bonstein <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">44</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">James Shannon, M.D. <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">68</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Class II Directors</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Daniel Curran, M.D. <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">58</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Robert Ross, M.D. <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">51</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Yuan Xu, Ph.D. <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">57</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Class III Directors</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Paul J. Clancy <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">63</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director, Chair of the Board</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Christina Rossi <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:30.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Aoife Brennan, M.D. <sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.14%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.52%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:48.66%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Director</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(1) </span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Member of the audit committee</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(2) </span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Member of the compensation committee</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:14.4pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">(3) </span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:8pt;">Member of the nominating and corporate governance committee</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:14.4pt;text-indent:-14.4pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><a id="_Toc193224645"></a><a id="_Toc193225858"></a><a id="_Toc193708082"></a><a id="_Toc193805362"></a><a id="_Toc194481022"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Class&#160;I Director Nominees&#8212;For a Three-Year Term Expiring at the 2028 Annual Meeting of Stockholders</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Ren&#233; Russo, Pharm.D.,</span> has served as our chief executive officer and as a member of our board of directors since May 2019 and served as our president from May 2021 to August 2022 and since September 2023. Dr. Russo served as entrepreneur-in-residence at New Enterprise Associates, a venture capital firm, from November 2018 to May 2019. Prior to that, she served as president and chief executive officer of Arsanis, Inc., or Arsanis, a biopharmaceutical company, from </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-8-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">May 2016 to December 2018, and as its chief development officer from June 2015 to May 2016. Prior to joining Arsanis, Dr. Russo served in various roles of increasing responsibility over an 11-year period, culminating in her serving as vice president, global medical affairs, at Cubist Pharmaceuticals, Inc., or Cubist, a pharmaceutical development company, focused on the development and commercialization of infectious disease therapeutics, from 2004 until its acquisition by Merck Research Laboratories, a healthcare company, in May 2015. Prior to Cubist, Dr. Russo held R&amp;D roles at Bristol-Myers Squibb Company from 1999 to 2004, where she contributed to the successful development and global commercialization of multiple therapeutics. Dr. Russo served as chair of the board of directors of Invivyd, Inc. (formerly, Adagio Therapeutics, Inc.), a biotechnology company that she co-founded, from July 2020 to June 2022. Additionally, she served as a member of the board of directors of Arsanis from May 2016 to March 2019 and, following its merger with X4 Pharmaceuticals, Inc., or X4 Pharmaceuticals, served as a member of the board of directors of X4 Pharmaceuticals from March 2019 to November 2021. Dr. Russo currently serves on the board of directors of PRxCision, Inc. a private healthcare technology company, and the supervisory board of Leyden Laboratories B.V., a private biopharmaceutical company. Prior to joining the biotechnology industry, Dr. Russo held clinical positions at Robert Wood Johnson University Hospital and Princeton Hospital. Dr. Russo received her Pharm.D. and B.S. from Rutgers University and completed a post-doctoral fellowship in infectious diseases with Bristol-Myers Squibb. We believe Dr. Russo is qualified to serve on our board of directors because of her expertise and experience as our president and chief executive officer and her expertise in clinical development and commercialization of therapeutics in the life sciences industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Sara M. Bonstein</span> has served on our board of directors since August 2021. Ms. Bonstein has more than two decades of operational and financial leadership in the life sciences industry and has served as chief financial officer of Insmed, Inc., or Insmed, a biopharmaceutical company, since January 2020, where she is responsible for Insmed&#8217;s key financial functions, including accounting, financial planning and analysis, procurement, and investor relations. Prior to joining Insmed, she served as chief financial officer and chief operating officer of OncoSec Medical Incorporated, a biotechnology company, from May 2018 to January 2020 and as the chief financial officer at Advaxis, Inc., or Advaxis, a biotechnology company, from February 2014 to April 2018. In these roles, Ms. Bonstein has led multiple capital markets and licensing transactions, while establishing strong financial controls, streamlined business operations, and building high performing teams. Prior to Advaxis, Ms. Bonstein served in various finance roles of increasing responsibility, including at Eli Lilly &amp; Company and Johnson &amp; Johnson, or J&amp;J. Ms. Bonstein currently serves as a member of the board of directors of scPharmaceuticals Inc., a public pharmaceutical company. She holds a B.S. in finance from The College of New Jersey and an M.B.A. from Rider University. We believe Ms. Bonstein is qualified to serve on our board of directors because of her experience as a senior executive of several life sciences companies, including her finance and operations expertise and knowledge of the life sciences industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">James Shannon, M.D., </span>has served as a member of our board of directors since June 2024. &#160;Dr. Shannon has more than 30 years of drug development and leadership experience. From 2012 until his retirement in 2015, Dr. Shannon served as the chief medical officer of GlaxoSmithKline PLC. Prior to that, Dr. Shannon spent more than a decade with Novartis, including as global head of pharma development, where he was responsible for all of Novartis&#8217; development activities, from preclinical through Phase 4 clinical development, and oversaw an annual development budget of approximately $4 billion. Dr. Shannon currently serves as chair of the board of directors of MannKind Corporation, a public biopharmaceutical company, ProQR Therapeutics N.V., a public biotechnology company, and Kyowa Kirin (NA), a private biopharmaceutical company and subsidiary of Kyowa Kirin Co., Ltd. Dr. Shannon also serves on the board of myTomorrows, a private health technology company, and the supervisory board of Leyden Laboratories B.V., a private biopharmaceutical company. Dr. Shannon previously served on the board of directors of Horizon Therapeutics plc, a public biopharmaceutical company. &#160;Dr. Shannon is trained in Medicine and Cardiology and received his undergraduate degree and M.D. from Queen&#8217;s University in Belfast, Northern Ireland. Dr. Shannon is also a Member of the Royal College of Physicians (UK). We believe Dr. Shannon is qualified to serve on our board of directors because of his extensive experience in the life sciences and pharmaceutical industry.</p><a id="_Toc193224646"></a><a id="_Toc193225859"></a><a id="_Toc193708083"></a><a id="_Toc193805363"></a><a id="_Toc194481023"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Class&#160;II Directors&#8212;Term Expiring at the 2026 Annual Meeting of Stockholders</span></p><a id="_Hlk158889632"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Daniel Curran, M.D.,</span> has served as a member of our board of directors since December&#160;2020. He has more than 20&#160;years of pharmaceutical experience in strategy, business development, project leadership and development roles. Dr. Curran currently serves as a managing partner at Mountainfield Venture Partners, LLC, a company-creation firm, since March 2024. Previously, Dr.&#160;Curran held roles of increasing responsibility at Takeda Pharmaceutical Company&#160;Ltd., or Takeda, a pharmaceutical company, since 2008, and most recently served as a senior vice president and the head of the rare genetics and hematology therapeutic area unit from January 2019 until December 2023. Prior to Takeda, he served as vice president, </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-9-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">corporate development at Millennium Pharmaceuticals,&#160;Inc., or Millennium, a wholly owned subsidiary of Takeda, from 1999 to 2008. Prior to Millennium, Dr.&#160;Curran held a business development role in the product planning and acquisition group at DuPont Merck Pharmaceuticals, a pharmaceutical company. Dr. Curran previously served on the board of directors of Tome Biosciences, a private biotechnology company. Dr.&#160;Curran received an M.D. from the University of Pennsylvania School of Medicine, an M.B.A. from The Wharton School of the University of Pennsylvania and a B.S. in chemistry from King&#8217;s College. We believe Dr.&#160;Curran is qualified to serve on our board of directors because of his diverse experience in the life sciences industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><a id="_Hlk158889835"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Robert Ross, M.D.,</span> has served as a member of our board of directors since June 2022. <span style="background:#ffffff;">Dr. Ross currently serves as chief executive officer, president and a member of the board of directors of Clasp Therapeutics, Inc., or Clasp, a private biotechnology company, since November 2023. Prior to Clasp, Dr. Ross served as chief executive officer and a member of the board of directors of Surface Oncology, Inc., or Surface, a biotechnology company, from April 2021 until its acquisition by Coherus Biosciences, Inc. in September 2023. Dr. Ross also served as Surface&#8217;s chief medical officer from October 2016 to April 2021. Before Surface, Dr. Ross served as the head of oncology at bluebird bio, Inc., or bluebird bio, and earlier served in roles as senior vice president of clinical development and pharmacovigilance and vice president of clinical development. Prior to bluebird bio, Dr. Ross worked at Genentech and Infinity Pharmaceuticals, Inc. Dr. Ross was a Fellow in Medical Oncology and a faculty member at the Dana Farber Cancer Institute, or DFCI, from 2003 to 2007, and then he maintained a clinical practice at DFCI until 2015. Dr. Ross currently serves on the board of directors of Obsidian Therapeutics, Inc., a private biotechnology company. Dr. Ross received a B.S. in biological sciences and a B.A. in philosophy from Stanford University, an M.S. in medical science from Harvard Medical School and an M.D. from Columbia University College of Physicians and Surgeons. He completed his residency training in Internal Medicine at the University of California, San Francisco.</span> We believe Dr. Ross is qualified to serve on our board of directors because of his experience as a biopharmaceutical executive with more than 25 years of experience and his diverse experience in the life sciences industry.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Yuan Xu, Ph.D.,</span> has served as a member of our board of directors since January 2022. Dr. Xu served as chief executive officer at Legend Biotech Corporation, or Legend Biotech, a biotechnology company, from March 2018 to August 2020. In this capacity, she played a leading role in Legend Biotech&#8217;s initial public offering, global clinical development of Legend Biotech&#8217;s autologous CAR T-cell therapy CARVYKTI&#174; (ciltacabtagene autoleucel) and a strategic partnership with Janssen Biotech, Inc. Prior to joining Legend Biotech, she served as senior vice president at Merck &amp; Co., Inc., or Merck, from August 2015 to August 2017, where she led discovery, preclinical and technical development, and manufacturing for Merck&#8217;s biologics and vaccines subdivision. Prior to that, Dr. Xu served as general manager and vice president of biologics at Gilead Sciences, or Gilead, from March 2014 to August 2015, where she led biologics and vaccines development and oversaw all operational aspects of Gilead&#8217;s Oceanside manufacturing facility as site head. Prior to Gilead, Dr. Xu served as vice president at Novartis and led several functions in the U.S. and Europe, including the biotherapeutics development unit focusing on innovative medicines. Earlier in her career, Dr. Xu held positions of increasing responsibility at Amgen Inc., Chiron, Inc., GlaxoSmithKline PLC and Genentech Inc. Dr. Xu currently serves as a member of the boards of directors of Fate Therapeutics, Inc., a public biotechnology company, and Akero Therapeutics, Inc., a public biotechnology company. Dr. Xu received a B.S. in biochemistry from Nanjing University and a Ph.D. in biochemistry from the University of Maryland, and she completed her post-doctoral training in virology and gene therapy at the University of California, San Diego. We believe Dr. Xu is qualified to serve on our board of directors because of her experience as a biopharmaceutical executive with more than 25 years of experience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Class III Directors-Term Expiring at the 2027 Annual Meeting of Stockholders</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Paul J. Clancy</span> has served on our board of directors since July 2020 and has served as chair of our board of directors since June 2022. Mr. Clancy has more than 35 years of experience in financial management and strategic business planning. Mr. Clancy served as executive vice president, senior advisor of Alexion Pharmaceuticals, Inc., or Alexion, a biopharmaceutical company, from November 2019 to July 2020, and as chief financial officer of Alexion from July 2017 to October 2019. Prior to Alexion, Mr. Clancy served as the executive vice president and chief financial officer at Biogen Inc. (formerly known as Biogen Idec), or Biogen, a biopharmaceutical company, since 2007. He also served as senior vice president of finance of Biogen Idec, with responsibilities for leading the treasury, tax, investor relations, and business planning groups. Prior to the merger of Biogen and Idec Pharmaceutical Corporation, Mr. Clancy was the vice president of portfolio management at Biogen. He joined Biogen in 2001 as vice president of U.S. marketing. Before Biogen, Mr. Clancy spent 13 years at PepsiCo Inc., a food and beverage company, serving in a variety of finance, strategy, and general management positions. Mr. Clancy serves as chair of the board of directors of Sionna Therapeutics, Inc., a public </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-10-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">biopharmaceutical company, and as a member of the boards of directors of Incyte Corporation, a public pharmaceutical company, and of Exact Sciences Corporation, a public cancer diagnostics company. Mr. Clancy served as a member of the board of directors of Agios Pharmaceuticals, Inc., a public pharmaceutical company, from September 2013 to June 2023. Mr. Clancy is a Senior Visiting Lecturer of Finance at Cornell University&#8217;s Graduate School of Business. Mr. Clancy received a B.S. in business administration from Babson College and an M.B.A. from Columbia Business School. We believe Mr. Clancy is qualified to serve on our board of directors because of his extensive financial and executive leadership experience at large multinational companies.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Aoife Brennan, M.D., </span>has served as a member of our board of directors since June 2024. Dr. Brennan has over 16 years of industry leadership and drug development experience and currently serves as chief executive officer, president and a member of the board of directors of Climb Bio, Inc. (formerly Eliem Therapeutics, Inc.), or Climb Bio, since June 2024. Prior to Climb Bio, Dr. Brennan served as chief executive officer, president and a member of the board of directors of Synlogic, Inc., or Synlogic, from October 2018 until March 2024, and previously served as its chief medical officer from September 2016 until October 2018. Prior to joining Synlogic, Dr. Brennan was vice president and head of the Rare Disease Innovation Unit at Biogen Inc., where she was responsible for research and development for programs ranging from preclinical to commercial-stage within Biogen&#8217;s rare disease portfolio. Dr. Brennan also currently serves on the board of directors of FibroGen, Inc., a public biopharmaceutical company, and Cerevance, LLC, a private pharmaceutical company. Dr. Brennan served as a member of the board of directors of RA Pharmaceuticals, Inc., a public pharmaceutical company, from September 2018 to April 2020. Dr. Brennan received her medical degree from Trinity College in Dublin, Ireland and completed her post-graduate training in internal medicine, endocrinology and metabolism at the Royal College of Physicians in Ireland. In addition, she completed post-doctoral training in clinical research and metabolism at the Beth Israel Deaconess Medical Center in Boston and is a graduate of the Harvard Medical School Scholars in Clinical Science Program. We believe Dr. Brennan is qualified to serve on our board of directors because of her extensive experience with drug development, executive leadership, and prior board experience.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Christina Rossi</span> has served as a member of our board of directors since April 2021. Ms. Rossi has served as chief operating officer of Blueprint Medicines Corporation, or Blueprint, a biopharmaceutical company, since April 2022, and from October 2018 to April 2022, Ms. Rossi served as chief commercial officer of Blueprint. From January 2016 to October 2018, Ms. Rossi served as the Multiple Sclerosis business unit head, North America, at Sanofi Genzyme, or Sanofi, a biotechnology company. Previously, Ms. Rossi served as vice president, Multiple Sclerosis Sales at Sanofi from May 2014 to December 2015 and vice president, Multiple Sclerosis Patient and Provider Services at Sanofi from June 2012 to May 2014. Prior to joining Sanofi, Ms. Rossi served in various roles at Biogen, including head, commercial strategy for Eidetica Biopharma GmbH, Biogen&#8217;s biosimilar-focused venture, and U.S. brand leader for TYSABRI&#174; (natalizumab). In addition, Ms. Rossi consulted in the healthcare practice at the Boston Consulting Group. Ms. Rossi holds a B.S. in biology, cum laude, from Duke University and an M.B.A. from Harvard Business School. We believe Ms. Rossi is qualified to serve on our board of directors because of her experience as a senior executive of several life sciences companies and knowledge of the life sciences industry.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-transform:uppercase;">OUR board of directors recommends voting &#8220;</b><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;text-transform:uppercase;">FOR</span><b style="font-weight:bold;text-transform:uppercase;">&#8221; the election of </b><b style="font-weight:bold;text-transform:uppercase;">REN&#201; RussO, sara M. bonstein AND JAMES SHANNON </b><b style="font-weight:bold;text-transform:uppercase;">TO serve as Class&#160;I directors for a three-year term ending at the annual meeting of stockholders to be held in 2028</b><span style="text-transform:uppercase;">.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-11-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_Toc192636843"></a><a id="_Toc192257192"></a><a id="_Toc193222798"></a><a id="_Toc194481024"></a><a id="_aa9e484e_2f7e_44dc_924c_26f59f138911"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PROPOSAL NO. 2&#8212;AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:10.0pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Background</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:10.0pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We are asking our stockholders to approve an amendment to our certificate of incorporation to increase the number of authorized shares of our common stock. Our certificate of incorporation currently authorizes 205,000,000 shares of capital stock, consisting of 200,000,000 shares of common stock, $0.0001 par value per share, and 5,000,000 shares of preferred stock, $0.0001 par value per share. On April 14, 2025, our board of directors approved, subject to stockholder approval, an amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 200,000,000 shares to 600,000,000 shares and, correspondingly, to increase the number of authorized shares of our capital stock from 205,000,000 shares to 605,000,000 shares. The additional 400,000,000 shares of common stock authorized for issuance pursuant to the proposed share increase amendment would be part of the existing class of common stock and, if and when issued, would have the same rights and privileges as the shares of common stock presently issued and outstanding. The holders of common stock are not entitled to preemptive rights or cumulative voting. The proposed amendment would not increase or otherwise affect our authorized preferred stock.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:10.0pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of March 31, 2025, out of the 200,000,000 shares of common stock presently authorized, 57,258,635 shares remained available for future issuance and 142,741,365 shares were issued or reserved for issuance, as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">51,775,264 shares of common stock are outstanding;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">10,857,092 shares of common stock are issuable upon the exercise of outstanding stock options pursuant to our 2020 Stock Incentive Plan, our 2021 Stock Incentive Plan, or the 2021 Plan, and our Amended and Restated 2022 Inducement Stock Incentive Plan, or the 2022 Inducement Plan;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">334,125 shares of common stock are issuable upon the vesting of outstanding restricted stock units pursuant to the 2021 Plan;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">2,217,457 shares of common stock are reserved for future issuance under the 2021 Plan;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">1,359,889 shares of common stock are reserved for future issuance under our 2021 Employee Stock Purchase Plan;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">592,200 shares of common stock are reserved for future issuance under the 2022 Inducement Plan; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">25,605,338 shares of common stock are issuable upon exercise of outstanding warrants and pre-funded warrants to purchase shares of our common stock; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">50,000,000 shares of common stock are reserved for sale and issuance pursuant to an &#8220;at-the-market offering&#8221; under the Sales Agreement, dated March 11, 2025, by and between us and Leerink Partners LLC, as agent.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-12-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Overview of the Proposed Amendment </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A copy of the amendment to our certificate of incorporation is attached as Appendix A to this proxy statement. The proposed amendment provides that Article Fourth of our certificate of incorporation be deleted in its entirety and replaced by the following (which is marked to show changes from the current provision):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 36pt;">FOURTH: The total number of shares of all classes of stock that the Corporation shall have authority to issue is <span style="text-decoration-line:line-through;text-decoration-style:solid;">205,000,000 </span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">605,000,000</span> shares, consisting of (i) <span style="text-decoration-line:line-through;text-decoration-style:solid;">200,000,000 </span><span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">600,000,000</span> shares of common stock, $0.0001 par value per share (&#8220;Common Stock&#8221;), and (ii) 5,000,000 shares of Preferred Stock, $0.0001 par value per share (&#8220;Preferred Stock&#8221;).</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">The proposed amendment, if approved by our stockholders, would become effective upon the filing of a certificate of amendment of our certificate of incorporation with the Secretary of State of the State of Delaware. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">Our board of directors reserves the right, notwithstanding stockholder approval and without further action by stockholders, to elect not to proceed with the proposed amendment if the board of directors determines that the proposed amendment is no longer in our best interests and the best interests of our stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 12pt 0pt;">If our stockholders approve the proposed amendment, subject to the discretion of our board of directors, we intend to file the certificate of amendment of our certificate of incorporation with the Secretary of State of the State of Delaware as soon as practicable after the 2025 annual meeting of stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Rationale for the Proposed Amendment </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our board of directors believes that it is in our best interests to increase the number of authorized shares of common stock in order to give us greater flexibility in considering and planning for potential business needs. Over the past several years, we have used shares of our common stock to, among other things, engage in financings, incentivize and compensate employees and other service providers and for other general corporate purposes. The increase in the number of authorized but unissued shares of common stock would enable us, without the expense and delay of seeking stockholder approval, to issue shares from time to time as may be required for proper business purposes. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We anticipate that we may issue additional shares of common stock in the future in connection with one or more of the following: </p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">our equity incentive plans;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">financing transactions, such as public or private offerings of common stock or convertible securities;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">licenses, partnerships, collaborations and other similar transactions;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">strategic investments and transactions; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">other corporate purposes that have not yet been identified.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">At this time, other than shares that will be reserved for issuance under our existing incentive plans, employee stock purchase plan, and &#8220;at the market&#8221; equity offering program, we do not have any plans, proposals or arrangements, written or oral, to issue any of the proposed additional authorized shares of common stock for general corporate or any other purposes. Because our directors and executive officers have outstanding equity awards under our incentive plans, and may be granted additional equity awards under these plans, they may be deemed to have an indirect interest in the share increase amendment because, absent the amendment, we may not have sufficient authorized shares to make future awards. However, our board of directors believes that the availability of additional authorized shares of our common stock will afford us needed flexibility in acting upon financing transactions to strengthen our financial position and/or engaging in strategic activities without using cash. Unless required by applicable law or stock exchange rules, no further vote of the holders of common stock will be required with respect to any such transaction. </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-13-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Potential Effects of the Proposed Amendment </b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The additional shares of common stock for which authorization is sought would be identical in powers, privileges and rights to the shares of common stock that are now authorized. Holders of common stock do not have preemptive rights to subscribe to additional securities that we may issue.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The issuance of additional shares of common stock may, among other things, have a dilutive effect on earnings per share and on stockholders&#8217; equity and voting rights. Furthermore, future sales of substantial amounts of our common stock, or the perception that these sales might occur, could adversely affect the prevailing market price of our common stock or limit our ability to raise additional capital. Stockholders should recognize that, as a result of this proposal, they will own a smaller percentage of shares relative to the total authorized shares of the Company than they presently own. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our board of directors has not proposed the increase in the amount of authorized shares with the intention of discouraging tender offers or takeover attempts. However, the availability of additional authorized shares for issuance may have the effect of discouraging a merger, tender offer, proxy contest or other attempt to obtain control. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:10.0pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-transform:uppercase;">OUR board of directors recommends voting &#8220;</b><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;text-transform:uppercase;">FOR</span><b style="font-weight:bold;text-transform:uppercase;">&#8221; </b><b style="font-weight:bold;">THE APPROVAL OF AN AMENDMENT TO </b><b style="font-weight:bold;">OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF OUR COMMON STOCK.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-14-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc192257193"></a><a id="_Toc192636844"></a><a id="_Hlk192849100"></a><a id="_Toc193222799"></a><a id="_Toc194481025"></a><a id="_f03a2a2f_4499_46fb_a1fd_24cbbc150569"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;padding-bottom:12pt;text-align:center;margin:0pt;">PROPOSAL NO. 3&#8212;AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO REFLECT DELAWARE LAW PROVISIONS REGARDING OFFICER EXCULPATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">We are asking our stockholders to approve an amendment to our certificate of incorporation to update our existing director exculpation provision to include certain of our senior corporate officers. Article Seventh of our certificate of incorporation currently provides for exculpation of directors in certain circumstances pursuant to and consistent with Section 102(b)(7) of the Delaware General Corporation Law, or the DGCL. Effective August 1, 2022, that provision of the DGCL was amended to permit eliminating or limiting monetary liability for certain senior corporate officers in limited circumstances. On April 14, 2025, our board of directors approved and declared advisable an amendment to our certificate of incorporation to update the exculpation provision and recommends that our stockholders approve the proposed amendment. &#160;If the stockholders approve this proposal, we will file a certificate of amendment to our certificate of incorporation adding the new language included below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;"><b style="font-weight:bold;">Overview of the Proposed Amendment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 12pt 0pt;">Consistent with Delaware law, the proposed amendment to our certificate of incorporation relating to officers is more limited in scope than the existing director exculpation provision and only permits exculpation of officers for certain direct claims. Further, the proposed amendment does <span style="text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">not</span> permit officers to be exculpated for liability arising out of:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">claims brought by Xilio itself; </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">claims brought by stockholders in the name of Xilio (derivative claims);</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">breaches of the duty of loyalty to Xilio or our stockholders;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">acts or omissions not in good faith;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">acts or omissions that involve intentional misconduct;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">acts or omissions that involve a knowing violation of law; or</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;width:100%;border:0pt;"><tr><td style="width:18.7pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any transaction in which the officer derived an improper personal benefit.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 12pt 0pt;">In accordance with Delaware law, the officers who will be covered by the expanded exculpation provision include our president; chief executive officer; chief operating officer; chief financial officer; chief legal officer; controller; treasurer; or chief accounting officer; any officer who is or was identified in our public filings with the SEC as one of the most highly compensated executive officers; and any officers who consent to being identified as an officer for purposes of service of process, at any time during the course of conduct alleged in the action or proceeding to be wrongful. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;">Rationale for the Proposed Amendment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">The State of Delaware, which is our state of incorporation, recently enacted legislation that authorizes Delaware corporations to limit the liability of certain of their officers in the limited circumstances described above. As a result of this development, we propose expanding our existing director exculpation provision to cover officers to the extent now permitted by Delaware law. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">Our board of directors&#8217; rationale for recommending this amendment is to balance stockholders&#8217; interest in accountability with their interest in attracting and retaining the highest quality officers and avoiding litigation abuse resulting from the current disparity that exists in the treatment of directors, who oversee and are ultimately accountable for corporate actions, and the officers who execute those actions on behalf of the board of directors. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt;">Our board of directors considered that the role of directors and officers requires them to make decisions on crucial matters in response to time-sensitive opportunities and challenges, which can create substantial risk of investigations, claims, actions, suits or proceedings seeking to impose liability on the basis of hindsight, especially in the current litigious environment and regardless of the absence of any underlying merit. This amendment will better align the protections </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-15-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">available to our officers with those currently available to our directors and avoid the practice among some plaintiff&#8217;s lawyers of adding officers to direct claims relating to the duty of care in M&amp;A-related and other litigation so that claims against the officers continue even when identical claims against directors are dismissed. The board of directors believes that limiting concern about personal liability will empower officers to best exercise their business judgment in furtherance of stockholder interests without the distraction of potentially being subject to claims following actions taken in good faith. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-bottom:12pt;text-align:justify;background:#ffffff;margin:0pt;">In addition, other companies with which we compete for employees have adopted exculpation clauses that limit the personal liability of officers as now permitted by the DGCL. The board of directors believes that failing to adopt the proposed amendment will impact recruitment and retention of exceptional officer candidates who conclude that the potential exposure to liabilities, costs of defense and other risks of proceedings exceeds the benefits of serving as an officer of Xilio as compared to serving as an officer at another company that does exculpate officers. &#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;background:#ffffff;margin:0pt 0pt 12pt 0pt;">Further, our board of directors noted that the proposed provision would not eliminate stockholders&#8217; right to pursue derivative claims relating to alleged breaches of the duty of care or limit the ability of Xilio itself to bring claims against officers. Therefore, taking into account the narrow class and type of claims for which officers&#8217; liability would be exculpated, our board of directors believes the proposed amendment would enhance the ability to attract and retain talented officers, potentially reduce litigation costs associated with frivolous lawsuits, and more generally align the protections available to our officers with those currently available to our directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Based on the above, our board of directors determined that it is in our best interests and that of our stockholders to amend the certificate of incorporation as described in this proposal.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Text of Proposed Amendment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Accordingly, we ask our stockholders to vote on the following resolution:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">RESOLVED, that the Company&#8217;s stockholders approve an amendment to the Company&#8217;s certificate of incorporation to replace the existing Article Seventh with the following (which is marked to show changes from the current director exculpation provision):</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">ARTICLE SEVENTH</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;line-height:1.07;text-align:justify;margin:0pt 72pt 12pt 36pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">To the fullest</b> <span style="text-decoration-line:line-through;text-decoration-style:solid;">Except to the</span> extent <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">permitted by</b> <span style="text-decoration-line:line-through;text-decoration-style:solid;">that </span>the General Corporation Law of the State of Delaware <span style="text-decoration-line:line-through;text-decoration-style:solid;">prohibits the elimination or limitation of liability of directors for breaches of fiduciary duty</span>, no director <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">or officer</b><b style="font-weight:bold;"> </b>of the Corporation shall be personally liable to the Corporation <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">(in the case of directors) </b>or its stockholders <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">(in the case of directors and officers) </b>for monetary damages for any breach of fiduciary duty as a director <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">or officer</b><span style="text-decoration-line:line-through;text-decoration-style:solid;">, notwithstanding any provision of law imposing such liability</span>. &#160;No amendment, repeal or elimination of this provision shall apply to or have any effect on its application with respect to any act or omission of a director <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">or officer </b>occurring before such amendment, repeal or elimination. &#160;If the General Corporation Law of the State of Delaware is amended to permit further elimination or limitation of the personal liability of directors <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">or officers</b>, then the liability of a director <b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">or officer </b>of the Corporation shall be eliminated or limited to the fullest extent permitted by the General Corporation Law of the State of Delaware as so amended.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-16-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Effectiveness of the Proposed Amendment</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our officers would receive the protections from liability afforded by the proposed amendment effective upon the filing of a certificate of amendment to our certificate of incorporation with the Secretary of State of the State of Delaware, which we anticipate doing as soon as practicable following stockholder approval of the proposed amendment. Our board of directors, however, reserves the right to abandon the proposed amendment at any time before it becomes effective, even if it is approved by the stockholders. If our stockholders do not approve the proposed amendment, Article Seventh of the certificate of incorporation will remain unchanged, our officers will not be entitled to exculpation as permitted under the DGCL, and the certificate of amendment setting forth the proposed amendment will not be filed with the Secretary of State of the State of Delaware.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><b style="font-weight:bold;text-transform:uppercase;">OUR board of directors recommends voting &#8220;</b><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;text-transform:uppercase;">FOR</span><b style="font-weight:bold;text-transform:uppercase;">&#8221; </b><b style="font-weight:bold;">THE APPROVAL OF AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO</b><b style="font-weight:bold;"> REFLECT DELAWARE LAW PROVISIONS REGARDING OFFICER EXCULPATION.</b><span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-17-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:11.5pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc192636845"></a><a id="_Toc192257194"></a><a id="_Toc193222800"></a><a id="_Toc194481026"></a><a id="_48c84f53_72eb_47ac_b2c6_8471d2e95959"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">PROPOSAL NO. 4&#8212;RATIFICATION OF THE SELECTION OF<br/>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our audit committee has selected the firm of Ernst &amp; Young LLP, an independent registered public accounting firm, as independent auditors for the fiscal year ending December 31, 2025. Although stockholder approval of our audit committee&#8217;s selection of Ernst &amp; Young LLP is not required by law, our board of directors believes that it is advisable to give stockholders an opportunity to ratify this selection. If this proposal is not approved at the annual meeting, our audit committee will consider whether it is appropriate to select another independent registered public accounting firm. Even if the selection is ratified, the audit committee in its discretion may select a different registered public accounting firm at any time during the year if it determines such a change would be in the best interests of the company and our stockholders. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Representatives of Ernst &amp; Young LLP are expected to be present at the annual meeting online and will have the opportunity to make a statement, if they desire to do so, and will be available to respond to appropriate questions from our stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Audit Fees and Services</b></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Fee Category</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.95%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2024</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="2" style="vertical-align:bottom;white-space:nowrap;width:13.93%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2023</b></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Audit fees<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 752,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 675,000</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Audit related fees<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Tax fees<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 19,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">All other fees<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:67.62%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 6pt;">Total Fees</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.24%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 772,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.46%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 675,000</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:10.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">(1) &#8220;Audit fees&#8221; consist of fees for the audit of our annual financial statements, the review of the interim financial statements included in our quarterly reports on Form 10-Q and other professional services provided in connection with regulatory filings or engagements.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">(2) &#8220;Audit-Related Fees&#8221; consist of fees billed by Ernst &amp; Young LLP for assurance and related services that are reasonably related to the performance of the audit or review of our consolidated financial statements. There were no such fees incurred in 2024 or 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">(3) &#8220;Tax Fees&#8221; consist of fees for professional services, including tax-related compliance, advice and planning services performed by Ernst &amp; Young LLP. Tax fees for 2024 consist of professional services related to a study of our inception to date ownership change activity under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended. There were no tax fees incurred in 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 12pt 0pt;">(4) There were no &#8220;other fees&#8221; incurred in 2024 or 2023.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Pre-Approval Policy and Procedures</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our audit committee has adopted policies and procedures relating to the approval of all audit and non-audit services that are to be performed by our independent registered public accounting firm. This policy provides that we will not engage our independent registered public accounting firm to render audit or non-audit services unless the service is specifically approved in advance by our audit committee, or the engagement is entered into pursuant to the pre-approval procedure described below.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">From time to time, our audit committee may pre-approve specified types of services that are expected to be provided to us by our independent registered public accounting firm during the next fiscal quarter. Any such pre-approval is detailed as to the particular service or type of services to be provided and is also generally subject to a maximum dollar amount.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">During our 2024 and 2023 fiscal years, no services were provided to us by Ernst &amp; Young LLP other than in accordance with the pre-approval policies and procedures described above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-transform:uppercase;">OUR board of directors recommends voting &#8220;</b><span style="font-style:italic;font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;text-transform:uppercase;">FOR</span><b style="font-weight:bold;text-transform:uppercase;">&#8221; the RATIFICATION OF THE SELECTION of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-18-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc194481027"></a><a id="_Toc193222801"></a><a id="_ea2e4050_7f5b_468f_ba1a_0926c004267e"></a><a id="CORPORATEGOVERNANCE_644861"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 8pt 0pt;">CORPORATE GOVERNANCE</p><a id="_Toc193224651"></a><a id="_Toc193225864"></a><a id="_Toc193708088"></a><a id="_Toc193805369"></a><a id="_Toc194481028"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 9pt 0pt;">Director Nomination Process</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Our nominating and corporate governance committee of the board of directors is responsible for identifying and evaluating individuals qualified to serve as directors, consistent with criteria approved by our board, and recommending the persons to be nominated for election as directors, except where we are legally required by contract, law or otherwise to provide third parties with the right to nominate director candidates. Our nominating and corporate governance committee establishes the process for identifying and evaluating director candidates, which generally includes initially seeking recommendations from our board of directors and members of management. Dr. Shannon, who was first elected as a director in 2024, was initially introduced to the nominating and corporate governance committee by another member of our board of directors. The nominating and corporate governance committee reviews the qualifications, experience, and background of candidates and selects the candidates. The committee may elect to use a third-party search firm in situations where particular qualifications or expertise are required or where existing contacts are not sufficient to identify an appropriate candidate. Final candidates are interviewed by the members of the nominating and corporate governance committee, and all members of the board of directors are also given the opportunity to meet with the candidate and provide their feedback. After review and deliberation of all feedback and data, the nominating and corporate governance committee makes its recommendation to our board of directors. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Board Member Selection Criteria</span><span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">Our board of directors aspires to have a board that, taken as a whole, embodies a broad spectrum of skills, experiences and backgrounds. Accordingly, the board strives to attract potential nominees with different skills, experiences and backgrounds in the candidate pool from which the nominating and corporate governance committee recommends candidates. Our nominating and corporate governance committee&#8217;s and our board of directors&#8217; priority in selecting board members is identification of persons who will further the interests of our stockholders.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">In considering whether to recommend to our board of directors any particular candidate for inclusion in our board of directors&#8217; slate of recommended director nominees, including candidates recommended by stockholders, the nominating and corporate governance committee applies the criteria set forth in our corporate governance guidelines. These criteria include the candidate&#8217;s reputation for integrity, honesty, and adherence to high ethical standards, demonstrated business acumen and experience, ability to exercise sound judgement in matters that relate to our current and long-term objectives, willingness to participate in meetings and contribute positively to our decision-making process, commitment to understanding our company and our industry, and the ability to understand the sometimes conflicting interests of our stakeholders and to act in the interests of all of our stockholders. In addition, nominees should not have, nor appear to have, a conflict of interest that would impair the nominee&#8217;s ability to represent the interests of all stockholders and to fulfill the responsibilities of a director.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">The director biographies included in this proxy statement indicate each nominee&#8217;s experience, qualifications, attributes and skills that led our nominating and corporate governance committee and our board of directors to conclude such individual should continue to serve as a director. Our nominating and corporate governance committee and our board of directors believe that each of the nominees has the individual attributes and characteristics required of each of our directors, and the nominees as a group possess the skill sets and specific experience desired of our board of directors as a whole.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stockholder Nominations</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Stockholders may recommend individuals to the nominating and corporate governance committee for consideration as potential director candidates. Any such proposals must be submitted to our corporate secretary at our principal executive offices in accordance with the procedures and deadlines referenced below under the heading &#8220;Stockholder Proposals for our 2026 annual meeting.&#8221; For such recommendation to be considered, the nominating stockholder must comply with the procedural requirements and provide the specific information required by our bylaws, which includes, without limitation, appropriate biographical information and background materials to allow the nominating and corporate governance committee to properly evaluate the potential director candidate, information with respect to the stockholder or group of stockholders proposing the candidate, including the number of shares of common stock owned by such stockholder or group of stockholders, as well as other information required by our bylaws or SEC regulations. </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-19-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">Assuming that the required information has been provided on a timely basis, any recommendations received from stockholders will be evaluated in the same manner as potential nominees proposed by the nominating and corporate governance committee. If our board of directors decides to nominate a stockholder-recommended candidate and recommends his or her election, then his or her name will be included on our proxy card for the next annual meeting.</p><a id="_Toc193224652"></a><a id="_Toc193225865"></a><a id="_Toc193708089"></a><a id="_Toc193805370"></a><a id="_Toc194481029"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 9pt 0pt;">Director Independence</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">Under the listing rules of Nasdaq, independent directors must comprise a majority of a listed company&#8217;s board of directors within one&#160;year of listing. In addition, the Nasdaq listing rules&#160;require that, subject to specified exceptions, each member of a listed company&#8217;s audit, compensation, and nominating and corporate governance committees be independent under the Securities Exchange Act of 1934, as amended, or the Exchange Act. Under applicable Nasdaq rules, a director will only qualify as an &#8220;independent director&#8221; if, in the opinion of the listed company&#8217;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">Audit committee members must also satisfy the independence criteria set forth in Rule&#160;10A-3 under the Exchange Act. In order to be considered independent for purposes of Rule&#160;10A-3, a member of an audit committee of a listed company may not, other than in his or her capacity as a member of the audit committee, the board of directors or any other board committee, accept, directly or indirectly, any consulting, advisory or other compensatory fee from the listed company or any of its subsidiaries or otherwise be an affiliated person of the listed company or any of its subsidiaries. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">In addition, compensation committee members must also satisfy the independence criteria set forth in Rule&#160;10C-1 under the Exchange Act. In affirmatively determining the independence of any director who will serve on a company&#8217;s compensation committee, Rule 10C-1 under the Exchange Act requires that the board must consider, for each member of a compensation committee, all factors specifically relevant to determining whether a director has a relationship to such company which is material to that director&#8217;s ability to be independent from management in connection with the duties of a compensation committee member, including, but not limited to: (1)&#160;the source of compensation of the director, including any consulting advisory or other compensatory fee paid by such company to the director; and (2)&#160;whether the director is affiliated with the company or any of its subsidiaries or affiliates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In March 2025, our board of directors undertook a review of the composition of our board of directors and its committees and the independence of each director. Based upon information requested from and provided by each director concerning his or her background, employment and affiliations, including family relationships, our board of directors has determined that each of our directors, with the exception of Dr.&#160;Russo, is an &#8220;independent director&#8221; as defined under applicable Nasdaq rules, including, in the case of all the members of our audit committee, the independence criteria set forth in Rule&#160;10A-3 under the Exchange Act, and in the case of all the members of our compensation committee, the independence criteria set forth in Rule&#160;10C-1 under the Exchange Act. In making such determination, our board of directors considered the relationships that each such non-employee director has with our company and all other facts and circumstances that our board of directors deemed relevant in determining his or her independence, including the beneficial ownership of our capital stock by each non-employee director. Dr.&#160;Russo is not an independent director under these rules&#160;because she is our president and chief executive officer.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><a id="_Toc193224653"></a><a id="_Toc193225866"></a><a id="_Toc193708090"></a><a id="_Toc193805371"></a><a id="_Toc194481030"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 9pt 0pt;">Board Committees</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">Our board of directors has established an audit committee, a compensation committee, and a nominating and corporate governance committee. Each of these committees operates under a written charter. A current copy of each committee&#8217;s charter is posted on the &#8220;Corporate Governance&#8221; section of the &#8220;Investors&#160;&amp; Media&#8221; section of our website, which is located at https://ir.xiliotx.com. Our board of directors also appoints from time-to-time ad hoc committees to address specific matters.</p><a id="_Toc193224654"></a><a id="_Toc193225867"></a><a id="_Toc193708091"></a><a id="_Toc193805372"></a><a id="_Toc194481031"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Audit Committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The current members of our audit committee are Sara M. Bonstein, Aoife Brennan, M.D., and Christina Rossi. Ms. Bonstein serves as chair of the audit committee. Our audit committee met five times during 2024. Our audit committee&#8217;s responsibilities include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">selecting, appointing, approving the compensation of, and assessing the independence of our registered public accounting firm;</span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-20-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">overseeing the work of our independent registered public accounting firm, including through the receipt and consideration of reports from such firm;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and discussing with management and our independent registered public accounting firm our annual and quarterly financial statements and related disclosures;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">monitoring our internal control over financial reporting, disclosure controls and procedures, compliance, and code of business conduct and ethics;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">overseeing our internal audit function;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">overseeing our risk assessment and risk management policies, including discussing with management our guidelines and policies that govern the process by which we manage our exposure to cybersecurity risks;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">establishing policies regarding hiring employees from our independent registered public accounting firm and procedures for the receipt and retention of accounting related complaints and concerns;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">meeting independently with our internal auditing staff, if any, our independent registered public accounting firm and management;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and approving or ratifying any related person transactions; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">preparing the audit committee report required by SEC rules.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">All audit and non-audit services, other than <i style="font-style:italic;">de minimis</i> non-audit services, to be provided to us by our independent registered public accounting firm must be approved in advance by our audit committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our board of directors has determined that Ms.&#160;Bonstein is an &#8220;audit committee financial expert&#8221; as defined in applicable SEC rules. We believe that the composition of our audit committee meets the requirements for independence under current Nasdaq and SEC rules&#160;and regulations. Our board of directors has also determined that each member of our audit committee can read and understand fundamental financial statements, in accordance with applicable Nasdaq requirements. In arriving at these determinations, the board of directors has examined each audit committee member&#8217;s scope of experience and the nature of their employment in the corporate finance sector. The audit committee may form and delegate authority to one or more subcommittees as it deems appropriate from time to time under the circumstances.</p><a id="_Toc193224655"></a><a id="_Toc193225868"></a><a id="_Toc193708092"></a><a id="_Toc193805373"></a><a id="_Toc194481032"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Compensation Committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The current members of our compensation committee are Christina Rossi, Paul Clancy and Robert Ross, M.D. Ms. Rossi serves as chair of the compensation committee. Our compensation committee met three times during 2024. Our compensation committee&#8217;s responsibilities include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and approving, or making recommendations to our board of directors with respect to, the compensation of our chief executive officer and our other executive officers;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">overseeing an evaluation of our senior executives;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">overseeing and administering our cash and equity incentive plans and our policies and practices regarding the timing of equity grants in relation to the release of material nonpublic information, as well as our executive compensation clawback policy;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and making recommendations to our board of directors with respect to non-employee director compensation;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and discussing annually with management our &#8220;Compensation Discussion and Analysis&#8221; disclosure, if and to the extent required by SEC rules; and</span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-21-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">preparing the compensation committee report if and to the extent then required by SEC rules.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We believe that the composition of our compensation committee meets the requirements for independence under current Nasdaq and SEC rules&#160;and regulations. The compensation committee may form and delegate authority to one or more subcommittees as it deems appropriate from time to time under the circumstances (including (a)&#160;a subcommittee consisting of a single member and (b)&#160;a subcommittee consisting of at least two members, each of whom qualifies as a &#8220;non-employee director,&#8221; as such term is defined from time to time in Rule&#160;16b-3 promulgated under the Exchange Act and the rules&#160;and regulations thereunder). As part of determining the performance and compensation of our named executive officers and directors, our compensation committee receives recommendations from our chief executive officer (except with respect to her own performance and compensation). Our chief executive officer&#8217;s performance and compensation is approved by our board of directors based upon the recommendation of our compensation committee. No member of the management team, including our chief executive officer, has a role in determining his or her own compensation. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">The compensation committee has the authority, in its sole discretion, to retain or obtain, at our expense, the advice of compensation consultants, legal counsel or other advisors to assist the compensation committee in performing its responsibilities. In 2024, the compensation committee used the services of Aon&#8217;s Human Capital Solutions practice, a division of Aon plc, or Aon (formerly known as Radford) to provide analysis and recommendations to the compensation committee regarding cash and equity compensation for our executive officers and directors. Aon was retained exclusively by the compensation committee and has not been retained by management to perform any work for the company other than projects performed at the direction of the compensation committee. Aon reports to the compensation committee and not to management, although it meets with management for purposes of gathering information for its analyses and recommendations. Representatives of Aon attend regular meetings of the compensation committee, including executive sessions from time to time without any members of management present. The compensation committee has assessed the independence of Aon pursuant to SEC and Nasdaq rules and concluded that no conflict of interest exists that would prevent Aon from independently representing the compensation committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><a id="_Toc193224656"></a><a id="_Toc193225869"></a><a id="_Toc193708093"></a><a id="_Toc193805374"></a><a id="_Toc194481033"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Nominating and Corporate Governance Committee</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The current members of our nominating and corporate governance committee are Daniel Curran, M.D., James Shannon, M.D. and Yuan Xu, Ph.D. Dr. Curran serves as chair of the nominating and corporate governance committee. Our nominating and corporate governance committee met two times during 2024. Our nominating and corporate governance committee&#8217;s responsibilities include:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">recommending to our board of directors the persons to be nominated for election as directors and to each of our board&#8217;s committees;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and making recommendations to our board of directors with respect to our board&#8217;s leadership structure;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">reviewing and making recommendations to our board with respect to management succession planning;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">developing and recommending corporate governance principles to our board of directors; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">overseeing an annual evaluation of our board of directors.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We believe that the composition of our nominating and corporate governance committee meets the requirements for independence under current Nasdaq and SEC rules&#160;and regulations. The nominating and corporate governance committee may form and delegate authority to one or more subcommittees as it deems appropriate from time to time under the circumstances.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-22-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc193224657"></a><a id="_Toc193225870"></a><a id="_Toc193708094"></a><a id="_Toc193805375"></a><a id="_Toc194481034"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Board of Director Meetings and Attendance</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our board of directors recognizes the importance of director attendance at board and committee meetings. The full board of directors met seven times during 2024. During 2024, each member of the board of directors attended in person or participated in 75% or more of the aggregate of (i)&#160;the total number of meetings held by the board of directors (during the period that such person served as a director) and (ii)&#160;the total number of meetings held by all committees of the board of directors on which such person served (during the periods that such person served).</p><a id="_Toc193224658"></a><a id="_Toc193225871"></a><a id="_Toc193708095"></a><a id="_Toc193805376"></a><a id="_Toc194481035"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Director Attendance at Annual Meeting of Stockholders</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our corporate governance guidelines provide that directors are responsible for attending the annual meeting of stockholders. For our annual meeting of stockholders in 2024, six of the eight directors serving on the board at such time were in attendance. </p><a id="_Toc193224659"></a><a id="_Toc193225872"></a><a id="_Toc193708096"></a><a id="_Toc193805377"></a><a id="_Toc194481036"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Code of Business Conduct and Ethics and Corporate Governance Guidelines</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We have adopted a written code of business conduct and ethics that applies to our directors, officers and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. We have posted a current copy of the code on the &#8220;Corporate Governance&#8221; section of the &#8220;Investors&#160;&amp; Media&#8221; section of our website, which is located at https://ir.xiliotx.com. In addition, we intend to post on our website all disclosures that are required by law or Nasdaq listing standards concerning any amendments to, or waivers from, any provision of the code of business conduct and ethics.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our board of directors has also adopted corporate governance guidelines to assist the board of directors in the exercise of its duties and responsibilities and to serve the best interests of our company and our stockholders. A copy of the corporate governance guidelines is available on the &#8220;Corporate Governance&#8221; section of the &#8220;Investors&#160;&amp; Media&#8221; section of our website, which is located at https://ir.xiliotx.com.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Insider Trading Policy</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="Narr_UsFXXTd2NkqWlxSCFdLGmg">We have adopted an insider trading policy</ix:nonNumeric> governing the purchase, sale and/or other dispositions of company securities by our directors, officers, employees and other covered persons. We believe the insider trading policy is reasonably designed to promote compliance with insider trading laws, rules and regulations, and Nasdaq listing standards. A copy of our insider trading policy is filed as Exhibit 19 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Policies and Practices Related to the Grant of Certain Equity Awards</b></p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" name="ecd:AwardTmgMnpiDiscTextBlock" id="Tb_DskSvD47Y0uiRboxB3qgdw" continuedAt="Tb_DskSvD47Y0uiRboxB3qgdw_cont1" escape="true"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" name="ecd:AwardTmgMethodTextBlock" id="Tb_vmCZwpgXrUOIjsVY0ngGYg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" format="ixt:fixed-true" name="ecd:AwardTmgPredtrmndFlag" id="Narr_EGvJY_lYZUetveHdGi7DPA">We grant stock options to our employees and directors on an annual basis. We also grant stock options to individuals upon hire or promotion or for retention or recognition purposes and have also granted restricted stock units for retention and recognition purposes. <ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" id="Tb_2R_ysF0xsEmNIVTNPQRVDA" escape="true"><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" format="ixt:fixed-false" name="ecd:AwardTmgMnpiCnsdrdFlag" id="Narr_Tn1Cc0NUPk-vVgHXkFp9yg">We currently do not grant stock appreciation rights or similar option-like instruments. </ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" format="ixt:fixed-false" name="ecd:MnpiDiscTimedForCompValFlag" id="Narr_sSy4N5x4lUyLLjfTTBBNwg">During the last fiscal year, neither the board of directors nor the compensation committee took material nonpublic information into account when determining the timing or terms of stock options, nor did we time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></p></ix:nonNumeric><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">While we do not have any policy or obligation that requires us to grant stock options to employees on specified dates, annual stock option grants to employees are typically approved in December and granted on January 1 of the following year. Stock option awards for new hires are typically approved with a grant date of the first day of the month following commencement of employment. Our annual stock option grants to non-employee directors occur automatically and without the need for any further action by the Board on the first business day following the date of each annual meeting of stockholders.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;visibility:hidden;background:#00ff00;">&#8203;</span></p></ix:nonNumeric></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-23-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:10.35pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Hlk130812659"></a><a id="_3a7df65b_0a01_40a3_a98a_9d3da0bd173f"></a><a id="Tc_9BX_lGv3ekCRvnBVXn4wtA_1_4"></a><a id="Tc_m4WjbYvVak2mU_-rxpJhgg_1_6"></a><a id="Tc_o3rCvwuFYUq7rM-mJqTeIA_1_8"></a><a id="Tc_JCWDap_ZDU6T2klfF10Y3Q_1_10"></a><a id="Tc_fIV7LEZmz0Kmj5bUT9FFPQ_2_4"></a><a id="Tc_WTwxClXu7kuuwcpf9Y4qSg_2_6"></a><a id="Tc_3JiZXGjuTUSq0sHMDSKAMg_2_8"></a><a id="Tc_MrOuu9I-n0KJpY-UAEPtrA_2_10"></a><a id="Tc_ybOdGbb4Wk-CvjPT45WLug_3_0"></a><a id="Tc__z361cg7f0evTocy3snFXQ_3_2"></a><a id="Tc_pjvZuBArQUyhpvoyO40T2w_3_4"></a><a id="Tc_Sl55_OLAJ0K5mRp2avT2og_3_6"></a><a id="Tc_k0mZzTFZgEe35mj9By0Htw_3_8"></a><a id="Tc_Aff4Vi-2_EKi5AN0exD-Ew_3_10"></a><a id="Tc_8IhyrCNm8UiH_KVObgTCEg_4_2"></a><ix:continuation id="Tb_DskSvD47Y0uiRboxB3qgdw_cont1"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table presents information regarding stock options, stock appreciation rights and/or similar option-like instruments granted to our named executive officers in the fiscal year ending December 31, 2024 during any period beginning four business days before the filing of a Form 10-Q or Form 10-K, or the filing or furnishing of a Form 8-K that discloses material nonpublic information (other than a Form 8-K disclosing a material new option award grant under Item 5.02(e)), and ending one business day after the filing or furnishing of such report with the SEC. </p><ix:nonNumeric contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw" name="ecd:AwardsCloseToMnpiDiscTableTextBlock" id="Tb_hAUX0GJ5C0SKqdv6vrYECg" escape="true"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Per-share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Percentage</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">securities underlying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">exercise price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">fair value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">change in the</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">the award</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of the award</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of the award</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">closing market price</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><ix:nonNumeric contextRef="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg" name="ecd:AwardsCloseToMnpiDiscIndName" id="Tc_hQMRu1kgrUu6e43ivIYlrg_4_0"><span style="font-size:9pt;">Christopher Frankenfield</span></ix:nonNumeric></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">August 3, 2024<sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"> <ix:nonFraction unitRef="Unit_Standard_pure_99kf4M5Iyk-m5QIB71yB2A" contextRef="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg" decimals="0" format="ixt:num-dot-decimal" name="ecd:AwardUndrlygSecuritiesAmt" scale="0" id="Tc_6AxgcVLSUUKRxOy_MWSu9w_4_4">52,000</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"> $<ix:nonFraction unitRef="Unit_Divide_USD_shares_c9xUV7cLfUGdKvEEazKsrg" contextRef="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg" decimals="4" format="ixt:num-dot-decimal" name="ecd:AwardExrcPrice" scale="0" id="Tc_jbP0kuTRq0awWICrywpDmg_4_6">0.8950</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">$ <ix:nonFraction unitRef="Unit_Standard_USD_OLynBvCv7kGDid3dGGWBgw" contextRef="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg" decimals="0" format="ixt:num-dot-decimal" name="ecd:AwardGrantDateFairValue" scale="0" id="Tc_Xy0PuzNRik2TqiVSYInDpw_4_8">35,578</ix:nonFraction></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">+<ix:nonFraction unitRef="Unit_Standard_pure_99kf4M5Iyk-m5QIB71yB2A" contextRef="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg" decimals="2" format="ixt:num-dot-decimal" name="ecd:UndrlygSecurityMktPriceChngPct" scale="0" id="Tc_B59tpbp5_EiSFLsJ7V73Lg_4_10">0.69</ix:nonFraction>%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Granted in connection with Mr. Frankenfield&#8217;s promotion to chief financial officer on August 3, 2024.</span></td></tr></table></ix:nonNumeric></ix:continuation><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><a id="_Toc193224660"></a><a id="_Toc193225873"></a><a id="_Toc193708097"></a><a id="_Toc193805378"></a><a id="_Toc194481037"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Board Leadership Structure</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our corporate governance guidelines provide that the nominating and corporate governance committee shall periodically assess the board of directors&#8217; leadership structure, including whether the offices of chief executive officer and chair of the board of directors should be separate. Our guidelines provide the board of directors with flexibility to determine whether the two roles should be combined or separated based upon our needs and the board of directors&#8217; assessment of its leadership from time to time. We do not currently have a lead independent director because the chair of our board of directors is independent within the meaning of the Nasdaq listing rules.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We currently separate the roles of chief executive officer and chair of the board of directors, and our nominating and corporate governance committee and board of directors believe it is appropriate for our chief executive officer to serve as a member of our board of directors. Our chief executive officer is responsible for setting the strategic direction for our company and the day-to-day leadership and performance of our company, while the chair of our board of directors presides over meetings of the board of directors, including executive sessions of the board of directors, and performs oversight responsibilities. Separating the duties of the chair from the duties of the chief executive officer allows our chief executive officer to focus on our day-to-day business, while allowing the chair to lead the board of directors in its fundamental role of providing advice to and independent oversight of management. Specifically, our chair runs meetings of our independent directors, facilitates communications between management and the board of directors, and assists with other corporate governance matters. Our board of directors believes that this structure ensures a greater role for the independent directors in the oversight of our company and active participation of the independent directors in setting agendas and establishing priorities and procedures for the work of our board of directors. Our board of directors believes its administration of its risk oversight function has not affected its leadership structure. Our board of directors has concluded that the current leadership structure described above is appropriate for us at this time, however, the nominating and corporate governance committee will continue to periodically review our leadership structure and may recommend such changes in the future as it deems appropriate. </p><a id="_Toc193224661"></a><a id="_Toc193225874"></a><a id="_Toc193708098"></a><a id="_Toc193805379"></a><a id="_Toc194481038"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Role of the Board in Risk Oversight</p><a id="_Hlk159337658"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">One of the key functions of our board of directors is informed oversight of our risk management processes. Our board of directors does not have a standing risk management committee, but rather administers this oversight function directly through the board of directors as a whole, as well as through various standing committees of our board of directors that address risks inherent in their respective areas of oversight. In particular, our board of directors is responsible for monitoring and assessing strategic risk exposure, including reviewing our policies and practices with respect to risk assessment and risk management, and regularly discusses with management our significant risk exposures, the potential impact of these risks on our business and the steps we take to manage them. Additionally, our audit committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including discussing guidelines and policies to govern the process by which risk assessment and risk management is undertaken, including the process by which we manage our exposure to cybersecurity risks, as well as directors&#8217; and officers&#8217; liability insurance. The audit committee discusses these matters with members of management on a periodic basis, and the audit committee is notified between such updates regarding significant new risks, including with respect to cybersecurity threats or incidents. The audit committee also monitors compliance with legal and regulatory requirements.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-24-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc193224662"></a><a id="_Toc193225875"></a><a id="_Toc193708099"></a><a id="_Toc193805380"></a><a id="_Toc194481039"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Communication with Our Directors</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Any interested party with concerns about our company may report such concerns to the board of directors, or the chair of our board of directors, or otherwise the chair of the nominating and corporate governance committee, by submitting a written communication to the attention of such director at the following address:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Xilio Therapeutics,&#160;Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">828 Winter Street, Suite&#160;300</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">Waltham, Massachusetts 02451</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;">Attention: Corporate Secretary</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">You may submit your concern anonymously or confidentially by postal mail. You may also indicate whether you are a stockholder, customer, supplier, or other interested party.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A copy of any such written communication may also be forwarded to our legal counsel and a copy of such communication may be retained for a reasonable period of time. The director may discuss the matter with our legal counsel, with independent advisors, with non-management directors, or with our management, or may take other action or no action as the director determines in good faith, using reasonable judgment and discretion.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Communications may be forwarded to all directors if they relate to important substantive matters and include suggestions or comments that may be important for the directors to know. In general, communications relating to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary business affairs, personal grievances, and matters as to which we tend to receive repetitive or duplicative communications.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The audit committee oversees the procedures for the receipt, retention, and treatment of complaints received by us regarding accounting, internal accounting controls, or audit matters, and the confidential, anonymous submission by employees of concerns regarding questionable accounting, internal accounting controls or auditing matters. Concerns regarding questionable accounting or auditing matters or complaints regarding accounting, internal accounting controls or auditing matters may be submitted in writing to our chief operating officer and the chair of our audit committee at 828 Winter Street, Suite&#160;300, Waltham, MA 02451 or via the toll-free telephone number 866-454-2061. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-25-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc194481040"></a><a id="_Toc193222802"></a><a id="_e196773f_ad88_46a1_91dc_a3e3be6f2c0f"></a><a id="EXECUTIVEANDDIRECTORCOMPENSATION_187467"></a><a id="EXECUTIVECOMPENSATION_781032"></a><a id="OFFICERS_278087"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 9pt 0pt;">EXECUTIVE OFFICERS</p><a id="_Toc193224664"></a><a id="_Toc193225877"></a><a id="_Toc193708101"></a><a id="_Toc194481041"></a><a id="_Toc193805382"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 9pt 0pt;"><span style="font-weight:normal;">Set forth below is certain information, as of April 15, 2025, regarding our executive officers who are not also directors.</span><span style="font-weight:normal;"> </span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:29.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:49.04%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.53%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Age</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.35%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.04%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Position(s)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Christopher Frankenfield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">43</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Chief Financial and Operating Officer</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.53%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Katarina Luptakova, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">49</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.04%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Chief Medical Officer</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:29.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Kevin Brennan</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">55</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:49.04%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Senior Vice President, Finance and Accounting</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;"><span style="font-size:1pt;font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;"><span style="font-style:italic;font-weight:bold;">Christopher Frankenfield</span> has served as our chief financial officer since August 2024 and our chief operating officer since August 2023. Mr. Frankenfield previously served as our chief legal and administrative officer from August 2022 to August 2023 and as our general counsel from March 2021 to August 2022. Prior to joining us, Mr. Frankenfield served in roles of increasing responsibility at Blueprint Medicines Corporation, or Blueprint, from August 2015 to March 2021, including as vice president of corporate legal affairs from July 2019 to March 2021. While at Blueprint, Mr. Frankenfield was responsible for a range of corporate legal activities, including public company reporting, capital markets strategy and follow-on equity offerings, collaborations and partnerships, and supporting commercial product launches. Prior to joining Blueprint, Mr. Frankenfield was a senior associate at Wilmer Cutler Pickering Hale and Dorr LLP, where his practice focused on capital markets and strategic transactions, public company reporting and corporate governance matters. Mr. Frankenfield began his career in the advisory practice at PricewaterhouseCoopers LLP. He received his B.A. in economics from the College of William &amp; Mary and his J.D. from the University of Virginia School of Law.</p><a id="_Hlk164156293"></a><a id="_Hlk164158948"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Katarina Luptakova, M.D.,</span> has served as our chief medical officer since September 2023. Dr. Luptakova previously served as our senior vice president, medical, from October 2022 to September 2023 and as our vice president, clinical research, from December 2021 to October 2022. Dr. Luptakova is a hematologist and oncologist with 20 years of experience in clinical practice and oncology drug development. Prior to joining us, Dr. Luptakova served as vice president, clinical development at Constellation Pharmaceuticals, Inc., a biopharmaceutical company, from April 2020 to October 2021, through its acquisition by MorphoSys AG in July 2021. Prior to that, Dr. Luptakova served as senior medical director and clinical lead at Tesaro, Inc., or Tesaro, a pharmaceutical company, from March 2018 to April 2020, and as medical director from September 2017 to March 2018. While at Tesaro, Dr. Luptakova contributed to the successful development and commercialization of multiple cancer therapies, including Zejula&#174; (niraparib) and Blenrep&#174; (belantamab mafodotin-blmf). Prior to Tesaro, Dr. Luptakova held roles of increasing responsibility in medical affairs at Takeda Oncology, the global oncology business unit of Takeda Pharmaceutical Company Limited. Earlier in her career, Dr. Luptakova was an attending physician in the Bone Marrow Transplant and Malignant Hematology division at Beth Israel Deaconess Medical Center. Dr. Luptakova received an M.D. from the Comenius University School of Medicine, Bratislava, Slovakia and completed her residency training in Internal Medicine at Caritas St. Elizabeth&#8217;s Medical Center and a clinical and research fellowship in hematology/oncology at the Beth Israel Deaconess Medical Center in Boston.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Kevin Brennan</span> has served as our senior vice president, finance and accounting, since March 2023. Mr. Brennan has more than 25 years of finance and accounting experience within the biotechnology industry. Prior to joining us, Mr. Brennan most recently served as vice president of finance at Allena Pharmaceuticals, Inc., or Allena, a public biopharmaceutical company, from November 2020 to March 2023, where he oversaw Allena&#8217;s accounting and finance operations and strategy, as well as public company reporting. From October 2011 to October 2020, Mr. Brennan held finance and accounting roles of increasing responsibility at Allena. Prior to Allena, Mr. Brennan served in finance and accounting roles at various companies within the biotechnology industry. Mr. Brennan began his career in the audit practice at KPMG LLP, and he received a B.S. in accounting from the Wallace Carroll School of Management at Boston College.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-26-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:10.35pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc194481042"></a><a id="_082ef24c_7bba_4392_856f_c28300bb7316"></a><a id="COMP_557777"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-transform:uppercase;">Executive Compensation</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following discussion provides an overview of the compensation for each of Ren&#233; Russo, Pharm.D., our president and chief executive officer, Christopher Frankenfield, our chief financial and operating officer, and Katarina Luptakova, our chief medical officer, whom we collectively refer to as our named executive officers. This section also provides qualitative information regarding the manner and context in which compensation is awarded to and earned by our executive officers and is intended to place in perspective the data presented in the tables and narrative that follow.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;visibility:hidden;">&#8203;</span></p><a id="_Toc193224666"></a><a id="_Toc193225879"></a><a id="_Toc193708103"></a><a id="_Toc193805384"></a><a id="_Toc194481043"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 9pt 0pt;">Summary Compensation Table</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information regarding compensation awarded to, earned by or paid to each of our named executive officers for the&#160;years ended December&#160;31, 2024 and 2023.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:8pt;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:21.83%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Non-Equity&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.83%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stock</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Option&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Incentive&#160;Plan&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All&#160;Other</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.83%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Salary</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Bonus</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Awards&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Awards&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total</b>&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:21.83%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name and Principal Position</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Year</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b></p></td></tr><tr><td style="vertical-align:bottom;width:21.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">Ren&#233; Russo, Pharm.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 613,947</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 97,350</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 391,761</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 337,671</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,610</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,455,339</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;"><i style="font-style:italic;">President and Chief Executive Officer</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 598,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,124,780</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 263,120</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,010</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,999,910</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">Christopher Frankenfield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 506,135</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(6)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 42,625</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 207,490</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 265,721</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,340</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,036,311</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;"><i style="font-style:italic;">Chief Financial and Operating Officer</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 481,108</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,156,022</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 210,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 13,740</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,860,870</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.83%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">Katarina Luptakova, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2024</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 465,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 36,575</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 49,039</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 182,280</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,610</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 747,504</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.83%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 6pt;"><i style="font-style:italic;">Chief Medical Officer</i></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.63%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2023</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.7%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 421,667</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(7)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:5.94%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.61%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.8%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 340,253</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 156,240</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.96%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 14,010</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:8.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 932,170</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The amounts reported reflect the aggregate fair value of restricted stock units awarded during the&#160;year computed in accordance with the provisions of Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 718. See Note&#160;10 to our consolidated financial statements appearing in our Annual Report on Form&#160;10-K for the year ended December 31, 2024 regarding assumptions underlying the valuation of equity awards.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The amounts reported reflect the aggregate fair value of stock options awarded during the&#160;year computed in accordance with the provisions of FASB ASC Topic 718. See Note&#160;10 to our consolidated financial statements appearing in our Annual Report on Form&#160;10-K for the year ended December 31, 2024 regarding assumptions underlying the valuation of equity awards.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The amounts reported represent annual performance-based bonus awards, earned for performance in the year indicated and paid in the subsequent year. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The amounts reported include life insurance premiums for Dr. Russo, Mr. Frankenfield and Dr. Luptakova in the amounts of $810, $540, and $810, respectively, for both 2024 and 2023. The amounts reported also include a 401(k) match for each of Dr. Russo, Mr. Frankenfield and Dr. Luptakova of $13,800 for 2024 and $13,200 for 2023.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Effective May 1, 2024, Dr. Russo&#8217;s annual base salary was increased to $621,920.</span></td></tr></table><a id="_Toc193224667"></a><a id="_Toc193225880"></a><a id="_Toc193708104"></a><a id="_Toc193805385"></a><a id="_Toc194481044"></a><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The amount reported for Mr. Frankenfield includes the increase in his annual base salary from $500,000 to $515,000, effective August 3, 2024, in connection with his promotion to our chief financial officer.</span></td></tr></table><a id="_Toc194481045"></a><a id="_Toc193224668"></a><a id="_Toc193225881"></a><a id="_Toc193708105"></a><a id="_Toc193805386"></a><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(7)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The amount reported for Dr. Luptakova includes the increase in her annual base salary from $400,000 to $465,000, effective September 5, 2023, in connection with her promotion to our chief medical officer.</span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"> </span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Narrative Disclosure to Summary Compensation Table</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;"><i style="font-style:italic;">Base Salary</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">We use base salaries to recognize the experience, skills, knowledge and responsibilities required of all our employees, including our named executive officers. None of our named executive officers is currently party to an employment agreement or other agreement or arrangement that provides for automatic or scheduled increases in base salary. However, on an annual basis, our compensation committee reviews and evaluates, with input from our chief executive officer, the need for adjustment, if any, of the base salaries of our named executive officers (other than with respect to herself), and our compensation committee review and evaluates without input from our chief executive officer, the need for adjustment, if any, of the base salary of our chief executive officer, in each case based on, among other things, changes and expected changes in the scope of a named executive officer&#8217;s responsibilities, including promotions, the individual contributions made by and performance of the named executive officer during the prior year, our overall growth and development as a company, general salary or other market trends in our industry and among a peer group of companies, and where the named executive officer&#8217;s salary falls in the salary range presented by that data.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In April 2024, our compensation committee increased the 2024 annual base salary for Dr. Russo to $621,920, effective May 1, 2024. In connection with Mr. Frankenfield&#8217;s promotion to our chief financial officer on August 3, 2024, his annual </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-27-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:9.2pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">base salary was increased from $500,000 to $515,000. In connection with Dr. Luptakova&#8217;s promotion to our chief medical officer on September 5, 2023, her annual base salary was increased from $400,000 to $465,000. Effective January 1, 2025, Dr. Russo, Mr. Frankenfield and Dr. Luptakova received annual base salary increases to $643,700, $533,100 and $481,300, respectively.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 10pt 0pt;">Annual Bonus</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our board of directors may, in its discretion, award bonuses to our named executive officers from time to time. Our employment agreements with each of our named executive officers provide that they will be eligible for annual performance-based bonuses up to a specified&#160;percentage of their salary, subject to approval by our board of directors. For 2024, the target annual bonus, expressed as a percentage of base salary, was 55% for Dr. Russo, 50% for Mr. Frankenfield, and 40% for Dr. Luptakova. We typically establish annual bonus targets based on a set of specified corporate goals for our named executive officers and conduct an annual performance review to determine the attainment of such goals. Our management may propose bonus awards to our compensation committee primarily based on such review process. For each of 2023 and 2024, our chief executive officer made recommendations to the compensation committee for bonus awards to our named executive officers (other than herself), and our board of directors made the final determination of the eligibility requirements for and the amount and form of such bonus awards based on the recommendation of the compensation committee. The final evaluation made by our board of directors does not involve a predetermined mathematical formula and final bonus amounts may be greater than 100% of the established bonus targets.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">The categories of corporate goals that we used to propose performance-based bonuses to our compensation committee included: progressing clinical development for our most advanced product candidates; advancing our discovery pipeline for the next generation of transformative tumor-selective therapies and immune cell engagers; and extending our cash runway to enable continued development of our pipeline. In December 2024, based on our achievement or partial achievement of specific goals within each category, as well as additional achievements that were not reflected in the approved corporate goals, and key challenges that were outside of the company&#8217;s control in 2024, our board of directors determined that the company achieved 100% of the corporate goals. Based upon these corporate achievements, and considering subjective factors related to individual performance, the compensation committee approved the following 2024 annual cash bonus payments for each of our named executive officers: </p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:25.93%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:19.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.65%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:21.25%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:20.59%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:25.93%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Named Executive Officer</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.97%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:19.1%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Target Award</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(% of Base Salary)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.65%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:21.25%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024 Actual Cash Incentive Payment ($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:20.59%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">2024 Actual Cash</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">Incentive Payment</b><b style="font-weight:bold;"><br/></b><b style="font-weight:bold;">(% of Target Award)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:25.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Ren&#233; Russo, Pharm.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">55%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 337,671</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">100%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:25.93%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Christopher Frankenfield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">50%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.65%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.25%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 265,721</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">105%</p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:25.93%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 6pt;">Katarina Luptakova, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">40%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.65%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:21.25%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 182,280</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.48%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:20.59%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">98%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:8.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Dr. Russo&#8217;s target award is weighted 100% with respect to corporate achievement. Mr. Frankenfield&#8217;s and Dr. Luptakova&#8217;s target awards are weighted 80% with respect to corporate achievement and 20% with respect to individual achievement.</span></td></tr></table><div style="margin-top:6pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">For 2025, the target annual bonus&#160;percentage is 55% for Dr. Russo, 50% for Mr. Frankenfield and 40% for Dr. Luptakova.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 10pt 0pt;">Equity Incentives</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 10pt 0pt;">Although we do not have a formal policy with respect to the grant of equity incentive awards to our executive officers, or any formal equity ownership guidelines applicable to them, we believe that equity grants provide our executives with a strong link to our long-term performance, create an ownership culture and help to align the interests of our executives and our stockholders. In addition, we believe that equity grants with a time-based vesting feature promote executive retention because this feature provides an incentive for our executive officers to remain in our employment during the vesting period. Accordingly, our board of directors periodically reviews the equity incentive compensation of our executive officers, including our named executive officers, and from time to time may grant equity incentive awards to them in the form of stock options or restricted stock units.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Prior to our initial public offering in October&#160;2021, our executive officers were eligible to participate in our 2020 Stock Incentive Plan. Following our initial public offering in October&#160;2021, our employees and executive officers became eligible to receive stock options and other equity awards pursuant to our 2021 Stock Incentive Plan.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Awards of stock options, restricted stock units and, prior to our initial public offering, restricted stock, to our executive </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-28-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:9.2pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">officers have been made by our board of directors or a committee delegated by our board of directors, and these awards have typically been subject to time-based vesting, generally over four&#160;years following the vesting commencement date. Upon certain terminations of employment in connection with a change of control, vesting is fully accelerated. During fiscal year 2024, we granted stock options to purchase shares of our common stock and restricted stock units to Dr. Russo, Mr. Frankenfield and Dr. Luptakova, as described in more detail in the table below under &#8220;&#8212;Outstanding Equity Awards at 2024 Fiscal Year End.&#8221; These grants included restricted stock unit awards granted in January 2024 as annual awards, as well as stock option awards granted in May 2024 in connection with our efforts to retain key executive officers and senior management. Additionally, Mr. Frankenfield received a grant of stock option awards in August 2024 in connection with his appointment as our chief financial officer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Outstanding Equity Awards at 2024 Fiscal&#160;Year End</span><span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth information regarding all outstanding stock options and shares of restricted stock held by each of our named executive officers as of December&#160;31, 2024. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:32.54%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td colspan="8" style="vertical-align:bottom;white-space:nowrap;width:40.83%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Option&#160;Awards</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;">&#160;&#160;&#160;&#160;</p></td><td colspan="4" style="vertical-align:bottom;white-space:nowrap;width:23.33%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stock&#160;Awards</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:32.54%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Market&#160;</b>&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Securities</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Securities</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Value&#160;of&#160;</b>&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Underlying&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Underlying&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Option</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares&#160;of&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Shares&#160;of&#160;</b>&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unexercised&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unexercised&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Option</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stock&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Stock</b></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options&#160;(#)&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options&#160;(#)&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Price</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Expiration</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">That&#160;Have&#160;</b>&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">That&#160;Have&#160;</b>&#160;</p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercisable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Unexercisable</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Not&#160;Vested&#160;(#)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Not&#160;Vested&#160;($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Ren&#233; Russo, Pharm.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 404,875</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 69,125</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(3)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.08</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4/30/2034</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 177,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 169,035</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 233,333</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 466,667</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.79</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8/15/2033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 167,708</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 182,292</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(6)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.69</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">12/31/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 106,250</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 43,750</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(7)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12.66</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2/21/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 75,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(8)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 13.83</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">12/21/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 39,615</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 10,426</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(9)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">10/20/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 112,611</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 22,523</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(10)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11.69</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8/22/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 443,751</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 29,583</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(11)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.89</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">3/10/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 170,831</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(12)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.51</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">7/22/2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 68,872</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(13)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 5.51</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">7/22/2030</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Christopher Frankenfield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4,333</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 47,667</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(14)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 0.90</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8/2/2034</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 30,333</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 177,667</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(3)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.08</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4/30/2034</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 77,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 74,013</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 100,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 200,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.79</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8/15/2033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 50,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 100,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(15)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.75</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8/2/2033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 56,062</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 60,938</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(6)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.69</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">12/31/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,666</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,334</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(16)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.13</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8/31/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 31,875</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 13,125</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(7)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 12.66</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">2/21/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 29,526</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,770</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(9)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16.00</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">10/20/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 22,300</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1,486</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(17)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6.65</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">3/31/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 145,397</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9,693</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(17)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 6.65</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">3/28/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Katarina Luptakova, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,652</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 50,681</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(3)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.08</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">4/30/2034</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 66,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 63,508</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 33,125</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 72,875</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(18)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.79</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">9/4/2033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,333</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16,667</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.79</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">8/15/2033</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 16,770</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 18,230</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(6)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.69</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">12/31/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,812</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 7,188</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)(19)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2.37</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">10/31/2032</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr><tr><td style="vertical-align:bottom;width:32.54%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.39%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 33,157</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 11,053</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 0pt 0.05pt 0pt;"><sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(20)</sup><span style="vertical-align:top;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 9.69</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;">12/6/2031</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.03%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.55%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.51%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.23%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:8.0pt;margin-bottom:6pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The market price of our common stock is based on the closing price of our common stock on the Nasdaq Global Select Market on December&#160;31, 2024 of $0.96 per share.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">This option vests over four years, in equal monthly installments, subject to continued service through each applicable vesting date. The vesting of </span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-29-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">this option award will accelerate upon a qualifying termination of the named executive officer&#8217;s employment with the company.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on May 1, 2028.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">This restricted stock unit vests in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> T</span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">he vesting of this restricted stock unit will accelerate upon a qualifying termination of the named executive officer&#8217;s employment with the company. </span></td></tr></table><a id="_Hlk193966862"></a><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">This option vested with respect to 1/3 of the shares of common stock underlying the stock option on August 16, 2024 and will vest with respect to the remaining 2/3 of the shares on August 16, 2025, subject to continued service through each applicable vesting date. </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The vesting of this option award will accelerate upon a qualifying termination of the named executive officer&#8217;s employment with the company.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on January 1, 2027.</span></td></tr></table><a id="_Hlk193196259"></a><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(7)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">February 1, 2026</span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(8)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on December 1, 2025.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(9)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on October 1, 2025. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(10)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on August 1, 2025. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(11)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">This option vested in full on March&#160;1, 2025. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(12)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">This option vested over four&#160;years, in equal monthly installments</span><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;"> </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">from the vesting commencement date of March 12, 2020 through February&#160;12, 2024. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(13)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">This option vested over four&#160;years, in equal monthly installments from the vesting commencement date of May&#160;15, 2019 through April&#160;15, 2023.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(14)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on August 1, 2028.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(15)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on August 1, 2027.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(16)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on August 1, 2026. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(17)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">This option vested over four years, with 25% of the shares vested on March 27, 2022 and the remaining number of shares vested thereafter in equal monthly installments through March 27, 2025.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(18)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on September 1, 2027.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(19)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Option will be vested in full on November 1, 2026.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(20)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">This option vests over four years, with 25% of the shares vested on December 2, 2022 and the remaining number of shares vesting thereafter in equal monthly installments through December 2, 2025, subject to continued service through each applicable vesting date. The vesting of this option award will accelerate upon a qualifying termination of Dr. Luptakova&#8217;s employment with the company.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="font-size:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_Toc193224669"></a><a id="_Toc193225882"></a><a id="_Toc193708106"></a><a id="_Toc193805387"></a><a id="_Toc194481046"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 8pt 0pt;">Other Compensation Policies and Practices</p><a id="_Toc193224670"></a><a id="_Toc193225883"></a><a id="_Toc193708107"></a><a id="_Toc193805388"></a><a id="_Toc194481047"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Health and Welfare Benefits</p><a id="_Toc193224671"></a><a id="_Toc193225884"></a><a id="_Toc193708108"></a><a id="_Toc193805389"></a><a id="_Toc194481048"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:normal;font-weight:normal;">Our named executive officers are eligible to participate in all of our employee benefit plans, including our medical, dental, vision, life and disability insurance plans, in each case, on the same basis as other employees.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Perquisites </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We do not provide perquisites or personal benefits to our named executive officers other than in connection with relocation assistance for new hires on a limited basis.</p><a id="_Toc193224672"></a><a id="_Toc193225885"></a><a id="_Toc193708109"></a><a id="_Toc193805390"></a><a id="_Toc194481049"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">401(k)&#160;Plan</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We maintain a defined contribution employee retirement plan for our employees, including our named executive officers. The plan is intended to qualify as a tax-qualified 401(k)&#160;plan so that contributions to the 401(k)&#160;plan, and income earned on such contributions, are not taxable to participants until withdrawn or distributed from the 401(k)&#160;plan (except in the case of contributions under the 401(k)&#160;plan designated as Roth contributions). Under the 401(k)&#160;plan, each employee is fully vested in his or her deferred salary contributions. Employee contributions are held and invested by the plan&#8217;s trustee as directed by participants. Effective July 2022, we began matching employee contributions to our 401(k) plan at 40% of the first 5% contributed to the plan, up to a maximum of 2% of eligible compensation. As of January 2023, we match 100% of the first 3% contributed to the plan and 50% of the next 2% of compensation contributed to the plan, up to a maximum of 4% of eligible compensation. Matching contributions are 100% vested immediately. Matching contributions made to each of our named executive officers in 2024 are included in the &#8220;Summary Compensation Table&#8221; above.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Clawback Policy</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In November 2023, our board of directors adopted an executive compensation clawback policy in compliance with Nasdaq listing standards and Rule 10D-1 under the Exchange Act. The clawback policy provides that, in the event that we are required to prepare an accounting restatement for periods ending on or after October 2, 2023, we will attempt to recover from our current or former executive officers, on a pre-tax basis, any amount of incentive-based compensation that (a) exceeds the amount that otherwise would have been received had it been determined based on the restated financial statement amounts, and (b) was received during the three fiscal years preceding the determination that we are required to restate our financial statements, as further specified in the clawback policy. For purposes of the clawback policy, incentive-based compensation means any compensation that is granted, earned or vested based wholly or in part upon the attainment </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-30-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">of a financial reporting measure, as defined in the clawback policy. The clawback policy is overseen and administered by our compensation committee.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Anti-Hedging and Pledging Policy</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our insider trading policy expressly prohibits all of our employees, including our named executive officers, as well as our directors, family members and controlled entities from engaging in speculative transactions in our securities, including short sales, puts/calls, purchases of financial instruments (including repaid variable forward contracts, equity swaps, collars and exchange funds), or otherwise engage in transactions, that hedge or offset, or are designed to hedge or offset any decrease in the market value of our securities, and margin accounts or pledges.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">No Tax Gross-Ups</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We do not provide for any tax gross-up payments to our named executive officers other than in connection with the tax protection of certain relocation expenses.</p><a id="_Toc193224673"></a><a id="_Toc193225886"></a><a id="_Toc193708110"></a><a id="_Toc193805391"></a><a id="_Toc194481050"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 8pt 0pt;">Agreements with our Named Executive Officers</p><a id="_Toc193224674"></a><a id="_Toc193225887"></a><a id="_Toc193708111"></a><a id="_Toc193805392"></a><a id="_Toc194481051"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 8pt 0pt;">Employment Agreements with Named Executive Officers</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">We have entered into employment agreements with each of our named executive officers, each of which provide for &#8220;at will&#8221; employment, and the employment of each executive officer can be terminated by us or the executive officer at any time and for any reason. Except in the event of certain involuntary terminations of the executive officer&#8217;s employment as described below, the executive officer must be an employee in good standing on the last day of the applicable bonus&#160;year in order to be eligible for any annual bonus.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:12pt;font-style:italic;font-weight:bold;visibility:hidden;">&#8203;</span></p><a id="_Toc193224675"></a><a id="_Toc193225888"></a><a id="_Toc193708112"></a><a id="_Toc193805393"></a><a id="_Toc194481052"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 8pt 0pt;"><span style="font-style:normal;font-weight:normal;">We have also agreed to provide the following benefits under the employment agreements with each of our named executive officers, including certain severance payments and benefits in connection with a change-in-control. We believe that reasonable and competitive change-in-control payments and benefits are an important part of an executive compensation program to attract and retain senior executives. We also believe such payments and benefits are in the best interests of our stockholders because they incentivize senior executives to continue to strive to achieve stockholder value in connection with change-in-control situations, particularly where the possibility of a change-in-control and the related uncertainty may lead to the departure or distraction of senior executives to the detriment of our company and our stockholders.</span></p><a id="_Toc193224676"></a><a id="_Toc193225889"></a><a id="_Toc193708113"></a><a id="_Toc193805394"></a><a id="_Toc194481053"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Severance Upon Termination of Employment; Change in Control</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 12pt 0pt;">Ren&#233; Russo, Pharm.D.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">Under the employment agreement with Dr.&#160;Russo and subject to her execution and non-revocation of a release of claims in our favor, in the event of the termination of her employment by us without cause or by her for good reason (each as defined in Dr.&#160;Russo&#8217;s employment agreement), Dr.&#160;Russo is entitled to the following: (i)&#160;continued payment of her base salary for 12&#160;months; (ii)&#160;a lump sum payment of her target bonus for the&#160;year of termination, pro-rated for the portion of the&#160;year during which she was employed by us, regardless of whether the metrics have been established or achieved (with the continued base salary and pro-rata bonus payment reduced by any amounts Dr.&#160;Russo is entitled to under a restrictive covenants agreement between her and us); and (iii)&#160;payment by us of the portion of the COBRA premiums for health benefits coverage on the same terms as were applicable to her prior to her termination until the earliest of (A)&#160;a period of 12&#160;months following the date that her employment with us is terminated, (B)&#160;if she becomes eligible to enroll in a health benefit plan with a new employer, or (C)&#160;the cessation of her continuation rights under COBRA. In addition, in the event that Dr.&#160;Russo&#8217;s employment is terminated by us without cause or by Dr.&#160;Russo for good reason within 12&#160;months following a change in control (as defined in the employment agreement), Dr.&#160;Russo is entitled to the following: (i)&#160;continued payment of her then-current base salary for 18&#160;months; (ii)&#160;a lump sum payment of 150% of the target annual bonus for the&#160;year of termination in which such termination occurred, regardless of whether the metrics have been established or achieved (with the continued base salary and target bonus payment reduced by any amounts Dr.&#160;Russo is entitled to under a restrictive covenants agreement between her and us); (iii)&#160;payment by us of the portion of the COBRA premiums for health benefits coverage on the same terms as were applicable to her prior to her termination until the earliest of (A)&#160;a period of 18&#160;months following the date that her employment with us is terminated, (B)&#160;if she becomes eligible to enroll in a health benefit plan with a new employer, or (C)&#160;the cessation of her continuation rights under COBRA; and </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-31-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">(iv)&#160;the automatic vesting and exercisability of any unvested equity awards that are subject to time-based vesting conditions then held by her on the later date of when her employment with us is terminated or the effective date of the separation agreement and release, which awards will remain exercisable for the time period set forth in the applicable grant agreement, provided that, to the extent any equity awards that Dr.&#160;Russo held prior to our initial public offering in October&#160;2021 contain more favorable acceleration terms, any such equity awards will remain subject to the terms of those awards and not the acceleration granted under her employment agreement. Under Dr.&#160;Russo&#8217;s employment agreement, if the payments and benefits payable to Dr.&#160;Russo in connection with a change in control are subject to Section&#160;4999 of the Internal Revenue Code, as amended, then such payments and benefits will either be paid in full or be reduced so that the Section&#160;4999 excise tax does not apply, whichever results in the better after-tax result for Dr.&#160;Russo.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In the event that Dr.&#160;Russo&#8217;s employment is terminated for any reason other than by us without cause or by Dr.&#160;Russo for good reason, then Dr.&#160;Russo will be entitled to the following: (i)&#160;her then-current base salary through her last day of employment; (ii)&#160;the amount of any documented expenses properly incurred by her on behalf of the company prior to any such termination and not yet reimbursed; and (iii)&#160;amounts or benefits to which Dr.&#160;Russo is then entitled under the terms of the benefits plans in accordance with their terms.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 12pt 0pt;">Employment Agreements with Named Executive Officers Other Than Chief Executive Officer</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Under the employment agreement with each of Mr. Frankenfield and Dr. Luptakova, in the event of the termination of employment by us without cause or by the executive officer for good reason (each as defined in the executive officer&#8217;s employment agreement), the executive officer is entitled to the following, subject to such executive officer&#8217;s execution and non-revocation of a release of claims in our favor: (i)&#160;continued payment of such executive officer&#8217;s base salary for twelve months and nine&#160;months for each of Mr. Frankenfield and Dr. Luptakova, respectively; (ii)&#160;a lump sum payment of such executive officer&#8217;s target bonus for the&#160;year of termination, pro-rated for the portion of the&#160;year during which the executive officer was employed by us, regardless of whether the metrics have been established or achieved (with the continued base salary and pro-rata bonus payment reduced by any amounts the executive officer is entitled to under a restrictive covenants agreement between the executive officer and us, to the extent applicable); and (iii)&#160;payment by us of the portion of the COBRA premiums for health benefits coverage on the same terms as were applicable to the executive officer prior to termination until the earliest of (A)&#160;a period of twelve&#160;months and nine months for each of Mr. Frankenfield and Dr. Luptakova, respectively, following the date that the executive officer&#8217;s employment with us is terminated, (B)&#160;if the executive officer becomes eligible to enroll in a health benefit plan with a new employer, or (C)&#160;the cessation of the executive officer&#8217;s continuation rights under COBRA.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In addition, in the event that the executive officer&#8217;s employment is terminated by us without cause or by the executive officer for good reason within 12&#160;months following a change in control (as defined in the employment agreement), the executive officer is entitled to the following: (i)&#160;continued payment of the executive officer&#8217;s then-current base salary for 12&#160;months; (ii)&#160;a lump sum payment of 100% of the target annual bonus for the&#160;year of termination in which such termination occurred, regardless of whether the metrics have been established or achieved (with the continued base salary and target bonus payment reduced by any amounts the executive officer is entitled to under a restrictive covenants agreement between the executive officer and us, to the extent applicable); (iii)&#160;payment by us of the portion of the COBRA premiums for health benefits coverage on the same terms as were applicable to the executive officer prior to termination until the earliest of (A)&#160;a period of 12&#160;months following the date that the executive officer&#8217;s employment with us is terminated, (B)&#160;if the executive officer becomes eligible to enroll in a health benefit plan with a new employer, or (C)&#160;the cessation of the executive officer&#8217;s continuation rights under COBRA; and (iv)&#160;the automatic vesting and exercisability of any unvested equity awards that are subject to time-based vesting conditions then held by the executive officer on the later date of when the executive officer&#8217;s employment with us is terminated or the effective date of the separation agreement and release, which awards will remain exercisable for the time period set forth in the applicable grant agreement, provided that, to the extent any equity awards that the executive officer held prior to our initial public offering contain more favorable acceleration terms, any such equity awards will remain subject to the terms of those awards and not the acceleration granted under the executive officer&#8217;s employment agreement. If the payments and benefits payable to the executive officer in connection with a change in control are subject to Section&#160;4999 of the Internal Revenue Code, as amended, then such payments and benefits will either be paid in full or be reduced so that the Section&#160;4999 excise tax does not apply, whichever results in the better after-tax result for the executive.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In the event that the executive officer&#8217;s employment is terminated for any reason other than by us without cause or by the executive officer for good reason, then the executive officer will be entitled to the following: (i)&#160;the executive officer&#8217;s </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-32-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">then-current base salary through the last day of employment; (ii)&#160;the amount of any documented expenses properly incurred by the executive officer on behalf of us prior to any such termination and not yet reimbursed; and (iii)&#160;amounts or benefits to which the executive officer is then entitled under the terms of the benefits plans in accordance with their terms.</p><a id="_Toc193224677"></a><a id="_Toc193225890"></a><a id="_Toc193708114"></a><a id="_Toc193805395"></a><a id="_Toc194481054"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment of Inventions Agreements</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Each of our executive officers has entered into a standard form of agreement with respect to non-competition, non-solicitation, confidential information and assignment of inventions. Under this agreement, each executive officer has agreed not to compete with us during his or her employment and for a period of nine&#160;months (or 12 months in the case of our chief executive officer) after the termination of his or her employment, not to solicit our employees, consultants, customers, prospective customers or suppliers during his or her employment and for a period of 12 months after the termination of his or her employment, and to protect our confidential and proprietary information indefinitely. In addition, under this agreement, each executive officer has agreed that we own all inventions that are developed by such executive officer during his or her employment with us that are made, conceived, discovered or developed by the executive officer, or result from or are suggested by any work performed by the executive officer for or on our behalf. Each executive officer also has agreed to provide us with a worldwide, nonexclusive, royalty-free, irrevocable, perpetual, transferable and sublicensable (through multiple tiers) license to use any prior inventions that such executive officer incorporates into inventions assigned to us under this agreement.</p><a id="_Toc193224678"></a><a id="_Toc193225891"></a><a id="_Toc193708115"></a><a id="_Toc193805396"></a><a id="_Toc194481055"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;">Limitation of Liability and Indemnification</span><span style="font-style:italic;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our certificate of incorporation provides that we will indemnify our directors and officers to the fullest extent permitted by Delaware law. In addition, we have entered into indemnification agreements with each of our directors and executive officers. These indemnification agreements may require us, among other things, to indemnify each such executive officer or director for some expenses, including attorneys&#8217; fees, judgments, fines and settlement amounts incurred by him or her in any action or proceeding arising out of his or her service as one of our executive officers or directors. We also maintain a general liability insurance policy, which covers certain liabilities of directors and officers of our company arising out of claims based on acts or omissions in their capacities as directors or officers. Certain of our non-employee directors may, through their relationships with their employers, be insured and/or indemnified against certain liabilities incurred in their capacity as members of our board of directors.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-33-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:9.2pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc194481056"></a><a id="_4d79f1e1_8f51_449a_b79f_60941b679548"></a><a id="DIRECTORCOMPENSATION_251517"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">DIRECTOR COMPENSATION</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The following table sets forth a summary of the compensation for each of our non-employee directors during 2024. </p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:58.06%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:58.06%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Fees&#160;Earned&#160;or</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Option&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">All&#160;Other&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:8pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Paid&#160;in&#160;Cash&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Awards&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Total&#160;</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Director</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">($)</b></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Sara M. Bonstein</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 50,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,058</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 69,058</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Aoife Brennan, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 23,352</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 40,155</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 63,507</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Paul J. Clancy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 70,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,058</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 89,058</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Daniel Curran. M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 41,198</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,058</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 60,256</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Tomas J. Heyman<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 22,891</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 22,891</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Robert Ross, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 40,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,058</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 59,058</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Christina Rossi</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 52,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,058</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 71,558</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">James Shannon, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 23,352</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 40,155</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 63,507</span></p></td></tr><tr><td style="vertical-align:bottom;width:58.06%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">Yuan Xu, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.71%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 39,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.64%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:6.79%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 19,058</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.78%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:7.43%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 58,058</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:8.0pt;margin-bottom:6pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Dr. Russo also serves as our president and chief executive officer and does not receive any additional compensation for her service as a director. Information regarding her compensation can be found in the &#8220;Summary Compensation Table&#8221; and &#8220;Narrative Disclosure to Summary Compensation Table&#8221; included elsewhere in this proxy statement. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The amount reported represents cash compensation for services rendered by each member of our board of directors for their services on our board of directors or a committee thereof. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The amounts reported represent the aggregate grant date fair value of stock options awarded in 2024, calculated in accordance with FASB ASC Topic 718. See Note&#160;10 to our consolidated financial statements appearing in our Annual Report on Form&#160;10-K for the year ended December 31, 2024 regarding assumptions underlying the valuation of equity awards. </span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Mr. Heyman resigned from our board of directors on June 13, 2024. As of December 31, 2024, Mr. Heyman did not hold any stock options to purchase shares of our common stock.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">As of December 31, 2024, the aggregate number of stock options held by non-employee directors was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="font-size:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;table-layout:auto;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:normal;width:77.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Aggregate</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;"><b style="font-weight:bold;">Director</b></p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Option Awards</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Sara M. Bonstein</p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 104,613</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Aoife Brennan, M.D.</p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 50,000</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Paul J. Clancy</p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 219,095</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Daniel Curran. M.D.</p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 25,000</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Robert Ross, M.D.</p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 64,600</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Christina Rossi</p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 104,613</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">James Shannon, M.D.</p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 50,000</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:normal;width:77.32%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Yuan Xu, Ph.D.</p></td><td style="vertical-align:bottom;white-space:normal;width:3.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:normal;width:19.1%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 77,800</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_Toc193224680"></a><a id="_Toc193225893"></a><a id="_Toc193708117"></a><a id="_Toc193805398"></a><a id="_Toc194481057"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Narrative Disclosure to Director Compensation Table </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;text-align:justify;margin:0pt 0pt 12pt 0pt;">Amended and Restated Director Compensation Policy</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our non-employee director compensation policy is designed to provide a total compensation package that enables us to attract and retain, on a long-term basis, high caliber non-employee directors. Under our current non-employee director compensation policy, effective April 14, 2025, our non-employee directors are compensated as follows:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Each non-employee director will receive an annual cash fee of $40,000 ($70,000 for the chair of the board of directors).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Each non-employee director who is a member of the audit committee will receive an additional annual cash fee of $7,500 ($15,000 for the audit committee chair).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Each non-employee director who is a member of the compensation committee will receive an additional annual </span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-34-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">cash fee of $5,000 ($10,000 for the compensation committee chair).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Each non-employee director who is a member of the nominating and corporate governance committee will receive an additional annual cash fee of $4,000 ($8,000 for the nominating and corporate governance committee chair).</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Each new non-employee director will receive an initial grant of a stock option to purchase 62,000 shares of common stock under the 2021 Plan upon his or her initial election to our board of directors.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:18pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">Each continuing non-employee director that has served on our board of directors for at least six&#160;months will receive an annual grant of a stock option to purchase 31,000 shares of common stock under the 2021 Plan on the date of the first board meeting held after each annual meeting of stockholders.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">All cash fees are paid quarterly, in arrears, or upon the earlier resignation or removal of the non-employee director. The amount of such payments is prorated for any portion of such quarter that the non-employee director is not serving on our board of directors, based on the number of calendar days served by such non-employee director. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The stock options granted to our non-employee directors will have an exercise price equal to the closing price of our common stock as reported on Nasdaq on the date of grant and will expire 10 years after the date of grant. The initial stock options granted to new non-employee directors will vest as to one-third of the shares of common stock underlying such option annually on the grant date until the third anniversary of the grant date, subject to the non-employee director&#8217;s continued service as a director through the applicable vesting date. The annual stock options granted to continuing non-employee directors will vest in full on the earlier of the first anniversary of the grant date or immediately prior to the first annual meeting of stockholders occurring after the grant date, subject to the non-employee director&#8217;s continued service as a director. In addition, the vesting of all stock options granted to non-employee directors will accelerate as to 100% of the shares upon a director&#8217;s death or disability or a change in control of us, each as defined in the form of non-employee director stock option agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We also reimburse our non-employee directors for reasonable travel and other expenses incurred in connection with attending meetings of our board of directors and any committee of our board of directors on which he or she serves.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Under the 2021 Plan, which became effective upon our initial public offering in October 2021, the maximum aggregate amount of cash and value of equity awards granted under the 2021 Plan in any calendar&#160;year to any individual non-employee director in his or her capacity as a non-employee director shall not exceed $1,000,000. Fees paid by us on behalf of any non-employee director in connection with regulatory compliance or to a non-employee director as reimbursement of expenses, as well as any cash or equity awards granted to a non-employee director in his or her capacity as an advisor or consultant to us, will not count toward the foregoing limit. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-35-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc194481058"></a><a id="_a4ce2cbb_8a57_49e1_8d95_057fd717ed30"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS</p><a id="REPORTOFTHEAUDITCOMMITTEEOFTHEBOARDOFDIR"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">The audit committee has reviewed our audited consolidated financial statements for the fiscal&#160;year ended December&#160;31, 2024 and discussed them with our management and Ernst&#160;&amp; Young LLP, our independent registered public accounting firm.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The audit committee has also received from, and discussed with, Ernst&#160;&amp; Young LLP various communications that Ernst&#160;&amp; Young LLP is required to provide to the audit committee, including the matters required to be discussed under the applicable requirements of the Public Company Accounting Oversight Board and the SEC.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In addition, Ernst&#160;&amp; Young LLP provided the audit committee with the written disclosures and letter required under applicable requirements of the Public Company Accounting Oversight Board regarding the independent registered public accounting firm&#8217;s communications with the audit committee concerning independence, and the audit committee has discussed with Ernst&#160;&amp; Young LLP its independence.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Based on the review and discussions referred to above, the audit committee recommended to the board of directors that the audited consolidated financial statements be included in the Company&#8217;s Annual Report on Form&#160;10-K for the&#160;year ended December&#160;31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">By the audit committee of the board of directors of Xilio Therapeutics,&#160;Inc.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sara M. Bonstein, Chair</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Aoife Brennan, M.D.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;">Christina Rossi </p><a id="PROPOSALNO2_388332"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-36-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:10.35pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_b4efe118_5471_4f0a_8103_b5b33e236b58"></a><a id="SECURITIESAUTHORIZED_517448"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS</p><a id="_Toc193224682"></a><a id="_Toc193225896"></a><a id="_Toc193708120"></a><a id="_Toc193805401"></a><a id="_Toc194481060"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Equity Compensation Plan Information</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table provides information as of December 31, 2024 about the securities authorized for issuance under our equity compensation plans, consisting of the 2020 Plan, the 2021 Plan, the 2021 ESPP, and <span style="background:#ffffff;">the 2022 Inducement Plan. Each of the 2020 Plan, the 2021 Plan, and the 2021 ESPP were approved by our stockholders. The 2022 Inducement Plan was first approved by our board of directors in November 2022 for use exclusively in granting equity awards to individuals who were not previously an employee or&#160;non-employee&#160;director (or following a bona fide period of&#160;non-employment),&#160;as an inducement material to such individual&#8217;s entering into employment with us, pursuant to Rule 5635(c)(4) of the Nasdaq Listing Rules. </span>A description of the material terms of the 2022 Inducement Plan is included in Note 10 to the consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;margin-bottom:12pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td colspan="6" style="vertical-align:bottom;white-space:nowrap;width:52.17%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">As&#160;of&#160;December&#160;31,&#160;2024</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number&#160;of&#160;Securities</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Securities&#160;to&#160;be</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Remaining&#160;Available</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Issued&#160;upon</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Weighted&#160;Average</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">for&#160;Future&#160;Issuance</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Exercise&#160;Price&#160;of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">under&#160;Equity</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Outstanding</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Compensation</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options,&#160;Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Options,</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plans&#160;(Excluding</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">and&#160;Rights, or upon</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Warrants</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Securities&#160;Reflected</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Vesting of RSUs</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">and&#160;Rights</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">in&#160;Column&#160;(a))</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Plan Category</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(a)</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(b)</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">(c)</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">Equity compensation plans approved by security holders<sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(2)(3)(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,169,532</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.21</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 2,839,310</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">Equity compensation plans not approved by security holders<sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 164,400</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 1.58</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 610,600</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:46.35%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">Total</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.47%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 8,333,932</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.11%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;">$</p></td><td style="vertical-align:bottom;white-space:nowrap;width:14.58%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 4.15</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:17.84%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0.05pt 0pt;"><span style="white-space:pre-wrap;"> 3,449,910</span></p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The weighted average exercise price does not reflect the shares of common stock issuable upon the vesting of outstanding restricted stock units, which have no exercise price.</span></td></tr></table><div style="margin-top:6pt;"></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Consists of the 2020 Plan, 2021 Plan and 2021 ESPP.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">As of December&#160;31, 2024, 1,938,102 shares of our common stock were available for issuance under the 2021 Plan. The number of shares reserved for issuance under the 2021 Plan will be cumulatively increased on January&#160;1 of each calendar year (through January&#160;1, 2031) by 5% of the number of shares of our common stock outstanding on such date or such lesser amount determined by our board of directors. The shares of common stock underlying any awards that are expired, forfeited, canceled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, repurchased or are otherwise terminated by us under the 2021 Plan or the 2020 Plan are added back to the shares of common stock available for issuance under the 2021 Plan. On January&#160;1, 2025, the number of shares reserved for issuance under the 2021 Plan increased by 2,293,405 shares.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:6pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">As of December&#160;31, 2024, 901,208 shares of our common stock were reserved for issuance under the 2021 ESPP. The number of shares reserved for issuance under the 2021 ESPP will be cumulatively increased on January&#160;1 of each calendar year (through January&#160;1, 2031) by 1% of the number of shares of our common stock outstanding on such&#160;date or such lesser amount determined by our board of directors (up to a maximum increase of 584,062 shares of common stock per year). On January&#160;1, 2025, the number of shares reserved for issuance under the 2021 ESPP increased by 458,681 shares.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Consists of shares of common stock reserved for issuance under the 2022 Inducement Plan. On March 7, 2025, the board of directors reserved an additional 500,000 shares for issuance under the 2022 Inducement Plan.</span></td></tr></table><div style="margin-top:6pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-weight:bold;visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-37-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc193222806"></a><a id="_Toc194481061"></a><a id="_d17d30f0_c05e_4e09_b21f_d4158c5bff9f"></a><a id="CERTAINRELATIONSHIPSANDRELATEDPERSONTRAN"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</p><a id="_Toc193224684"></a><a id="_Toc193225898"></a><a id="_Toc193708122"></a><a id="_Toc193805403"></a><a id="_Toc194481062"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Policies for Related Person Transactions</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our board of directors has adopted written policies and procedures for the review of any transaction, arrangement or relationship in which our company is a participant, the amount involved exceeds $120,000, and one of our executive officers, directors, director nominees or 5% stockholders, or their immediate family members, each of whom we refer to as a &#8220;related person,&#8221; has a direct or indirect material interest.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">If a related person proposes to enter into such a transaction, arrangement or relationship, which we refer to as a &#8220;related person transaction,&#8221; the related person must report the proposed related person transaction to our chief financial and operating officer or chief legal officer, as applicable. The policy calls for the proposed related person transaction to be reviewed and, if deemed appropriate, approved by our audit committee. Whenever practicable, the reporting, review and approval will occur prior to entry into the transaction. If advance review and approval is not practicable, the audit committee will review, and, in its discretion, may ratify the related person transaction. The policy also permits the chairperson of the audit committee to review and, if deemed appropriate, approve proposed related person transactions that arise between committee meetings, subject to ratification by the committee at its next meeting. Any related person transactions that are ongoing in nature will be reviewed annually. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">A related person transaction reviewed under the policy will be considered approved or ratified if it is authorized by the audit committee after full disclosure of the related person&#8217;s interest in the transaction. As appropriate for the circumstances, the audit committee will review and consider:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the related person&#8217;s interest in the related person transaction;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the approximate dollar value of the amount involved in the related person transaction;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the approximate dollar value of the amount of the related person&#8217;s interest in the transaction without regard to the amount of any profit or loss;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">whether the transaction was undertaken in the ordinary course of our business;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">whether the terms of the transaction are no less favorable to us than terms that could have been reached with an unrelated third party;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the purpose of, and the potential benefits to us of, the transaction; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any other information regarding the related person transaction or the related person in the context of the proposed transaction that would be material to investors in light of the circumstances of the particular transaction.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Our audit committee may approve or ratify the transaction only if it determines that, under all of the circumstances, the transaction is in, or is not inconsistent with, our best interests. Our audit committee may impose any conditions on the related person transaction that it deems appropriate.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In addition to the transactions that are excluded by the instructions to the SEC&#8217;s related person transaction disclosure rule, our board of directors has determined that the following transactions do not create a material direct or indirect interest on behalf of related persons and, therefore, are not related person transactions for purposes of this policy:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">interests arising solely from the related person&#8217;s position as an executive officer of another entity, whether or not the person is also a director of the entity, that is a participant in the transaction where the related person and all other related persons own in the aggregate less than a 10% equity interest in such entity, the related person and his or her immediate family members are not involved in the negotiation of the terms of the transaction and do not receive any special benefits as a result of the transaction, and the amount involved in </span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-38-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"/><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the transaction is less than the greater of $200,000 or 5% of the annual gross revenues of the company receiving payment under the transaction; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">a transaction that is specifically contemplated by provisions of our certificate of incorporation or bylaws.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The policy provides that transactions involving compensation of executive officers shall be reviewed and approved by our compensation committee in the manner specified in the compensation committee&#8217;s charter.</p><a id="_Toc193224685"></a><a id="_Toc193225899"></a><a id="_Toc193708123"></a><a id="_Toc193805404"></a><a id="_Toc194481063"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Related Person Transactions</p><a id="_Toc193224686"></a><a id="_Toc193225900"></a><a id="_Toc193708124"></a><a id="_Toc193805405"></a><a id="_Toc194481064"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">Other than the compensation arrangements for our named executive officers and directors, which are described elsewhere in the &#8220;Executive Compensation&#8221; and &#8220;Director Compensation&#8221; sections of this proxy statement, set forth below is a description of transactions since January 1, 2023 to which we were or will be a party, and in which:</span></p><a id="_Toc193224687"></a><a id="_Toc193225901"></a><a id="_Toc193708125"></a><a id="_Toc193805406"></a><a id="_Toc194481065"></a><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:26.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">the amounts involved exceeded or will exceed $120,000; and</span></td></tr></table><a id="_Toc193224688"></a><a id="_Toc193225902"></a><a id="_Toc193708126"></a><a id="_Toc193805407"></a><a id="_Toc194481066"></a><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:12pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:26.4pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">any of our directors, executive officers, nominees for director or holders of more than 5% of our capital stock, or any member of the immediate family of, or person sharing the household with, the foregoing persons, had or will have a direct or indirect material interest.</span></td></tr></table><a id="_Toc193224689"></a><a id="_Toc193225903"></a><a id="_Toc193708127"></a><a id="_Toc193805408"></a><a id="_Toc194481067"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="font-weight:normal;">We believe the terms obtained or consideration that we paid or received, as applicable, in connection with the transactions described below were comparable to terms available or the amounts that would be paid or received, as applicable, from unrelated third parties.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock Purchase Agreement and Investor Rights Agreement with Gilead Sciences, Inc.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In March 2024, we entered into a license agreement with Gilead Sciences, Inc., or Gilead, pursuant to which we granted Gilead an exclusive global license to develop and commercialize our clinical-stage product candidate, XTX301, a tumor-activated IL-12, and specified other molecules directed at IL-12. In connection with the license agreement, we entered into a stock purchase agreement with Gilead, pursuant to which we initially issued and sold 6,860,223 shares of our common stock to Gilead in a private placement at a purchase price of $1.97 per share and received aggregate gross proceeds of approximately $13.5 million. In April 2024, we issued and sold an additional 485,250 shares of our common stock at a purchase price of $0.76 per share and prefunded warrants to purchase up to an aggregate of 3,882,450 shares of our common stock at a purchase price of $0.7599 per prefunded warrant, and we received approximately $3.3 million in aggregate gross proceeds. In December 2024, we issued and sold an additional 1,759,978 shares of our common stock at a purchase price of $1.04 per share and prefunded warrants to purchase up to an aggregate of 6,092,816 shares of our common stock at a purchase price of $1.0399 per prefunded warrant, and we received approximately $8.2 million in aggregate gross proceeds. The prefunded warrants are exercisable any time at an exercise price of $0.0001 per share, subject to Gilead not being deemed a beneficial owner of greater than 19.99% of our common stock upon the exercise of the prefunded warrants.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with entering into the stock purchase agreement, we entered into an investor rights agreement with Gilead, pursuant to which Gilead is subject to certain transfer and standstill restrictions and is entitled to certain registration rights with respect to shares issued pursuant to the stock purchase agreement after the termination of the transfer restrictions. We and Gilead have each granted the other customary indemnification rights in connection with the registration of the shares issued under the stock purchase agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">March 2024 Private Placement </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In March 2024, we entered into a securities purchase agreement with certain existing accredited investors, including certain of our 5% stockholders and their affiliates, and issued and sold an aggregate of 1,953,125 shares of our common stock at a price of $0.64 per share and to one of these investors, in lieu of shares of common stock, prefunded warrants to purchase up to an aggregate of 15,627,441 shares of our common stock at a purchase price of $0.6399 per prefunded warrant, through a private placement. We received aggregate gross proceeds of approximately $11.3 million from the private placement, before deducting placement agent fees and expenses payable by us.</p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-39-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:10.35pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table sets forth the aggregate number of shares of our common stock and prefunded warrants that we issued and sold to such 5% stockholders and their affiliates, and the aggregate purchase price paid by such stockholder for such shares and prefunded warrants:</p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:56.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.21%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr style="height:3pt;"><td style="vertical-align:bottom;white-space:nowrap;width:56.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:56.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of Shares</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;white-space:pre-wrap;"> Underlying Prefunded </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Cash Purchase</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.5%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Purchaser</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares Purchased</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.21%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Warrant Purchased</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Price</b></p></td></tr><tr><td style="vertical-align:bottom;width:56.5%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Entities affiliated with Bain Capital Life Sciences Investors, LLC</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.21%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 15,627,441</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">$ 9,999,999.50</p></td></tr><tr><td style="vertical-align:bottom;width:56.5%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt;">Entities affiliated with Rock Springs Capital Management LP<sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-family:'Calibri','Helvetica','sans-serif';font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.6%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,562,500</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.21%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.97%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:11.74%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:right;margin:0pt 3pt 0pt 0pt;">$ 1,000,000.00</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18.75pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">See &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; for additional information about shares held by these entities.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Consists of (i) 1,330,625 shares of common stock purchased by Rock Springs Capital Master Fund LP and (ii) 231,875 shares of common stock purchased by Four Pines Master Fund LP.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 0pt 18pt;"><span style="font-size:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with entering into the securities purchase agreement, we entered into a registration rights agreement with each of the investors in the private placement, pursuant to which we agreed to file within 30 days of the closing of the private placement, a registration statement covering the resale by the investors of the shares of common stock issued and sold in, and the shares of common stock underlying the prefunded warrants issued and sold in, the private placement. The registration rights agreement requires us to pay certain expenses relating to such registration, and we have granted the investors, and the investors have granted us, customary indemnification rights in connection with the registration statement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Stock Purchase Agreement and Investor Rights Agreement with AbbVie Inc.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In February 2025, we entered into a collaboration, license and option agreement with AbbVie Inc., or AbbVie, for up to four programs leveraging our proprietary tumor-activation technology and platform. In connection with the collaboration, license and option agreement, we entered into a stock purchase agreement with AbbVie, pursuant to which we issued and sold 4,347,826 shares of our common stock to AbbVie in a private placement at a purchase price of $2.30 per share and received aggregate gross proceeds of approximately $10.0 million. As a result of its stock purchase, AbbVie owned approximately 8.4% of our outstanding shares of common stock as of March 31, 2025. &#160;See &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; for additional information about shares held by AbbVie.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">In connection with entering into the stock purchase agreement, we entered into an investor rights agreement with AbbVie, pursuant to which AbbVie is subject to certain transfer and standstill restrictions and is entitled to certain registration rights with respect to shares issued pursuant to the stock purchase agreement after the termination of the transfer restrictions. We and AbbVie have each granted the other customary indemnification rights in connection with the registration of the shares issued under the stock purchase agreement.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-40-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);min-height:10.35pt;"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc193222807"></a><a id="_Toc194481068"></a><a id="_4e86d840_4575_4290_802c_3e8636d347f8"></a><a id="STOCKOWNERSHIPANDREPORTING_51571"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">STOCK OWNERSHIP AND REPORTING</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Security Ownership of Certain Beneficial Owners and Management</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Unless otherwise provided below, the following table sets forth information with respect to the beneficial ownership of our common stock as of March 31, 2025 by:</p><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each person, or group of affiliated persons, who is known to us to be the beneficial owner of 5% or more of the outstanding shares of our common stock.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each of our directors;</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">each of our named executive officers listed in the Summary Compensation table above; and</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="width:36pt;"/><td style="font-family:'Times New Roman','Times','serif';font-size:10pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">&#9679;</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:normal;font-weight:normal;">all of our directors and executive officers as a group.</span></td></tr></table><div style="margin-top:12pt;"></div><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Beneficial ownership is determined in accordance with the rules&#160;and regulations of the SEC and includes voting or investment power with respect to our common stock. Shares of our common stock subject to options that are currently exercisable or exercisable within 60&#160;days after March 31, 2025 are considered outstanding and beneficially owned by the person holding the options for the purpose of calculating the&#160;percentage ownership of that person but not for the purpose of calculating the&#160;percentage ownership of any other person. Except as otherwise noted, the persons and entities in this table have sole voting and investing power with respect to all of the shares of our common stock beneficially owned by them, subject to community property laws, where applicable. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The column entitled &#8220;Percentage of Shares Beneficially Owned&#8221; is based on a total of 51,775,264 shares of our common stock outstanding as of March 31, 2025. Except as otherwise set forth below, the address of the beneficial owner is c/o&#160;Xilio Therapeutics,&#160;Inc., 828 Winter Street, Suite&#160;300, Waltham, Massachusetts 02451. Beneficial ownership representing less than one percent of our outstanding common stock is denoted with an &#8220;*.&#8221; </p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:55.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Total Shares</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Percentage of</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Owned plus</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:solid;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Right to </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Right to </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Beneficially</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;"><b style="font-weight:bold;">Name of Beneficial Owner</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Shares Owned</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Acquire</b><sup style="font-size:6pt;font-weight:bold;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Acquire</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">Owned (%)</b></p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">5 % Stockholders</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Gilead Sciences, Inc.<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(2)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9,105,451</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 9,105,451</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">17.6%</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">GKCC, LLC<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(3)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7,000,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 7,000,000</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">13.5%</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">AbbVie, Inc<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(4)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4,347,826</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 4,347,826</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">8.4%</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Entities affiliated with Rock Springs Capital Management LP<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(5)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,003,259</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,003,259</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5.8%</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Entities affiliated with Bain Capital Life Sciences Investors, LLC<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(6)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,805,413</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,805,413</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">5.4%</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-style:italic;font-weight:bold;">Named Executive Officers and Directors</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Ren&#233; Russo, Pharm.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 244,883</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 1,945,892</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 2,190,775</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">4.1%</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Christopher Frankenfield</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 19,375</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 598,515</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 617,890</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">1.2%</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Katarina Luptakova, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 16,625</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 168,176</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 184,801</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Sara M. Bonstein</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 79,613</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 79,613</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Aoife Brennan, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Paul J. Clancy</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 194,095</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 194,095</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Daniel Curran, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Robert Ross, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,800</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 30,800</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Christina Rossi</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 79,613</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 79,613</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">James Shannon, M.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Yuan Xu, Ph.D.</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> &#8212;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 52,800</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 52,800</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td></tr><tr><td style="vertical-align:bottom;width:55.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">All executive officers and directors as a group (12 persons)<sup style="font-size:7.5pt;line-height:100%;top:0pt;vertical-align:top;">(7)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.22%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 285,883</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,202,628</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.37%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"><span style="white-space:pre-wrap;"> 3,488,511</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.57%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">6.3%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;margin-top:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18.75pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Consists of shares of our common stock that may be acquired upon&#160;the exercise of stock options to purchase shares of our common stock that are exercisable on or within 60&#160;days of </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">March 31, 2025.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18.75pt;padding:0pt;">(2)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Based on a Schedule 13G/A filed by Gilead Sciences, Inc., or Gilead, on December 19, 2024, reporting beneficial ownership as of December 18, 2024. Consists of 9,105,451 shares of common stock owned by Gilead and excludes prefunded warrants to purchase up to 9,975,266 shares of common stock held by Gilead. The prefunded warrants may not be exercised to the extent that Gilead would beneficially own more than 19.99% of our shares of outstanding common stock after giving effect to such exercise. The address for Gilead is 333 Lakeside Drive, Foster City, California 94404.</span></td></tr></table></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-41-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(3)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Based solely on a Schedule 13G filed by GKCC, LLC, on September 27, 2024, reporting beneficial ownership as of June 7, 2024. Consists of shares of common stock held by GKCC, LLC and beneficially owned by GKCC, LLC and Yekaterina Chudnovsky, who is the sole member and manager of GKCC, LLC. Each of GKCC, LLC and Yekaterina Chudnovsky has sole voting and dispositive power over the shares of common stock. The address GKCC, LLC and Yekaterina Chudnovsky is 501 Silverside Road, Suite 87AVA, Wilmington, DE 19809.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(4)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Based solely on a Schedule 13G filed by AbbVie, Inc., or AbbVie, on February 18, 2025, reporting beneficial ownership as of February 11, 2025. Consists of shares of common stock held by and beneficially owned by AbbVie. AbbVie has sole voting and dispositive power over the shares of common stock. The address of AbbVie is 1 North Waukegan Road, North Chicago, Illinois, 60064-6400.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(5)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Based solely on a Schedule 13G/A filed by Rock Springs Capital Management LP, or RSCM, Rock Springs Capital LLC, or RSC, and Rock Springs Capital Master Fund LP, or RS Master Fund, on November 12, 2024, reporting beneficial ownership as of September 30, 2024. Consists of (i) 2,600,625 shares of common stock held by RS Master Fund and beneficially owned by RSCM and RSC (ii) 402,634 shares of common stock held by Four Pines Master Fund LP and beneficially owned by RSCM and RSC. Each of RSCM and RSC have shared voting and shared dispositive power over 3,003,259 shares and RS Master Fund has shared voting and shared dispositive power over 2,600,625 shares. The address of RSCM and RSC is 650 South Exeter, Suite 1070, Baltimore, Maryland 21202, and the address of RS Master Fund is c/o Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman, KY1-9008, Cayman Islands.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(6)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Based on a Schedule 13G/A filed by Bain Capital Life Sciences Fund II,&#160;L.P., on November 14, 2024, reporting beneficial ownership as of September 30, 2024. Consists of (i)&#160;1,348,682 shares of common stock held by Bain Capital Life Sciences Fund II,&#160;L.P., or BCLS II, (ii) 1,292,469 shares of common stock held by BCLS II Investco, LP, or BCLS II Investco, and (iii)&#160;164,262 shares of common stock held by BCIP Life Sciences Associates, LP, or BCIPLS, </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">and, together with BCLS II and BCLS II Investco, the Bain Capital Life Sciences Entities. </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Amounts reported do not include prefunded warrants to purchase up to 15,627,441 shares of common stock held by BCLS II Equity Opportunities, LP, or BCLS II Equity. The prefunded warrants may not be exercised to the extent that the holder (together with its affiliates) would beneficially own more than 9.99% of our shares of outstanding common stock after giving effect to such exercise. </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">BCLS II has shared voting and dispositive power over all shares held by the Bain Capital Life Science Entities, and each of the other Bain Life Sciences Entities shares voting and dispositive power over the shares it holds with BCLS II</span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">. </span><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">The address of Bain Capital Life Sciences Entities is c/o Bain Capital Life Sciences, LP, 200 Clarendon Street, Boston, MA 02116.</span></td></tr></table><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18.75pt;padding:0pt;">(7)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Consists of (a) 285,883 shares of common stock and (b) 3,202,628 shares of common stock underlying options exercisable within 60 days of March 31, 2025.</span></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-42-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc193222808"></a><a id="_Toc194481069"></a><a id="_e0779d1b_32aa_4458_8466_153f357b33a9"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">DELINQUENT SECTION 16(a) REPORTS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Section 16(a) of the Exchange Act requires our directors, executive officers and persons who own more than 10% of our common stock to file with the SEC initial reports of beneficial ownership and reports of changes in beneficial ownership. Directors, executive officers and persons who own more than 10% of our common stock are required by SEC regulations to furnish us with copies of all such reports. To our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, we believe that for fiscal year 2024, all required reports were filed on a timely basis under Section 16(a), except for one late Form 3 reporting the holdings of GKCC, LLC, filed on September 27, 2024.</p><a id="_Toc193222809"></a><a id="_Toc194481070"></a><a id="_7d5056f2_50ce_4b80_af98_74b9fdc974a4"></a><a id="HOUSEHOLDING_704521"></a><a id="STOCKHOLDERSSHARING_298650"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 9pt 0pt;">STOCKHOLDERS SHARING THE SAME ADDRESS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">Some banks, brokers and other nominee record holders may be participating in the practice of &#8220;householding&#8221; proxy statements and annual reports. This means that only one copy of our proxy materials, including the notice of internet availability of proxy materials or, if requested, the 2024 Annual Report and proxy statement, may have been sent to multiple stockholders in your household, unless you have requested otherwise. We will promptly deliver a separate copy of any of the above documents to you if you write or call us at Xilio Therapeutics, Inc., 828 Winter Street, Suite 300, Waltham, Massachusetts 02451, Attention: Corporate Secretary, telephone: (857) 524-2466, e-mail: <i style="font-style:italic;">investors@xiliotx.com</i>. If you would like to receive separate copies of the notice of internet availability of proxy materials, proxy statement or annual report to stockholders in the future, or if you are receiving multiple copies and would like to receive only one copy per household, you should contact your bank, broker or other nominee record holder, or you may contact us at the above address, phone number or e-mail.</p><a id="_Toc193222810"></a><a id="_Toc194481071"></a><a id="_4b3339dc_046d_4fbd_88d7_2a68ed53db00"></a><a id="STOCKHOLDERPROPOSALSFOROUR2023ANNUALMEET"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 9pt 0pt;">STOCKHOLDER PROPOSALS FOR OUR 2026 ANNUAL MEETING</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">A stockholder who would like to have a proposal considered for inclusion in our 2026 proxy statement must submit the proposal in accordance with the procedures outlined in Rule 14a-8 of the Exchange Act so that it is received by us no later than __________. However, if the date of the 2026 annual meeting of stockholders is changed by more than 30&#160;days from the first anniversary of the previous&#160;year&#8217;s meeting, then the deadline is a reasonable time before we begin to print and send our proxy statement for the 2026 annual meeting of stockholders. SEC rules&#160;set standards for eligibility and specify the types of stockholder proposals that may be excluded from a proxy statement. Stockholder proposals should be addressed to Xilio Therapeutics,&#160;Inc., 828 Winter Street, Suite&#160;300, Waltham, Massachusetts 02451, Attention: Corporate Secretary.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">If a stockholder wishes to propose a nominee for election to our board of directors or present a proposal at an annual meeting but does not wish to have the proposal considered for inclusion in our proxy statement, the nominating stockholder must comply with the advance notice procedure set forth in our bylaws and the additional requirements and procedures outlined in Rule 14a-19 of the Exchange Act. Stockholders at an annual meeting may only consider proposals or nominations (i) specified in the notice of meeting or (ii) brought before the meeting (a) by or at the direction of the board of directors or (b) by a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has complied with the procedures in our bylaws and timely delivered to our corporate secretary notice in proper form of the stockholder&#8217;s intention to bring such business before the meeting.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">The required notice must be in writing and received by our corporate secretary at our principal executive offices not less than 90&#160;days nor more than 120&#160;days prior to the first anniversary of the preceding&#160;year&#8217;s annual meeting. Therefore, for stockholder proposals to be brought before the 2026 annual meeting of stockholders, the required notice must be received by our corporate secretary at our principal executive offices no earlier than February 10, 2026 and no later than March 12, 2026. However, in the event that the date of the 2026 annual meeting is advanced by more than 30 days, or delayed by more than 60 days, from the first anniversary of the preceding year&#8217;s annual meeting, a stockholder&#8217;s notice must be so received no earlier than the 120th day prior to such annual meeting and not later than the close of business on the later of (A) the 90th day prior to such annual meeting and (B) the tenth day following the day on which notice of the date of such annual meeting was mailed or public disclosure of the date of such annual meeting was made, whichever first occurs. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">In addition to satisfying the foregoing requirements, to comply with the SEC&#8217;s universal proxy rule, stockholders who intend to solicit proxies in support of director nominees other than the company&#8217;s nominees in compliance with Rule 14a-19 under the Exchange Act must comply with the additional requirements of Rule 14a-19(b), including providing notice of such proxy solicitation. Such notice must be provided by no later than March 12, 2026; however, if the date of our 2026 annual meeting of stockholders changes by more than 30 calendar days from the first anniversary of our 2025 annual </p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-43-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 9pt 0pt;">meeting of stockholders, then such notice must be provided by the later of 60 calendar days prior to the date of the 2026 annual meeting of stockholders or the 10th calendar day following our public announcement of the date of the 2026 annual meeting of stockholders.</p><a id="_Toc193222811"></a><a id="_Toc194481072"></a><a id="_63258253_59b3_42b2_aeb4_1ffc73c1b4fb"></a><a id="OTHERMATTERS_34947"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">OTHER MATTERS</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">As of the date of this proxy statement, we do not know of any other matters to be brought before the annual meeting. However, if any other matters not mentioned in this proxy statement are properly brought before the meeting, the individuals named in the proxy intend to use their discretionary voting authority under the proxy to vote the proxy in accordance with their best judgment on those matters.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-44-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><a id="_Toc194481073"></a><a id="_1a54f821_eed3_447d_add2_6f1a0b73d99c"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">APPENDIX A</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">CERTIFICATE OF AMENDMENT OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">RESTATED CERTIFICATE OF INCORPORATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">XILIO THERAPEUTICS, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:11pt;">(Pursuant to Section 242 of the</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="font-size:11pt;">General Corporation Law of the State of Delaware)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:11pt;">Xilio Therapeutics, Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware, does hereby certify as follows:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt;"><span style="font-size:11pt;white-space:pre-wrap;">A resolution was duly adopted by the Board of Directors of the Corporation pursuant to Section 242 of the General Corporation Law of the State of Delaware setting forth a proposed amendment to the Restated Certificate of Incorporation of the Corporation and declaring said amendment to be advisable.  The stockholders of the Corporation duly approved said proposed amendment in accordance with Section 242 of the General Corporation Law of the State of Delaware. The resolution setting forth the amendment is as follows:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:108pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">RESOLVED</span><span style="font-size:11pt;">:</span></p></td><td style="padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;"><span style="font-size:11pt;">That the first sentence of Article FOURTH of the Restated Certificate of Incorporation of the Corporation be and hereby is deleted in its entirety and the following is inserted in lieu thereof:</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:108pt;text-indent:-108pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0pt 36pt;"><span style="font-size:11pt;white-space:pre-wrap;">&#8220;FOURTH:  The total number of shares of all classes of stock that the Corporation shall have authority to issue is 605,000,000 shares, consisting of (i) 600,000,000 shares of common stock, $0.0001 par value per share (&#8220;Common Stock&#8221;), and (ii) 5,000,000 shares of preferred stock, $0.0001 par value per share (&#8220;Preferred Stock&#8221;).&#8221;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;padding-left:36pt;text-indent:-36pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;">IN WITNESS WHEREOF, this Certificate of Amendment has been executed by a duly authorized officer of the Corporation on this __ day of _______, 2025.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:234pt;margin:24pt 0pt 18pt 0pt;"><b style="font-family:'Times New Roman Bold';font-size:11pt;font-weight:bold;text-transform:uppercase;">XILIO THERAPEUTICS, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:234pt;margin:0pt;"><span style="font-size:11pt;">By: ________________________________</span></p><a id="_Hlk192055667"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:234pt;margin:0pt;"><span style="font-size:11pt;">Ren</span><span style="font-size:11pt;">&#233;</span><span style="font-size:11pt;"> Russo </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:234pt;margin:0pt;"><span style="font-size:11pt;">President and Chief Executive Officer</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-45-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:79.3%;border:0;margin:30pt 10.35% 30pt 10.35%;"></div><div style="max-width:100%;padding-left:10.35%;padding-right:10.35%;position:relative;"><div style="margin-top:21.6pt;min-height:41.75pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 10pt 0pt;"><a href="#TOC"><span style="font-style:normal;font-weight:normal;">Table of Contents</span></a></p></div><div style="clear:both;margin-left:-10.0pt;margin-right:-10.0pt;max-width:100%;position:relative;width:calc(100% + 20.0pt);"><div style="padding-left:10pt;padding-right:10pt;position:relative;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><a id="_Toc193222812"></a><a id="_Toc194481074"></a><a id="_f337a94b_c4e2_4e54_9111_552ec3736f84"></a><a id="_Toc192636858"></a><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:center;margin:0pt 0pt 12pt 0pt;">APPENDIX B</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">CERTIFICATE OF AMENDMENT OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">RESTATED CERTIFICATE OF INCORPORATION</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">OF</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><b style="font-size:11pt;font-weight:bold;">XILIO THERAPEUTICS, INC.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;">(Pursuant to Section 242 of the</span><span style="font-size:11pt;"><br/></span><span style="font-size:11pt;">General Corporation Law of the State of Delaware)</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;">Xilio Therapeutics, Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the State of Delaware, does hereby certify as follows:</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;">A resolution was duly adopted by the Board of Directors of the Corporation pursuant to Section 242 of the General Corporation Law of the State of Delaware setting forth a proposed amendment to the Restated Certificate of Incorporation of the Corporation and declaring said amendment to be advisable.&#160;&#160;The stockholders of the Corporation duly approved said proposed amendment in accordance with Section 242 of the General Corporation Law of the State of Delaware.&#160;&#160;The resolution setting forth the amendment is as follows:</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr><td style="vertical-align:top;white-space:nowrap;width:23.07%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">RESOLVED</span><span style="font-size:11pt;">:</span></p></td><td style="vertical-align:top;width:76.92%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;">That Article SEVENTH of the Restated Certificate of Incorporation of the Corporation be and hereby is deleted in its entirety and the following is inserted in lieu thereof:</span></p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;white-space:pre-wrap;">&#8220;SEVENTH:  To the fullest extent permitted by the General Corporation Law of the State of Delaware, no director or officer of the Corporation shall be personally liable to the Corporation (in the case of directors) or its stockholders (in the case of directors and officers) for monetary damages for any breach of fiduciary duty as a director or officer.  No amendment, repeal or elimination of this provision shall apply to or have any effect on its application with respect to any act or omission of a director or officer occurring before such amendment, repeal or elimination.  If the General Corporation Law of the State of Delaware is amended to permit further elimination or limitation of the personal liability of directors or officers, then the liability of a director or officer of the Corporation shall be eliminated or limited to the fullest extent permitted by the General Corporation Law of the State of Delaware as so amended.&#8221;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:11pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;"><span style="font-size:11pt;">IN WITNESS WHEREOF, this Certificate of Amendment has been executed by a duly authorized officer of the Corporation on this __ day of _______, 2025.</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:234pt;margin:24pt 0pt 18pt 0pt;"><b style="font-family:'Times New Roman Bold';font-size:11pt;font-weight:bold;text-transform:uppercase;">XILIO THERAPEUTICS, Inc.</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:234pt;margin:0pt;"><span style="font-size:11pt;">By: ________________________________</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:234pt;margin:0pt;"><span style="font-size:11pt;">Ren&#233; Russo</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:234pt;margin:0pt;"><span style="font-size:11pt;">President and Chief Executive Officer</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"><span style="visibility:hidden;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p></div></div><div style="clear:both;margin-bottom:30pt;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;">-46-</p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:10.35%;margin-right:10.35%;margin-top:30pt;page-break-after:avoid;width:79.3%;border:0;"></div><div><div style="align:center"><div style="align:center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td style="padding:0in 5.4pt 0in 5.4pt;valign:top;width:92.3%"><p style="align:center;margin:0in 0in .0001pt;text-align:center;"><img src="xlo-20250610xpre14a_bg001.jpg" alt="GRAPHIC"/></p></td><td style="padding:0in 5.4pt 0in 5.4pt;valign:middle;width:7.7%"><p style="margin:0in 0in .0001pt;"><span style="font-family:Arial;font-size:1;color:white;font-size:1.0pt;">Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
KEEP THIS PORTION FOR YOUR RECORDS
DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
V71580-P29250
! ! !
For
All
Withhold
All
For All
Except
For Against Abstain
! ! !
! ! !
! ! !
XILIO THERAPEUTICS, INC. To withhold authority to vote for any individual
nominee(s), mark "For All Except" and write the
number(s) of the nominee(s) on the line below.
1. To elect each of the Class I directors nominated by our
Board of Directors to serve for a three-year term expiring
at the 2028 Annual Meeting of Stockholders and until
such director&#8217;s successor has been duly elected and
qualified:
2. To approve an amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 200,000,000 to
600,000,000.
3. To approve an amendment to our certificate of incorporation to reflect Delaware law provisions regarding officer exculpation.
4. To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.
Note: The proxies are authorized to vote, in their discretion, on any other business as may properly come before the Annual Meeting or any adjournment
or postponement thereof.
The Board of Directors recommends voting FOR ALL of the
nominees listed in Proposal 1 and FOR Proposals 2, 3 and 4.
Nominees:
Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor,
administrator, or other fiduciary, please give full title as such. Joint owners should each sign
personally. All holders must sign. If a corporation or partnership, please sign in full corporate
or partnership name by authorized officer.
01) Ren&#233; Russo, Pharm.D.
02) Sara M. Bonstein
03) James Shannon, M.D.
SCAN TO
VIEW MATERIALS &amp; VOTEw XILIO THERAPEUTICS, INC.
828 WINTER STREET, SUITE 300
WALTHAM, MA 02451
VOTE BY INTERNET
Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above
Use the Internet to transmit your voting instructions and for electronic delivery of information
up until 11:59 P.M. Eastern Time on June 9, 2025. Have your proxy card in hand when
you access the website and follow the instructions to obtain your records and to create an
electronic voting instruction form.
During The Meeting - Go to www.virtualshareholdermeeting.com/XLO2025
You may attend the meeting via the Internet and vote during the meeting. Have the information
that is printed in the box marked by the arrow available and follow the instructions.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until
11:59 P.M. Eastern Time on June 9, 2025. Have your proxy card in hand when you call and
then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we
have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way,
Edgewood, NY 11717. Proxies submitted by mail must be received by
Broadridge Financial Solutions, Inc. no later than June 9, 2025.</span></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:always;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="align:center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td style="padding:0in 5.4pt 0in 5.4pt;valign:top;width:92.3%"><p style="align:center;margin:0in 0in .0001pt;text-align:center;"><img src="xlo-20250610xpre14a_bg002.jpg" alt="GRAPHIC"/></p></td><td style="padding:0in 5.4pt 0in 5.4pt;valign:middle;width:7.7%"><p style="margin:0in 0in .0001pt;"><span style="font-family:Arial;font-size:1;color:white;font-size:1.0pt;">V71581-P29250
XILIO THERAPEUTICS, INC.
Annual Meeting of Stockholders
June 10, 2025 11:00 AM ET
This proxy is solicited by the Board of Directors
The stockholder(s) hereby appoint(s) Ren&#233; Russo and Caroline Hensley, or each of them, as proxies, each with the
power to appoint his/her substitute, and hereby authorize(s) them to represent and to vote, as designated on the
reverse side of this ballot, all of the shares of Common Stock of Xilio Therapeutics, Inc. that the stockholder(s) is/are
entitled to vote at the Annual Meeting of Stockholders to be held at 11:00 AM ET on June 10, 2025, via a live webcast at
www.virtualshareholdermeeting.com/XLO2025, and any adjournment or postponement thereof.
This proxy, when properly executed, will be voted in the manner directed herein. If no such direction is made, this
proxy will be voted in accordance with the Board of Directors' recommendations.
Continued and to be signed on reverse side
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The 2024 Annual Report, Notice of Meeting and 2025 Proxy Statement are available at www.proxyvote.com.</span></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:avoid;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>xlo-20250610xpre14a_a003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 xlo-20250610xpre14a_a003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" "0 .<# 2(  A$! Q$!_\0
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M?O#\10)Z'[)_#[XI>$_BKI]Q?>$M>LM>M;>3RII;.4.$?&<'TX-=7@U^!7[
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ML/@>W_:8\=I\.Y$D\+B^/E>2 (5FVCSQ%C@QB7?M(XQC'&#7ZH_\%-OVO/\
MA17PT;P9X<O?+\:>)(6B\R)\/96IX>3U#-RJ_B>PK\:OAQ\/];^+/CS1O"F@
M6S7NLZO=+;P1C^\QY9CV &22>@!H(?8Q='%D=7LAJ)D73S,GV@Q??$>X;L>^
M,U_29\!H/"-O\'O":>!#$WA3[!$;%HL?,FWJV/XLYS[YK\'?VOOV5-:_90^(
M\6@7T[:GI-Y;I<6&JB/8EQ\H$BXYP5;(QZ;3WKZJ_P""47[7O_"'Z_\ \*C\
M47NW1]2D,FC3S-Q!.?O19/9NH]Z 6FA^NU?S=_M7:?XKL/VCOB''XRCN$UU]
M;NG<S@_,C2L8RF?X"A4KCC!&*_I$KD/%OPC\$>/=2MM0\2>$=$UV_ML"&YU"
MPBFD0 Y #,I.,]NE!9\O?\$G]/\ %5A^RO;?\)(MS':2ZA,^E)= [A;8497/
M\)8''XUZ1_P4%_Y,W^)__8/C_P#2B*OH&VMH;.WC@MXD@@B4(D4:A511P  .
M !Z5\_?\%!?^3-_B?_V#X_\ THBH _GSC_UB_45_3/\ "C_DEO@[_L#6?_HA
M*_F8C_UB_45_3/\ "C_DEO@[_L#6?_HA*"(GGG[:_P#R:E\3?^P/)_Z$M?SL
MU_1-^VO_ ,FI?$W_ + \G_H2U_.S0$C^ESX$?\D2^'__ & +#_TG2NX;K7#_
M  (_Y(E\/_\ L 6'_I.E=PW6@L_.G]O?_DM,7_8/B_K6I_P3T_Y*KKW_ &"&
M_P#1L=9?[>__ "6F+_L'Q?UK4_X)Z?\ )5=>_P"P0W_HV.OBX_\ (S_[>/ZA
MK?\ )!K_ *]+\T?:/Q@+CX5^+3'_ *S^S+C;CUV&ORETWH*_7OQ!IB:UH6H6
M$@RES \1'U4BOR2NM)FT'6;W3;@%9[2=X'!'=6(/\J.(HOW)=-3YWPQK1]AB
MZ/6\7\M4?K%X%$8\%Z$(<>7]BAVX_P!P5NUY1^S'XUB\9_"/1R) UU8)]DG7
M/(9>A/U&*]7KZO#5(U:,)QV:1^(YC0GA<96HU-XR:_$****Z3S@KS']H,(?!
M$.[[PO$V_7:W],UZ=7AG[1GB%))M,T6-@60FYE [<;5_]FKY+BRO"ADV(<^J
MLO5NW_!/?R&E*KF-)1Z._P D<+\-MW_"9Z-MZ_:%KZJKYK^"VF-J'C6T?&4M
MP96/I@<5]*5\KX=4I0RVK4>TIZ?)(]?BR:EC(Q6ZC^K"BBBOU<^)%'6N'^-O
MQ>T3X%_#36O&6OS".ST^$LL>?FFD_@C7U).*[9G6-2[D*JC))Z 5^)'_  4U
M_:Z;XY?$I_!OAZ\+^#?#LS1%XS\MW=#AW]U7H/Q- F['R_\ &[XOZW\=/B9K
M7C+7YVEO=0F++'GY88Q]R-?0 8%?J7_P2=_9)_X5_P"#W^+7B6SV^(->A\O2
M(I5^:ULCUDP>C2?^@C_:-?#'[ '[*L_[37QEMEU&!O\ A#=#9+S5I>@EP<I
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M%KYZ_P""@O\ R9O\3_\ L'Q_^E$5!1_/G'_K%^HK^F?X4?\ )+?!W_8&L_\
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MH2.R_P Z_+\SQN/XPQ<,+AH6@NG1?WI/^NR/KL/@<)PSAI5J\KS?7OY)'??
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M^->BT4#/RI7_ ((JZFK _P#"Q+/@Y_X]7K]0/"6B'PSX4T71VD$S:?90VAD
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MWE3H4;!$>#@UY)^VIHW@>;]M3P[?_$_PYJ.N^"5\,R1LMC;R2XN-X\O[G/\
M>H ^T_V??#/C#PSX1NX_&7CZ+XB7D]VTMOJ<,*1I'%M5?+&S@X8,<^]>-?\
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,Y"I*** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>xlo-20250610xpre14a_a004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 xlo-20250610xpre14a_a004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  = 'X# 2(  A$! Q$!_\0
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%BB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>xlo-20250610xpre14a_bg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 xlo-20250610xpre14a_bg001.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1, U$# 2(  A$! Q$!_\0
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M"_I78R-2I/!#/9AAFG/&&.20-=(?L:#ZG\R&H=UW_H/ZA_H[D?\ +2+^7/\
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M1_: _KZ>S;_U?,?Y9RZX11$1$<G^P!_,]<__ ,).5_\ S:ZP7)_L ?S/7/\
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MCM3JA?Z"RPZ.LLCE9;_TEC,C8I"!'*Z,0<VL<2-B1]8^T*IOOR#?Q4G]?_\
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MS]/==H&-I>UY:"]H(#B/(W]4;&UA<6M#2X[G8;;G[2A7!-C2G5K5_M)]=/\
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MK1=\M,_ =PL].6WG;\FZ]40$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1
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M[(0'618G9,U[G@_$6ANV_P!>^_CT1'[6T7@<ADL=.[(S27=.1,H/#7-8SDR
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M\NT#T_@T%!+#6FC?$^O5@X10")N\,0C+]@3Y=L#^3;U*(EB(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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M=H)#1Z'X0$"]TCU&)X98;T5R*26>6]3GREF)EHNDF,6[PUQ'!LD>P _]V!Z
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M';XA]$;N^+P%[HJPRG4O,PVM*0U\;!#>S=4.=!/;;)# ]SV GE&#SV#CL6N
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MR*&WNK&G\;?RM*S-/';QL#;,\#8B^3@YS6^&MW)/)[1MM]?C=?5?JI@[-CL
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M5-,6K5AK0QKI>[SV;'MR;*73-V ^([;ANP$NM]/ZLIQ1I7[N(?CJ;L?&ZD6
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MK!D:]T;VAL>S"UNS2?H@>@"TYZ7:HR>KKUW)Y"N,1:N,EEJ5KLK6RQLDD('
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MTWC*&$IUI&4:-6.&*4EO$AHXANV^^^PW/C;SZHB%ZZP^ICJPY#"?*,E:2A%
M]M6S$UH LM=*&-D< )'1%W%Q&WCU!V6WJ8#*:@Z<6,7F))X,C.V=L<D[V.FB
M'=>:[GF/=I>UHB)()\@^2M;JSIY9U5U+Q.5D,=?'4*C'"R(FNG[S;#9 R-Y=
MO&"&[.(:>326[C=:C(8OJ!6P./;#8R5O(.@M22&&>L#';+V^[]SD0TP-:';M
M;N?M!*##GQ/4 4/E-M:U4R^29///6I6*_P#LUH"-E5LCGNV="&M>7!A/EY\%
M?N4T[K^M;L08>YD*E:7+VIWV7F&R[@X,,!:U\S-H@>8+=]]]OA(\K<Y6AK:U
MF]3-9%)+B)1%\EQR20.XN$D?=+@?J(!+-]]@'[[$M"Q(,7U!D9JUUO(VV/E>
M\4(J]> M#>^3&8W&<'8Q;-<"(SY)!Y#<E;7JET^M=0,AIVN#%'1@=8]ZLOA;
M(Z'E%Q:Z(.<.,F_T7@.XGSLM+E\1U K13NJV<G:DDEONKMAGK#LO[H%(OYD;
MPB,$N W<2?()VVL&J,I8T7&)HY<=F7T=G,9(R>2&8Q^@<XAKR'?62 2/790-
MTG4&M@L8R+'7'VWU9:\H%FNYS)18CX3/+Y/ =$)#Q:YY;OQ\G8HC'SM3J!<J
MV&X^;(P7'9243V8G5I8C5'=[/N[#,S;B>SSY%KCL?I>B6:G4*LZYL,AD3%=@
MG9+W8*[;3-GB2+B)CVF-/%W,;EVX!8=G$^>-T_KG'1ZI@HMR-/OC)257RSU7
M1F:2USK/@&Y+?FW2%W< \D;[[>,S_1S7%:MG(/?+>3BGK78ZK+LM=X#A+'[M
MMX'K&9-R[\G+SL@^:F$U]6N/L,L25F13@0UB^ 5S&Z:R9'O:WR?A-<_;X\>>
M2=(-6Y.];O07Y,EDXI)8(([#Y(+,4<PKE\[N["2P,+AX&^X+@-AZ#VSFE<_)
MD]02P'+R129S'7J_8NL:U]=@A$S& O'$ MD):=M_&VZ\H<?U&#-5RS79W222
MN%*O%% T=OWC<&"0RG9W8^'9[&#EL2?4D-SK ZH=G+C\5#<MUO<1'0]TGA9!
M%:)D:]U@.<'N !C( W'PN\ K!T=@M2X#4E2BQUI^ J.?!W72P.JOJMA:(@UH
M/<[W<!+B1Y^/R1Q"WW2S$9'#::L19."U7L2Y&W8:R[)')-VWS/=&7NC);OQ(
M^O?[?.ZK^A!K#1.GM06I3<H5J4=FW&R[/6?'/,+CI(HX>!):V2(\"';'=[?[
M6Y0>NJ-"ZGFZOV\_B\>\1]D"&\/=FCQ4E8&\R_N[B1S/@+>!]2? 6P]QZ@XN
MY!V?E#*/ACC+736:S:\K/=W&5DG]H2F?T<UO$#CL=@X*?8"/+-T?5^4)#)FG
MUNY*3L.,S@7<1]6S2>(_( H+I;":^Q%ZG8OWK^38&L$]>U8K\'$TB7^6CP?>
M0T C?8>@X[H(OEL'U+RVC+N.O0Y*?OLN1Q10SU(Y27,A[/=+Y7 Q@FP#\1/H
M=AXVE%K#ZW;CX+$,]JW9D=;=.Z.6OWFPNNP&..!QV:TFLR3;SZ^7'ELO+2>,
MUW:@A&=K2AHN3/#;+H'/CA?2(#>0D>3M.7#?<$CZFM\";8G'9/&=-:=")AAS
M%?$,@8P.:2R=L(:!OOQ\.'KOL@J.K-JW2EK3V*ELWJMFU>8^"D;=1TG"3(S/
MG=88UQ<\&!T9Y1@ANSO+3N5/>F$NK,9!'6U=)=NY"Z[D-ZL;8J[FL!D/<9*\
M<'.(X@\3]C0/36X33^OL=:F,V4O6V/BEB;[W- YK2:L98_X0#O[QW!^0>-N.
MR_!)K^Y'6LOQ^0@,>0K;T'SUF]V$01ME<Y[)3Q:).XX <B[;8MV((*VNL-)V
M;747!9VAC9KEJ$1023SQU'U((!(XR.W>>\V7BX[&/P3Q!W&^VXZ>8"73M+,U
MGQ=F.3+6IX6]T2$QO?R!)W)W.^_GSY\K]T)BLAB9-0QW_>W";*S3UY+4[96N
MA=L6\-B2UH\C8@;$>BAS,)K;'ZMU--BHK5>&U/:G@DM35W4W[U8VP%K [N!_
M>;YY #B#N=N*(C;NFFL16DQ+:CODE^<.>)]ZCW$GO_+M;<OHEFT_YP1Z^%O-
M/83J;*^!V4RMACS9=)/%VX(XP6Q3<=G-D>YT3I.SX#6$!OIY<IKTQIZAIZ<+
M=26K%F\Z4N:+4,<<D;>+=VDQRR!WQ<COR^O;8 !134>&ZA.QS1C<E;CGGRUM
M\KV-@E?#6W>*W!IDC;P X$@NY'QN"-P@\(<=U"FN:;[4^4H5V@.R3K8K6'.G
MYQ\]PV9H$1:)  T';<GB"&K1RZ>ZE&_:N1?*,-V:&K!;L/DJR%X;+8=)[LT2
MLXL^.$_$YIX[[?%N#,\S6UL3JCW,VW9$UPW$6&.@%,#MQ[CMEX=W>?<(+_A^
MC\0"\*.%UNS&,<^U)-?9C;7:GGBACD$_?C?#$[:23<%K2TNY$$>3L4&WT#5U
M32S62BS\EF]6,$#HK\XBB:Z0-V>QL+)'@#<<N7CZ6WG;<P'-=/=7'-9)V.A/
M:J6)*>.VM,!=3NE[K,NQ=X[3GLV!\GL?"#N-Y%'0ZB6,]IN::Y+3I.B;8O11
MQ0S-CE=,YTD$A[K?A$9;&US0_P!"?7;?(Z:X74U;5N3R.H8;H?+CX8'3VIH'
MQOF;-,Y_9;&2YL?%S-@X#\V^Z",:CR6O-*Y3+W*<3ZV*J!D=#'R30O9:<)8X
MXHV'F7;R1F0[<&[. !+MMU;NF;,[Z'NEDV9;5'A6FM6(N LR"-I=(S[6DNVW
MV W! ]%"]2X74G^L^+)8N*\VC+!0A?8@F@;7XLL2NL"5KCS/S3_AX@^2/0C=
M;+I1D,UE\9D;>7M>]1LM/ITY&\2V>*$EG?!;]<C@X_9X&R"<HB("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@Q\AS]PL]KEW>T[CP]=]CMM
M^54)T]RW42AIF)K*^1LV'/;(_P"5:UMSG<:)>8P;)#V%TS TN\LW>0S\G0:(
M*2RW4?6]+%$T<7>R,XF#H;+L+8A$H$3'/B=%P<]IYN+6NV (:07 M)*#4&NK
MVJY)(X[5>1X95>R3$3"O4#KH8XM<2&RD0CGS!V&Y)^$["[404=>U#K:;)8ZJ
M*-Z%L.1:^.O'CYW-LL$T_)TD^Y$;0&Q>'';9V^VSF[8=?J9U#N7O<:5:.=['
M1&>:[B+5?L2NA:_LN8UCW<"XN ?Q V:!R)()OP@.!!&X/J"L/%87'8*NZ#&T
M*V/@<XO=%5A;$TN/J2&@#?QZH()K*EJ"QKCWFDVT_'U,++*(F6++(GV.3MFA
ML;@V1^VWAVYV]-EJ(]7ZXQU&S:LXZS-"Z*>.&O!C9#) YA@;$\D\B[?N2$[@
M^(]P"00;?1!3N!UEU#NQ5K=C%D-C[43Z9Q\L9G+GV&N?S>&EH CA=]$;<_(V
M(V_+6M-50XRG;BK9*W;L4R)9!B+$+:EATL(+#&6N/!H,GQ<7NV'C< JXT05E
MIBSGL_T_U':R[K^ R=UL<C7QU9C)7+J-?D8HMN>PD[GPMV.X=Z.6JP&K]5-D
MQ-5F*O4ZO.")L=BI;M>]M=9?'/*Z>7XX@V-K96B78_$!\7A7$B"F<?JC5\6"
MI8-M+(P9#W%C6VG8Z9Y8T8SGR=(1Q[GO(+-B=]_&R^':QUI1QH=#4NRN,)EC
MGEQ,\K[<[:M4LB<P;=IKWOF!=LT L/H0=[I1!4V4U-KJG'EI6P[QDVW5VMQD
MI=&V*VR.-K2T/+G20N<X$M(W .W'=2'.Z@LY_I[;LX0W?E*-T,3XXXG,L12!
M\9D86C^T 2';;@?$-_!4X7X !Z#;Z_""HYM6ZZJ3,]ZKRMI6IWB2S!B)9'T(
MFV)6-(8-S(7,;$?(.W(NVX^%.=1YC(0:+REO#1RV<M7KN[#9J<@[DH:"#V]F
MEP\^@_*-_"DB(*CGU?KFAEGTGTY;#:\XCKS,Q,KFY#><-<'/;\,(;&>7([ G
MSY#2%E]2M0:DTUDLK8P=*];EFITXZ[HZLD\#9&FX]^X8QY&^T33Q:3NY@/'<
M.%HH@H^?5W46K;FCJUW2OLWR_>_C[ BK,->%T<0,<3R6%[I07;>"P@D$J5Y&
M[JRSTMU#=,TM7/[VG5&5:1[D3&2.;&&L.Y>2UH.^WGEX'HK%1!3D.>UAIQF9
ML]F_DZ=F:X^NT8Z0RPD/A$3_ #N>)[DCBWCZ,^%I+2#D:3U;KW*6<=/D:)KU
M1)!!/ <=*PR!\D['R\GAI: V.%WT1MS\C9PVMM$%;9S569P^L\A-7J9&SAHS
M3KR\:,\K6GMVW/=$UK?B^+W8.<T$>0#Z>-0-8]0VX^3(LQ)GD-8"/'/Q\D9[
MGR<)^3G;[_\ K&\6VW_1^DK@1!6GOFILSTNL3Y"?W;)"=K@ZC#<ADE@;*TEA
M A$T;G-Y-+F,.V^X6TZ4Y>U/I>"CEG3-S-=KYY:\[I9)8H'S2^[A[I 'EW;:
MWZ0#_'Q $J;K\#0"3L-SZE!0<EW*7*]JY$W65/ 3WI>-+M9'WV'C7>(G;N'=
MXOD'+BTEC?@#MMW!;5CLSG<CDJ[K6HL#<BP!@NVS5O2P2W'Q1DR5V#YOYK8_
MS1#GN>0/HDJZ$00[IE?LRX%M:Y7NQS1RRB.>W':!L1M?L)#[P7/87;^&/<3L
M-QN/*F*(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(
MB("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B@5KJ]5QV0
MSM:_I_,TH\.V,SV7BL]DAD.T+8VQS.>YTAV#1Q]2-]D$]117"Z_BRS\K6GP^
M3Q.5QT#;,N,N-B,SXG!W!S#'(]C@XL<WP_<$;'98>2ZNX''8_&VP+5QN1I,N
MUHZL0>][7OC9$S;<;/>^5K6C[0[<@ E!-D5=Y#K-#BZ=V2QI?/,N49H(;>/_
M -D[T F<&PO)]XX.8]QV!8YVQ:[?;8K=Z>UT[46<O8V/ 92I[B]L5JU8=6[4
M4IB9)VSQF<XGC(WRUI;OOY02E%&\WKW&8#5V T[;$[;N:;,ZM*U@,0,0:2U[
MM]P3R&W@[D;>/&^FL]9\!7Q^J;C8KUB/3UQM"=D$(<^Q,0W9L Y?'Y=Q\[>6
MGZAN@GJ*#9GJ[B,-?H0>ZW;E6U6KW#?JB(PPQ32B*)SN4@>=W$>&-=Z[K.TO
MU)Q6L<A)4Q<=JPZ#NBS)VQVZSF2.C#)';^'.+20T;GCL2 "-PE:*NK/7'"TK
MN1@M8_)UXZCK+&6',B<RR:\C(YA&&R%PXN>WZ;6[[^-UM]3=1H-/92?'P8?*
MYRS5JB[<;C(XG>ZPDN#7/[DC.1/!^S&<G'B?A]-PER*(8WJ33U!DF5\%C<AG
M*@$)FR500MK0=QC9&\C)(QSCP>UQ#&N(#AOY.RUD76_3]G#6LI5@O6ZE6-AG
M?%&P".5\@CC@+G/#1(XN!VWV:T@N+01N%A(HUF]:C3VEX<Q=P^1CEEFAKMQK
M3 ZSW)96QL;N)>WY<X>>>VQ]5JL%U9IZER=.CC<+E;$LT3I;#MJ[6TPV=\#A
M)RE!<0^-X^;#]P-QON$$Z10Q_5*A+B<%;Q^-R.7LYMCI:>.J,B$[F,&[WN,D
MC(VM;NW<EX\N &Y.RUK^NNG8L%ELF^#(L&,@9-/4-<>\<G3/A,36\O+VRQN8
M1OMOML2""@L5%&G]0,4*>=ML[TU;#TV7;$L;00YCHC*&L\^7< #MX^DWSY6H
MQW6C3V3ER4,0MMGQ^0JXZ6*2(-<76',;&]OQ>6<G[$_46N\>/(3Q%"LOU5QN
M$U8<'8H9 EKX(7WV-B,#))@\Q,([G<)/ ^0P@>-R%L<5KW&Y@Z<[#+ ^7J;[
MU3FP#:-K6.(?Y\':1O@;_6@DB*$X#JG4U1F(*&+P^3M-= VQ+:V@9%78Z26,
M%_*4./Q0O^@UWC;[5^ZCZJ4=.Y#)0'%Y3(5<4QDF4OTHXW0T&N'(<^4C7N(9
ML\B-KR&D$@;A!-44,P/5+&Z@U/)A8:5Z!W<L107)A$8++H"T2\.,CG#;FWR]
MK0?JW6OR76[#8C(Y:M;Q^3BBQYLM][X1.BG?!$V65D8$A?N&N!W>UH/IN@L-
M%&]6:_Q6C&X@Y$S;9.RRM%VF<NWR_P#>/\_"P$M!=]7(+\KZW9D-0V,7C\/D
M<C%4G%:WDH>RVM7EXAQ:2^1KWD C?@UVV^WJ" $E1131_4G%:ZE+<1':GCCC
MYSSF,".!V^PB>[?^<(^+B-]AL3MR;OI8.N^FI\EEZ'&['8QM&QD'B2$ 2QPR
MRQR-C/+RX&%QXG;P0?MV"Q44/T]U1P^J,P<9C8[=BY')(RPT1C:LUOCG(>6S
M0X^&CZ3MCL-FN(S<CKS&8S66,TS-WOE"_$Z6-[6;Q,V#BUKW;^'.#)"T;>>V
M[[/(2-%&M*ZX@U;2N7ZN.NP8V![VQ7+!AX6>#G-<6-;(YXV+3XD:P_D6EI]7
MH<AB\/:KZ9SDMG,,[V/Q[?=>_8A# ]TV_?X,8 YN_-[3NX  DH)^BAV#ZJ8;
M/LM&O';CDJ4G7;$,T0:^'A))&^-PW^FU\3P1Z> 02"OJ_P!2:L%?">X8O)9N
M[EZINUJ%%L0F$ :TND>99&,:!S8/+MR7 #=!+T5<S=>-,PZ=R.8<V_V*#8'2
MP^[[3?.O<S8,)]6O9(UP.VQC=Z[>=C>ZJX^#4;<'2Q]_+Y%TAC$=/LM:=HHY
M'N#I9&-(:V6,D \OB\ ['8)JB\*EZM?8]]:Q%88R1T3G1/#@U[3LYIV]""""
M/J(7N@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("
M@^H.F8SLVI9ADG5ILK[E) ]L(=[K-6=SC?Y=\8Y!I+?'@$;^=Q.$01/2VDLG
M0U!D,]G<I6R64M5XJ;!1INK00PQN>X -=)(XN+I'$DN_W0!XW,;AZ)"I2S+(
M,R66IKT-O%S.K!S<>R&8SQ0\>7SC!(^3?RW=K@WQL"K01!74W2[(9F#-3YK-
MUY\MDY*.\U.BZ*"&&M,)61MC=*XDDE^[B_\ M#QXV/P[ISE,#J[4NJ,,<#;R
M63<)(1=Q;A9B=V8XN)M"7<Q_-\BT,&^^VX]59"((/K[IJ_6U^M>BRGR;<J4Y
MH:LK:_<,4[I898YA\0WX.@'P_P!H$C<+04^@=>O:A#\[<%".:.V8:H=!*^PR
MNV$2.E:_<[_./(V\EX_W?-KH@IV+V=*D$E"895LUS#PLAPMRQ3$DU ,LNFC^
M,OW<.#NT=N/)H\^JDF@.EKNG=V=^.RI-*[/9M7Z3J^T<TTDKGME9\?S;P'!K
MO4/#0=@?*GR(*5O^SFZWD]178,QCZ-C*NMO%BOA^,[N](V0-LR";Y]D9;\+=
MF>3ON%)KF@M5NR-W)4M3XRKD,E393OO.'>Z(AA?VY(F&SNQX$C@>3G@[-.PV
MV-B(@@&D^F]_I_8;5T_EJK,#)V3/2OTG33!T<3(BZ.5LK .38V[AS7;.W/H=
ME@:5Z/6=#8.UB\/EJDM&W%)[S1R6.,]62=[]W2A@E:6A[2X/9N0X[.\'ERLY
M$%:W>CSKO2V'1\N1IS]NW':#K6/,U0-99$X@%<R[]H ",-+SLT#SXV6MTWT'
M_P!&\_A<DRYA;;<?"86P6,)R%=IL/FVIGO?[,UH?P:-G\0UOKMLK<1!5F%Z4
MZCT_4P1J:FQCKV$ADJ5)),/)VY*\FQ>R5OO.[G;LC(<TMVXG<$.\?53H>R/*
MZ?R%G,&S/3L6K63;[J&LR,DTG='CD>VUDOQ-'Q>!MO\ 6K11!7NFNDHT]TYS
M>EG99UN7)QV(C??!L6,?'VHAPY'?MQ-C;ZCEPW\;[#4V.@K))J%B'-FO<K9F
M/)22MJ[B>!KH7FLX<_K= QP?O\)^H[G>V$05?J/HHW/]1SJKWZA \FLYK_DS
ME>B[(>"R.SW!Q9('[/;P.XW&_G<?N(Z7ZCPN-TTR'4N+DR&GZ[J529V'D$4D
M#HVL<)&>\[EV\;"'-<T#8C8[^+/1!5FF^B/^C6J,7EX[F+ONJ4H:CWW\1W+(
M<V2:1\D$PE'9Y&9WCB[8 >2MAJ;IIELI;U''B\_7QN*U&QK<C!-0,TS3VA"]
MT$@E:&%T;6CXFO (W_(K#1!7.D>C%#1>K7Y_&SPPV[$MKWPLJ!KK4$A#HXWN
MY;DQ.:-G'?P7#8;^(_FO9W^5L[J7),RV/I2YCWO_ &B#$;6]IX!%VYIN]\]$
MT@/#.+?B#?(V\W,B"LLWT;FUM)))JG/R67?)[\="S#1R4(V,>=Y'$&60N+MH
M_4[#M_E6STEHC4&D+19#J"G=Q]F46;L=G'.[SYRQHE=&]LP#0]S>7%S7<2X^
M2-@)TB" ]->EKNF3!6Q^6,N,E:^2S2=7V8ZRYY<9HSR^;+@3S;\0<=G?">1=
M&<I[.K,EB=1UFY\U[N3:\U;K*>YIO=/:D)VY_&"VVZ,MW;N ?(W\7(B"NM&=
M(W:%SMK)XW,%KLA:DGR5<UOFK32 &>.?PR,V [@WW;\):=FEOGG.C+,YFK^;
M?GKT&8EO07*LD;G""N(-NTPP\MG@#F"=QOW'>FZLE$$)T]H"UBM29_+V;U(.
MRL(B=7QE%U:-S@7?/2@ROYR[.#>0X^&_7XVT^)Z,-T=C-,_Z*V<;B,MAZSJL
MMAV,!@O->R-LCI(V2,/(F)C@[F2-MCONK.1!5>+Z.9;#WK5JOJ.H]^2J2U\F
M;&+<XS/DFEE>^(MG:(QO,0&D/V#1Y/E9./Z;:GQ+,%9K:EQ1RV*HG%ME?AI.
MQ-6(C\/C]YY<PZ)K@X/ \D<?.XLM$%6TNA-:#)X&U8RKK<=.&R,A"^N ,C-*
MZ1XD/Q? &/GG(;L[Z8\_#Y\!T0N1=/*^EVYJE:F[TD\^6N8US[ D)VCE@(F;
MVI8VAK0[=WT0?M!ME$&-0BLP0%EJ>.P\.=Q?'&6?!O\ """X[N VW/@$^=AZ
M+)1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$6GU?D;^'TQD[^+KLMWJL#IXZ
M\F^TO'R6>"/) ('Y2$&X15GE>I%Z_C,_E\)=QU3!XFM#-[Y;I26C8>Z(RN8U
MK9H_[+X /)^)Q"V6/U-JB+,X7'92ECA+:T_/?G%;N<_?(G5VNC:TD@1_/$>K
MB2/4;>0G2*DO]<F>I:1AFO/K,U$ZS5AMT1I^VR6D)6.=NVJ93);\L<!VB/#7
MG;X"%^X+K5G,K0K9>:+$PXNK)CZV1C:'.D?)9<&E\;^YQC#.;"6.#SOS:7#C
MN0NQ%4>H.L=R?6%"AI&2AJ+'358; -&K+=$Y=9,3P+$3^W"&-:7<G@@D$>$N
M]2M2XUF<B>_%6X:.0K43G8*,PJUN8<9N[$)G.?VMF N#VC>0 \>+D%N(JBP?
M53.9S'Z3OUGXV<93(28Z;'-I3,FF$4TD<UF)SI/FXVM9W.+V.]0WEN05C8_J
MOJ21L6-NFE2U->N15J]"UAK-=M6-[Y!W7.=-M8:&QG^;+/B(W(W""YD4=T#J
M*SJ?3C;5V.*.]#9L4['NX(C=)#,^)SF DD-)9N 2=M]MSMNI$@(B("(B B(@
M(B("(H9KWJ95T%D\%1FIS7K.9=-#4AKN'<EF8T.;&UI\$NW/DD!H:23L"@F:
M*J,SUOEP62U)2MT,/%8P6/\ ?9ZC\WQM2N]W[Q$479^)@^B9-QML3Q\;+$SG
MM!,P-'$V)*^ NMO06;/*CGQ*Q[871-[4#C .],[N^(]F^1MR\H+B10W5VL,W
M@LWI^ECL+1OP9>8UVS6\B^L^)XBDE.[! _<<8S_:WW.VP]5$G>TE@I,)4MTQ
M4OWI*-R[8QU?(1OFK>[MW+7@ D;GQN0-D%OHH?H;7<VLK^9B=3J468^PZN8/
M?2^XTAQ =- 8VB,. Y-(>[DT@J$8KVB'9K)#%TL)4N96U8?6IUZN5$C6O;+(
MPBT[M;USQB?(  \EK3MN1L@N=%3.I_:%DTC)[ED\/CZ>8AGF@LU[.7[<3BR*
M.5@KR&'>9\C96AC"UA+MQX6WS_5G-:?RV1BFTU4-"GCXLD93E'ML&.21T;6F
M+W?8/#FG<<R!]I]$%GHJV=U:N1\<F[ ,&E9,B[%QY$7?]H,@E,(D,';V$1E'
M$.[A=L0>.WI]=/NL];7T>G S&24+64K6)IZTLH<ZHZ,0N#3L/B#FS,<'>/!!
MV\^ L=%5&/ZX299UF"CCL5<R+LK)B*>/@S/*<R,DE:7V6]GYAG&%[]QS.W@
ME8&I_:%DTC)[ED\/CZ>8AGF@LU[.7[<3BR*.5@KR&'>9\C96AC"UA+MQX07,
MBBFK.H-;1=#&Y3*UI*N%L?#:NR'8TG%N\8D9MZ./P;@^'%HV.^XC,G5[,FCE
M,A#I'>CA863Y5L^0[=B$.C$Q9%&(R)'MB<QS@YS "[B"[8E!:**"1=5(+&(@
MR$5%SXILV[#L^=]=GN:)?3T/'?C^7U6'TFZPLZHT+MF.E4B97@AG,F/O^^1
MR-<[LO?P9PF8&@N9L=@]IW\H+'149B_:;BRF AR+,?AHVRV*D L/SH]R@=.R
M1_":QV?FY6",<H^)V[C//E3^AKC*Y[,R4L-B:%VO3; +]Z3)N9"U\D;9.,!;
M"XS;,>UW(]L'DW\NP31%60ZPW(ZU7,3Z?9'IB]9DJ4[S;W*PYXYACI(>V QC
MRP@$2.(Y-W:-SMJ=-=?K.K<-3LXO"XVY:N7:U.(P9@R4PZ6!\Q:Z=L!(DC#-
MGL##L7-\^4%QHJSH]89[^H,;A3B*V.O2SS5;?RED#%&R:-S0Z*![8G"=Y:X2
M-:>!+2#X.X%F("(B B(@(B("J/->T[I3 YF_C+&(UG)8I6)*TCZND<E-$YS'
M%I+)&0%KV[CPYI((V()"MQ$%28/VF]*:@S5#%UL1K**Q=G97C?:TCDH(FN>X
M-!?(^ -8W<^7.( 'DG92[J)U,Q73*A5N96IF;D5F4Q,;AL19R#P0-]W-@8\M
M'Y2 %+404O\ =9:._N377[%97^'5C:$USC^H>!&7QE;)U:ID=%V\MCIZ,V[=
MMSVIFM=MY\';8J1(@IJ;VK='P3/C=A=<%S'%I+=&90C<?81!Y6TTE[16F=::
MBIX6CBM6U[=MSFQR9'2V0J0-V:7'G++"UC? /J1N=AZE6BB"$]1NKN%Z7R4&
M9:CGKANAYC.%PEO(AO'COS,$;^'TAMRVW\[>A4-^ZRT=_<FNOV*RO\.KH1!H
M-/ZTH:DT?'J2K7R,-"2*280W,?-7M!K"X$&![1(#\)V!;N?&V^X5;?=9:._N
M377[%97^'5T(@KC0O7K3O4//-Q&,QNIZMIT;I1)E=-WJ,.S?4=V:)K-_/@;[
ME>_4+K;@>FF7@QN5Q^H[<\T L-?A]/W<A$&ESF[&2")[0[=I^$G?;8[;$*P$
M04O]UEH[^Y-=?L5E?X=63)K2A%H@:J-?(G'&D+_8;CYC<[9;RX^[\>[SV/T.
M/+?QMNM^B"E_NLM'?W)KK]BLK_#J5=/.M."ZF9*S1Q6/U%4FKP]Y[LS@+F/C
M+>0&S7SQ,#CN?0'?;<J?(@K77'7[3F@-02X;)8S5-JU$QKW28O35^[ 0X;C:
M6&)S"?M /CZUH?NLM'?W)KK]BLK_  ZNA$&@U3K2AI#2<VHKM?(ST8F1O=#0
MQ\UJR0]S6C:"-KI"=W#<!O@;D[ %5M]UEH[^Y-=?L5E?X=70B"%].>K&&ZHC
M('$TL[3]Q[?=^6L+:QW+GRVX=^-G/Z!WX[[;C?;<+0:I]H_3&D-07</=Q6KI
M[51_"22AI7(VH''8'X)8X7,>//JTE6FB"G*GM4Z0NVX:\>&UNU\KVQM,FC<H
MQH).PW<8-@/RGP%/]?:^QW3C!MRN4K92W6=,V 1XC&SWYN1!(/;A8YW'X3N[
M;8>/M"DB(*7^ZRT=_<FNOV*RO\.I]T]ZD8OJ9B[-_%5,O4A@F[#F9G%6,?(7
M<0[=K)V,<YNSA\0&V^X^I2I$%19?VG])X3+7<=/A]9R3U)WUY'UM(9*:)SF.
M+26/; 6O;N/#FD@CR#LO3 >TSI74>;H8JKB-8Q6;L[*\;[>DLE!"USCL"^1\
M :QOGRYQ 'UE6RB"(]1.IV)Z8TJ=K+4\S<CM2&-C<-B+.0>"!ONYL#'EH_*=
M@H+]UEH[^Y-=?L5E?X=7++*R"-\DCVQQL!<Y[CL&@>I)4/J]:>GMY[V5M=Z9
ML/C8Z1[8LQ7<6M:-W..S_  ]3]2#9Z&UO0Z@X!F8QM?)5:KY'1B/*X^:C/NT
M['>*9K7@?8=MC]2KA_M8:.C>YIPNN26G8[:+RA'^75GY'6. Q#I6W\WC:3HJ
MXN2"Q;CC+("X-$IW(V9R('+TW.VZ\[&N=-U=2PZ=GU!BX=03MYQ8J2[&VU(W
M;?=L1=R(V!/@((7H_P!HC3.M]1T\)0Q>K*]NT7!DF2TOD*<#>+2X\I986L;X
M:=MR-SL!Y(6XZB]7\+TPGHQ9:CG[CKC7NC.%P=O(AH:0#S,$;PP^1L';;^=O
M1;R]KK3>+SL.$N:AQ53-3@&+'3W8V6) ?0MC+N1WV.VP7QC]?Z7R^<GPU'4F
M(NYB!SFRX^O>BDL1EOT@Z,.+@1]>X\(*V^ZRT=_<FNOV*RO\.K)PFM*&>T<S
M4M>OD8L>^!]@0VL?-#:XLY;@UWM$@=\)V;QW/C8>0E#J#I;*9^Q@J6I<1;S=
M;?OXV"_$^S%MZ\HP[DW;\H7Z[7VF&8VMD7:CQ(Q]F1T4%LWHNU*]N_)K7\MG
M$<7;@'<<3]B"M?NLM'?W)KK]BLK_  ZD6@^N^GNHN=^2<9C=35;/:=-W,MIR
M]1AXMVW'<FB:W?SX&^Y4QBU7A)VXMT68H2-RH)H%EIA%P!O(]KS\YX\_#OX\
MK'U/KO36B6UW:BU#BL"+#N,)R=V*MW3]C>;AN?S((WU!ZX8#IIFH<9E<=J2W
M8EKMLM?A]/7<A$&ESF@&2")[0[=A^$G< @[;$*,?=9:._N377[%97^'5KG4>
M)&7@Q1RE(92Q";,-+WAG>DB'K(UF_(M_Z0&RP*74/2N2S%C$5-38>UE:Q<)Z
M,%^)\\1;]+DP.Y-VV\[CP@_;.M*%31(U2^OD78XTVWNPS'S.M]MS0X-]W#>[
MSV/EG'D#N"-PJV^ZRT=_<FNOV*RO\.K+TYKW3.L))8\#J+$YM\0WD;CKT5@L
M'Y0QQV_XK)OZHPV+L68+N7H5)ZU;WR>*>RQCHH-]NZX$[M9OXY'QO]:"+]/.
ML^#ZFW[5/%4-0TY:T0E>[,X&YCV$$[;-=/&P./Y 25@:V]H#3F@=0SX;(XS5
M-FW"UCG28O3-^[ 0YH<-I8H7,)V/D ^#X*E^-USIO,Z>ES^/U!B[V"B#G29.
MM=CDK,#?I$RAQ:-OK\^%F?Z08OO8^'Y2I]W(M<^E'WV<K30WD3&-_C ;\1+=
M_'E!4_W66CO[DUU^Q65_AU9.KM:4-%Z6FS]^OD;%*(1ET6.Q\UNR>;@T;0Q-
M<\^7#?8>!N3L 5ZQ:VT[/A)<S'GL9)AXGF.3(-N1FNQX=Q+3)RX@\B!MOZ^%
MZ935N#P;Y69+,X_'OAK&Y(VU:9$60!P:93R(V8'$#D?&Y W05;]UEH[^Y-=?
ML5E?X=3;ISU6P_5".^_$TLY3%(L$GRUAK6.+N?+;@)XV<_HG?COMXW]0M]I_
M56%U;4=;P>8H9FJT\3/C[3)V _9R82-UB9SJ!I?3&4J8W,:DQ&)R-O;W>G>O
M10S3;G8<&.<"[SX\!!"=3^TCI?2>?NX>YB=7SVJ<G;DDHZ4R-F!Q_P"A+'"6
M/'GU:2%A4?:GTCD+M>K'AM;,DGD;$UTNCLFQ@+CL"YQ@ ://DGP%9LFJL)%D
M+M!^8H,O4H/>K55UI@E@A_\ KCV[[M9_TCL%CRZ\TS#6L6)-18F.O7@BM32N
MO1!D4,G\W(X\M@Q_]EQ\'ZMT&-K_ *@8WIOA(\IE*N5MUGSMKAF(QD]^8.(<
M03'"QS@WX3\6VP.PW\A5[]UEH[^Y-=?L5E?X=6T,[C79*''#(5#D)H#9CJ"=
MO=?%OMW&LWW+=R!R V\K =KS33*U2P[46);7N633K2F]%PGG!(,3#RV<\$$<
M1YW!\(,/I[U%QG4O$6,CBJN6J00SFNYF8Q5C'REP:UVX9.QCBW9P^(#;?<;[
M@J%97VH=)8?)W*$^'UH^:K,^![J^C\G+&7-<6DM>V M<W<>' D$>0K'CU?@I
M<M\E,S>.?E.XZ'W)MN,S=QK0]S.&_+D&D.(VW (/HM?D^J&C<)698R.K<%0@
M?-)7;+:R4,;72QG:2,%S@.32=B/4?6@AVGO:6TKJ;.4<34Q.L(;-R9L$<ES2
M>1KPM<X[ OD?"&L;]KG$ *4]1>J.)Z8U:5C+4\U<9;>YD8PV'LY%S2 ">;8&
M/+1Y\$[;K:U];:=MRS109_%S2P56WI61W(W.CKD;MF< [Q&1Y#CXV^M>]W4^
M&QN!^6[F6HU<+VFS_*,]EC*_;< 6O[A/'B01L=]CN@JK[K+1W]R:Z_8K*_PZ
MLG1&M*'4#3T68QU?(UJDKWQB/*X^:E/NT['>*9K7@?82//U+UQ6MM.YT43C<
M]C,B+\3YZGNER.7WB-AV>^/BX\VM) )&X'UK7T^K&B,A/D(:NLM/V9L=&Z6[
M'#E('NJL;X<Z0!WP ?67;;(*<H=:NE>+T_%@ZND]<18J*V+K:PTAF".Z)>Z"
M28=R \ AI);L -M@ IEI7K=H_J'K;&TZ>'U97R\E>Q6@M9'3>1HP1QN#9) Z
M62)K&[]AFQ)!W  .[MC8,VMM.UH(IYL_BXH9JKKT<C[D8:^NW;E,"7>8QN-W
MCP-QY6LCZNZ%FQ4N4CUKIU^,BE;!)=;E8#"R1P):POY[!Q ) WW\((%U%GZ?
M],I:M?,8K5U^W>>+<=_$U\MD[,;HP6-WLP\Y(]A(\!O( A[O!W*A]/JKTCQ]
MRE9KZ3U]%)4,;F-&E\X8Y'L<YS'RL,?&5X<]S@^0.=N=]]]ET?BLO1SM"*[C
M;M?(4I1O'9JRMEC>/R.:2"O*#4.+LY:WBX<E3ER=1C9;%)D[#-"QWT7/8#NT
M'ZB1Y0:#&9;!YS!R:ZAHY*(3XUS7=ZI9@N>[L+W</=R!('[\B &AQW&WU*F,
M+U?Z7Z<P,F&QN%ZGU,>\@\&8741>P@D_"\M+F[DDGB1RW\[J^Z>M].Y"G4MU
M<_B[-6Y.:M:>&Y&]D\PWWC8X.V<_X3\(\^#]B\\!K_2^K+4U;":DQ&9LP[]V
M''WHIWLV.QY!CB1Y^U!5/37-].-:ZTJ# 8366*RM&CPBEOT,QC:W98_D6$RA
MD3RYS^1#MW/.Y/+9??4?-]/- 9R7'9S#ZRRF0MPQ6A=Q]'+Y,Q-;(YS!'9B#
M^R0\$\&.:?(W&Q"M3.:^TQIG(P8_,:CQ.)OV&\X:MZ]%#+(W?;=K7.!(W!'@
M+.R^H<5@*T-C*9.GC8)Y6P12VYV1-DD=]%C2X@%Q^H#R4%+X+VE= ::Q4&-Q
MVGM=05(=^#':.R\CB22YSG.= 7.<222XDDDDDJV;VM*&/T5_I1+7R+L=[HR[
MV(L?-);X.:"![N&F3GL1NSCR!W!'A8>4ZLZ'PF6DQ>1UGI_'Y.)P8^E:RD$<
MS'';8%CG@@G<>-OK7U5ZK:)NV+L%?6& L3T8WRVHHLG YU=C#L]T@#MVAOUD
M[;?6@@'W66CO[DUU^Q65_AU+>G?63!]3KMRKB:&H*<E6,2/=F<#<Q[""=OA=
M/&P./Y!N5)-.ZOP.L*S[&!S>.S<$9XOEQUN.PUI^PEA("VZ"L]:>T'IO0>H[
M.%R.,U59MUPPODQFF+]V \FAPXRQ0N8[P1OL?!W!\A:/[K+1W]R:Z_8K*_PZ
MNA$&@UEK6AH;34V<R%?(V:<18'18W'S7+!Y. &T,37//D^=AX&Y/HJV^ZRT=
M_<FNOV*RO\.KH1!#NG753$=3X;TN)I9NFVFYC9!FL-:QQ<7 D<!/&PO'PG<M
MWV\;^JC6I/:3TMI;/7L1<Q.KYK-.4Q224M)Y&S"XCZV2QPEKQ^5I(5K(@I_'
M>U+I')Y"K3BPVM62V)6PL=-H[)QL!<0 7.=  T>?))V'UK9]<?\ 1;'8S%YC
M55/-Y"M!*^K!#@\=/=E;)*SD)"R"-TC"WM MD''B[CYW(6ZUGG<]6U-@,+@I
ML=5ER$-J:2;(U9+#1VA'LT!DL>V_<\G<[;>BB.F^K.<UEJ6ICJHJXELF.BL/
M:[$6L@WONEL1/!GC>QD; Z#<%X'('ZD%<6.J>B+<>;BGN]5I8<U4%2]&[15K
MYXB#LB7?W#D'[;'P0W<?1VW"MOI3:Q.O&5-35;FI;DV+%C&,?J3%'&S$/$+W
M?-.KPES1Q8 \-V\O&Y(\1O(]9M0Z<T:W(Y"S@+>6LY&W6K5A ^G&8:LDHF)+
MYW\G.;$ T#;9\C0>04SPFL<KKO.6G:=MXRM@:/NW.>U5?9EM]V)DWS?&6,1M
MX2, <>>Y)\ #R5"=4^T#HF745'WS%:Z-K!7I9(S5TADI(GR=N2%WQ"N0]NSW
M$%I\^#N1ZZ#%:OZ>:XAP&CH*>OZX;#8QM>>WI>]69QL-XN=)+)6#&[#T<=@/
MKW4_Q/6>3)9;#XSW&9MJWG[F*F>['V6UQ%#[SQ<R<M[9>>RS<!Q]7>/LRM1=
M7H<'U1QFFN[0]R>8Z]Q\LP%B.Q.'&N&-W\M^ !W@^9H_3R@PM7YO"]']10:D
MSUC5&>MWH9*-5F.PDEX5H0]LA814K\@-^.SI"?0['?EO7LO6/I[_ *-4L16I
M=1Z3Z-QU^ID(=&9'WB"9SWN+ARJ%A&TCV[.:06G8_:MU7]HC-2Z/@M38VA6S
MON=RW+ 0]T18R!TU>1@Y EKN/%WGZ3'@'QNK+TWJ?,C/Y+!9LT;5NO1BR,%S
M'PO@CDC>Y[>#HW/>6N:Z,^>9#@?JV(01/1>B-+]1-..U ^;4-XW_ 'QEF7.T
MG4K4YD8V%W.!T,98&MB8&<6M'C?XB=U!LKUCZ>YJ*TVY2ZDS26<;!BY9CH[(
M\WLBD+P__P!5VYESCN=MOL 6VP77[467TD[(F.F)G3XR'OMPESYEUDGFP5>Y
MW9N+>!;(PAK^7CZ)4HS6NM7X?)6MKV'L4:^GILWPDPMBO,\Q[#MD/L[LW)W^
M)NX'C;?R@B&C-2:-U[JZI@J,NOX*$UV7)PXC*::LTL='..4Q<9Y:K7 <^3VL
M=)MS( !\-6WU-)HGH;J[3.0LU]6VKU7#'&0C$86SD89HF\&A\YKP. E 8 #N
MW<$^" -MKU#ZOY72TV+AJ0UF>^5*EA\SJ,]UT9EL-C=QAB<'R;!Q(:WSNM'6
M]H3,PUIK-_&T64G:?;D*UN/F&NMN%AT37M+CQ9(R#<#?DUQXDDD(-#8ZR]/I
M,!!C:]/J12EK9&7*5;\.C<CWZ\\DDCW%O*H6$?.O;Q<T@M.QW/E3C':(TOG-
M&3ZMO3:ARL5NG<M6WY"DZ*[89)"V-P=6$+7M<UD+0QC6-/@>'$[F1:WU)J/'
M8W35O#6L76^4K=:I,R]1DL;&8CXFEL\>VWGP=]_M"C#NNMJ.I5A]Q<_)'+7\
M?,]V-M1U2RNRR6N9*1VRXF!FX#SZN^SP1H,Q[0NA<]I7Y!NX_J)+ 8XF/L_Z
M&9+O/,;FN#B?=>.Y+1OX^L[ +)P>>TMUIU5F:&)LZZP+,K5$F5IV]/V,?4NL
M8&QD&6S6!:]S"UA$;VN+1^3<3+IWU!R^I<V*^:]TQ1L5&6J6/%*4/LQF.-QF
MCL&0L> 7D&,,Y,^'<^03&;/6O4E?*YR.'%U[U6O?FQL+O<;%>*O+[Q'! 9;+
MG&.4.,A);& YH:45@ZZS6C^F>L8Z.1.MK-46/EF/%8?3UB_09.\.;S[L-9SM
M]^3NV9-@2#ML0%J=)]:^G>C2/D_%]1.!Q]?'2,ET;DB)&PAP9([:J/G.+N)(
MV! 'CP%*-9]6-3Z!NNP^3EQ=BZ9*LK<E1P]J=@@E[X<#4CF=(7M= =N+R"';
M[#8K*J]1-8VWX.T9<)7J7\!/FWUO<999!VA#\#918#=G]W<'B>(V'Q>J#RR>
M@=-X'0^.U-5R&J,=4Q]*C8C&/I":Z\0L<V)[JSJ[W&7A,6N;PWV &PXJ(MZZ
MZ1K9QV4I3=3J,]@0^_QQZ(N.CO.C:&B1X=2/%Y: TF/@" /'@;2ZAU9U-D=+
MSZO9#B8\%1GA@LX]T,ALS B,32,E[G%FSI#Q86.Y!@W<.7CVT1UJR6HLAA<;
MD*%6ID+F3L5WMCY<7U!'8=#-'N?4F L=OOL6N^T(C2].&:5ZG79Z&-MZUAQ&
M,E?>AP^<PDN.JPR2\P#&^:LQ\G$O>6L+W!NX\;!NVHUMFM#Z U#\B&3J#3R&
M,-&3WG!Z9L7H'20UBR.02"I)$]QBD#7[;C=C1LTM*G^I.H>HZ0U9F,>S%C!:
M8G$-FI9AD=9N!L3)97,E$@;%LV39H+'\BWR0#XC-CVA,M4Q%]T^-I0Y*+(W8
MZS#S[=BG$VUPD'G?F'UN+QOXW!\<AL5$[/5;0-G&0XUPZFFBZT+MV-VBKSG7
MY^ZV7N2/-+DT\FC^;+    !L%U&/(5<9+J'G:6:Q>)BQ<,]G.PPRXNRUCS#'
MLT&SW_/C@T\V[$<^0;Z@E60B"(B B(@(B("(M;J#4N(TEBY<GG,K2PV-BV[E
MS(6&00L_.]Y '_>@V2*M/NF^CWXU]#_M'3_>)]TWT>_&OH?]HZ?[Q!9:*M/N
MF^CWXU]#_M'3_>)]TWT>_&OH?]HZ?[Q!9:*M/NF^CWXU]#_M'3_>)]TWT>_&
MOH?]HZ?[Q!9:*M/NF^CWXU]#_M'3_>)]TWT>_&OH?]HZ?[Q!9:*M/NF^CWXU
M]#_M'3_>)]TWT>_&OH?]HZ?[Q!9:*M/NF^CWXU]#_M'3_>)]TWT>_&OH?]HZ
M?[Q!9:*M/NF^CWXU]#_M'3_>)]TWT>_&OH?]HZ?[Q!9:*M/NF^CWXU]#_M'3
M_>)]TWT>_&OH?]HZ?[Q!9:*M/NF^CWXU]#_M'3_>)]TWT>_&OH?]HZ?[Q!9:
M*M/NF^CWXU]#_M'3_>)]TWT>_&OH?]HZ?[Q!9:*M/NF^CWXU]#_M'3_>)]TW
MT>_&OH?]HZ?[Q!9:*M/NF^CWXU]#_M'3_>)]TWT>_&OH?]HZ?[Q!9:*M/NF^
MCWXU]#_M'3_>)]TWT>_&OH?]HZ?[Q!9:*M/NF^CWXU]#_M'3_>)]TWT>_&OH
M?]HZ?[Q!9+V-D8YCVAS'#8M<-P1]BXKZA='KOR%[4@Q6B9VV;XILP9J8D\K#
M?=8Q(*O%GQCEN'!F_G?==%_=-]'OQKZ'_:.G^\3[IOH]^-?0_P"T=/\ >(KE
M/K%TDZCFSK9MYV7UQ+;Z=05*EFK@C"&RC(PO]U:(@0^0-:YVWTMMSML%84V(
MR6C?:ZDN:0PN5S4.H<I&_43,QIEXK4&-K\?>ZF3+0T#8!O:W=N2X#975]TWT
M>_&OH?\ :.G^\3[IOH]^-?0_[1T_WB"C>K7LY9?K?[2NJH;,GR)I:;!8D292
M;"FP^=\5B5YCJV7.:V&0;#DX!Y </ 5<8'HGK.EU:BSUG!Y'Y+EUKGFTGP8=
MT5NC/+"YM6]+.&E\E1Q)']E@.QW*ZY^Z;Z/?C7T/^T=/]XGW3?1[\:^A_P!H
MZ?[Q!RMHS15J?271S1V+Z<9S3_473&>KW,YG9\+)!##'&YYM3>^\>%@3@^&L
M<XNY>1X6YZ6:$SF+]HR+6V1T+EX>GVH<GDH,/B):<Q?@[,@8U]Z>N6_,LL]N
M3RX ,#AOMS*Z0^Z;Z/?C7T/^T=/]XGW3?1[\:^A_VCI_O$%6>SKT.ET5UHUW
M-=@RCL#IN;W#1T5^%S:]2K:'O%D5G$ / D=V^0)V:WBO'4U*OHCVGM6ZEUSH
M?+ZKP>8Q=*M@LKC\'+F(Z0C#A/6='$Q[HB]Y#N7$!WVJV?NF^CWXU]#_ +1T
M_P!XGW3?1[\:^A_VCI_O$'*^J<!U1O\ 5ZWUKH=/KCJN&S\%6A$Z2:/*'#1!
MU>:*/']CDYLIE?,#S'T00T[;K!TYT@U72ZOU]4Y3363LX&76^=?!#6PCXKE5
M\L+A7MRR\#))5?NYNWPL!V.Y]%UM]TWT>_&OH?\ :.G^\3[IOH]^-?0_[1T_
MWB#E?H/H/)W[W06'$].L[I;4.E>\_4VH<GAI,8Q]8LD::W.1K76"]SF$;!P&
MV^_JIY[1/35NM.K.M79O':C9I>UH:K6^4\%BI;KQ89DA(UK&-8X2ENS7.CV)
M+-_&WE79]TWT>_&OH?\ :.G^\3[IOH]^-?0_[1T_WB"*^SC#G=<=&LUB-;8"
M/'UI[5O'P2'#'$NR=)S0UMF2F?,+G@NW!V]-]@N<].8+JMB,!F^_I+.39S0F
M$?H?2TKJ4I;=GLV71^_L/$[Q,KM@WD^B-G;E=;?=-]'OQKZ'_:.G^\3[IOH]
M^-?0_P"T=/\ >(..;/2_J%TRZ3=3NG$F@;S,7D*>-S&*BT^9\Q#WXYH(K3.Z
MV!GSK^V)NWQW\N(W]5,NOD>8ZN7=7Y;3^C]6/J2=-[>*C9=T]<JRRVOE"L\1
M,CDC:YSBT%P 'D-=MZ%=*?=-]'OQKZ'_ &CI_O$^Z;Z/?C7T/^T=/]X@J3H=
MIF7(^T'+JW3FB,IH;2D>F(\;DGY+&.Q?RK>[C7,>VL\-<>#0X&1S1OOLH?U
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M7CA<)![NV'E9:WR#)L?4 ^JZC^Z;Z/?C7T/^T=/]XGW3?1[\:^A_VCI_O$$
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MHD #P3"]A(/%O@[CPL>ITVT_C\M4R5*K8H6*M>*I&RG>G@A[49<8V.A8\1O
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MMB?)!S[;W-#&?$YI)XM)W(&V;!TTTU6OX.]%C RWA'3NH2B:3>'O<N[O\7Q
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M62D%I#C([;?R$$WF]DSV3:^2I8Z7":7BR%YC)*M1^?E$MAKOH.C9[QNX'ZB
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MAQ<TQAX'(-' C<<6@^BWLO2#"Y"EBC7R-^%]"-QI6H9(RYA=898$GEA:2',
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M(B((B("(B N,/8(_IG]J3]-IO\S<79ZXP]@C^F?VI/TVF_S-Q%X[/1$1!$1
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MC :&M:T-$88/'D'RI$B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MQV0?T$:X/:'-(<TC<$'<$+]7#[=>=9L/H^RW%V]8V\9C[..9799TLZMD[?\
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M)T4W#D0T2,V<#&W8[D;;@CSN R<)K[':@U5G<+3E@E=AFQ>\RLLL<0][>6W
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MQ[2^Y&Z[$'5F@@$R#E\ !('G;U4.L]$HK%"S7&4:QTU+*5.Y[IY:;EELQ?\
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MZAR=@X:E%9-*=E\M8^"<2]HQNV<6[AWU@D;>02/*B/\ J-O?[ /](H=L+O\
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M4ST,?6^0'QOP<#V2N=8@XY@_*$%C:/:3QR9"\GN\/BD ^TC=V,3F;N!SF,&
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MP^.U5&<A=D$-:.U4L5FS2'T8U\L;6EQV\ '<_4@M1$1!QE_*O_U7JOZ0U/\
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MM*YU#>G?2'2G2IE\::QLE6:^YK[5JU=GN6)RT;-#YIWO>0T$[#EL-SL/*F2
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M/BW(  !!\[+=: Z2SZ:T'GL-?KPOFRD'9EK07&L@?M%VR6NBK1=LN^L\'.\
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M+W-S7[<2X22N<0#OM$WZME$+/L^ZE.B78:J,3&^R7&S%-)7?$V45^U'+%_L
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M8\Q+*X7JT,<36.JL:(R.#RUV_P 8&TK]VDCS@ZCZ9R87I5HO3-'!T,G+3R%
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MTC3RC</)9Q]/HN</4[B?H@K*WT T[DLG9NWI9;TUNJ*MET]2GSD C,;7->(
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MYCBYLSP[=I^HCB1NMYENF^%SF$P^'NPF7%8R1DK*3&1QPREC2UG-C&@; GD
MT- < =O&RE*(*\K=#=.T(,U7ION5*>3KS5G58I&".NR5S72=H%A(W<"[R3Y>
M[[?&1D>CV(R%&"N;E^$P.M/BEC?'R8^>RRP7>6$$MDC;QW&VW@ARG:(*GS'L
MY834#!\I9C*W972SS233MJO<Y\KV/<YH,!$9!8 ',#3MN-SXVF'^KW'?Z+4\
M#WK7N=6W'<8_DWN%[)Q. 3QVVY#8^/3Z]_*E"(*NL^SMI:UC)J,DM]\,CK#A
MSDC?Q$IB+6@.81QB$,;6-(( ;L[EN5ZT.@&FL=FJ&5C9&;=9C&/_ /1M$,EX
MR.D:>(K@1D.<[XH^)._DD@$68B" T>C>*IWJ-IV0R,[Z,[IJ['NB#6 SF<,\
M1@D!Q/J=]OK^M1[.=%;?RI!'A+DM3&6;<%O(OEN-WF[=QUG8Q>[DG8O<T%LK
M/!'+EQ\V^B"(:OZ;4]87)K$F2OXXVJ1QUQE)T0;:K%Q=VW<V.(^D\;L+3L\^
M?3;+BT'0@T;D--13VHJ-T6@^5D@$K.^][W\7 ;#8R';P? &^ZDB(*YTYT,P6
MFH+$=:Q:/?%H/#(Z\+!WX88G\611-:W9M=A&P]2XG??QD:"Z:C26JM09AW$-
MMQUZE6)LQDXQ11AID=\+0U\A:TN W'P-\J?(@JNM[.^!IY6WDX<EDHLA,\RL
MLL;6$D3_ '@6 _EV=Y'![=@92_X?'Y5XXSH<^EJ>>]\LWHQ"6V:>3$L3[ALO
MELR3.>PPB(,(LN8&\3X^P@%6TB"N*G0_%T)ZKJ^9R\4$=BO;L0!\);;GAE=,
MV20F+D"Y[R7!A:#XV 6>>D6'.&^3/>;W8^2'8;EW&<NR7<B[Z&W/<>NVWY%.
M$00>QTAPUFE/6=9O".:K>J.(D9N&6YA-*1\'J'#9OV#U!]5@X?H3IW!V+$E4
MR1B6XRZWC7K,D8YM@6./=;$)'M+VCP]SO'@$; BQD013$=.Z>#U$S+U+MQLN
M]ON0O,;HY18F[S@?@W'%_P!'8CQX.ZE:(@(B("(B B(@(B("(B B(@(B(.,O
MY5_^J]5_2&I_A3KLJ+^:9^8+C7^5?_JO5?TAJ?X4Z[*B_FF?F"+Q]HB(@B(@
M(B("XP]@C^F?VI/TVF_S-Q=GKC#V"/Z9_:D_3:;_ #-Q%X[/1$1!$1 1$0$1
M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1
M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1
M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$'&7\J_P#U7JOZ0U/\*==E1?S3/S!<
M:_RK_P#5>J_I#4_PIUV5%_-,_,$7C[1$1!$1 1$0%QA[!'],_M2?IM-_F;B[
M/7&'L$?TS^U)^FTW^9N(O'9Z(B((B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@XR_E7_P"J]5_2&I_A3KLJ+^:9^8+C7^5?_JO5?TAJ?X4Z[*B_FF?F
M"+Q]HB(@B(@(B("XP]@C^F?VI/TVF_S-Q=GKC#V"/Z9_:D_3:;_,W$7CL]$1
M$$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0<9?RK_]5ZK^D-3_  IU
MV5%_-,_,%QK_ "K_ /5>J_I#4_PIUV5%_-,_,$7C[1$1!$1 1$0%QA[!'],_
MM2?IM-_F;B[/7&'L$?TS^U)^FTW^9N(O'9Z(B((B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B
M("(B B(@(B("(B B(@XR_E7_ .J]5_2&I_A3KLJ+^:9^8+C7^5?_ *KU7](:
MG^%.NRHOYIGY@B\?:(B((B("(B N,/8(_IG]J3]-IO\ ,W%V>N,/8(_IG]J3
M]-IO\S<1>.ST1$01$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1
M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1
M$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1!QE_*O
M_P!5ZK^D-3_"G7947\TS\P7&O\J__5>J_I#4_P *==E1?S3/S!%X^T1$01$0
M$1$!<8>P1_3/[4GZ;3?YFXNSUQA[!'],_M2?IM-_F;B+QV>B(B"(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B(
M"(B B(@(B("(B B(@(B("(B B(@(B(.,OY5_^J]5_2&I_A3KLJ+^:9^8+C7^
M5?\ ZKU7](:G^%.NRHOYIGY@B\?:(B((B("(B N,/8(_IG]J3]-IO\S<79ZX
MP]@C^F?VI/TVF_S-Q%X[/1$1!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$0$1$!$1 1$
M0$1$'&7\J_\ U7JOZ0U/\*==E1?S3/S!<:_RK_\ 5>J_I#4_PIUV5%_-,_,$
M7C[1$1!$1 1$0%QA[!'],_M2?IM-_F;B[/7&'L$?TS^U)^FTW^9N(O'9Z(B(
M(H!J?K+B]*Y/*4[6-R+F8_X)+C&Q=ATQ@=.V(?.<^18T^>''?QNM_#K_ $Y*
MVT'9W&Q34X1/;A?<C#ZK"!YD'+X!\0\G;U""0(M!7U_IBVYC8-18J9SX'6FB
M.[&[>$;[R>'?1'%VY]/A/V%9575F$O823,5LQ0L8B(.=)?BLL= P-^D2\'B-
MOK\^$&U11B3J5IBO"^S9S^*JT/@$=R;(0-BE+@2 T\_L:[UVWV.V^Q656UWI
MJ[DJ^.KZAQ4^0L,;)#5BNQNED:YG-KFM#MR"SX@1ZCSZ(-ZBU%_5V"Q62;CK
MN:Q].^Z(S"K/:8R4Q@$E_$G?B UQW]-FG["O*776FX+->O)J#%QSV)!%#$Z[
M&'2/(:0UHY>20]AV'^^W[0@WB**7^JFD,;?@I3:CQAMS7&T! RTQSVSD.(8X
M _"?@<//UC99>E=<8K5F&QU^M:AB==^%E9\S#().'<,9 /T@SXB/7;SZ() B
MT=O7&G*%R[4LY_&5[5*/O6H);D;7P,\?$]I.[1\3?)_WA]H6;%GL;/!3FCR%
M5\5P%U9[9FELX#2XEAW^+9H)\?4"4&>BT,6O=,SVGUHM18F2PR#WET3+L1<V
M+B']PCEOQXD.Y>FQ!]%[W-7X+'V8J]K-8ZM8F>R*.*6U&U[WO&[&@$[DD>0!
MZH-NBU%[5^"QF8@Q-S-8^KE+''LT9[3&3R<B0WBPG<[D$#8>2"L*7J7I""&>
M675.%CB@F]WE>_(1 ,DV)X$\O#MFN.WK\)^PH)(BCK.HNE),?8OLU-AW4:\C
M8IK+;\1CC>[Z+7.Y; GZ@?5>,/4C3\M^:N_)TX(A+'7@LS66-CM3/8).$1)^
M,AKXSX_WP@E"+28[5^.N8";+V)V8VK7?)':=;D:P5WQO+'A[B=ALX'SOMZ'Z
MUX'J-I0/HL.I\.'W@'5&F_%O8!<6 L'+XMW M\?6-O5!(D4=BZC:3G9>?'J?
M#R-HCE:<R_$1 .7'=_Q?#\7CS]?A>IUYIELE*,ZAQ0?=B[U5OOL>\\?GXV?%
M\3?A=Y'CP?L0;U%$6]5=+OL/+,UCW8Z.%LK\G[W'[JTO>YD;!)RV+G%DG@?[
MGY5E'7-,:<SN7[4A9AN_[Q"".1[;.?PGT(<PM<#]CP@DB*,5^INDI\/'E#J7
M$1T7O$)G??B#&REO+MEW+;EL=]O7;RO:SU$TI2%@V-38> 5YA7F,E^)O;E.Y
MX.W=X=\+O!\^#]B"0HM'8UUINK>LTI]0XJ&Y5B,\]>2[&V2*,-#B]S2[=K0T
M@DGQL05F834.+U+4=:Q&2J92JUYC,U*=LS X>K=VDC?R/'Y4&P10O)]6<'B)
MXH++;3)7YD80L$0)9,6AP>[SXCV<P\O^D/"^*/6#3EO4TV%FN1X^=I+(9+LT
M<0M/$\D!;$"[=WQQD?EW"";HH]+U#TK RX^34N'C;2D$-ESK\0$#R2 U_P 7
MPDD$;'SN"/J67-JW!U\''FI<Q0CP\@:69!UE@@<''9NTF_$[GP//E!MD49L]
M2-,XVN;&2SV+Q=<ROBBEMY"!C)>(!):>>WHX'8[$;C<#<+ZEZB:;[ER"MG,9
M=NU&ETU2&_#W6 .#3R!>..Q< =]O4#ZP@DB*/MZA:6=)?8-28@OQ[7/N-%Z+
M>LUKN+C)\7P .\'?;8^%E4=6X/*8:;+T\SC[>*AY=V]!:8^"/C]+D\'8;?7N
M?"#;(M'3USIO(S48JF?QEF6\'&JR&Y&]TX:2'< #\6Q!!V]""F6USI[!6K%6
M_F\?5N05W6I*LMEC9FQ-:7%_ G?;8$[[?4@WB*&8[K)HK*&3LZFQK6QTX+[W
MRVF,:V&8D1DDG8$D;;?42/M"V,O4;2<#&/DU/AHV/@%IKGY"(!T)/$2 \OHD
M^.7IOX02)%H&]0-+OCH2-U'B71WWF.HX7HMK#@[B6Q_%\1#B 0/K.WJMG2S.
M/R3F-J7JUISX6V&B"9KRZ)Q(:\;'RTD'8^AV*#,1:B_J[!8K)-QUW-8^G?=$
M9A5GM,9*8P"2_B3OQ :X[^FS3]A7E9UUIJFZ%L^H<5"Z:00Q"2[&TO>0UP:-
MW>20]AV^QS?M"#>(M/3UC@<CD)*%7-XZS=CE,#ZT-J-TC9 '$L+0=^0#'G;U
M^$_85K8>JFD)K>2KC4>,!QT4,UF1UN,1L9+_ #9Y;[;'Q_WC[0@E2+3T-8X'
M*W*]2EF\=<M6(?>88*]N-[Y8MR.XUH.Y;N#\0\>"MP@(B("(B B(@(B("(B
MB(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B
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MN[,\3CNUT3OI; .V(.^X]LIT5QXJ8VC6ST%-]>U?G$),\<<L,Y DC(BL1O/
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M[K-L],M.VFXIKZ4@CQE=E2M&RU*UHB8YCV-< [X]G1,(Y;^1^4J4H@C$O3C
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M@M!$1 1$0$1$!$1 1$0$1$!$1 1$05_[0G] ?4O]&<G_ )6133#_ /U(H_\
MVAG_ (0H7[0G] ?4O]&<G_E9%-,/_P#4BC_]H9_X0@S$1$!$1 1$0$1$!$1
M1$0$1$!$1 1$0$1$!$1 1$05IIO^L7K_ /1K ?YC+*RU6FF_ZQ>O_P!&L!_F
M,LK+0$1$!$1!1_5K^LWT%_/GO\DQ7@J/ZM?UF^@OY\]_DF*\$!$1 1$0$1$!
M$1 1$0$1$!$1!QE_*O\ ]5ZK^D-3_"G7947\TS\P7&O\J_\ U7JOZ0U/\*==
ME1?S3/S!%X^T1$01$0$1$!<8>P1_3/[4GZ;3?YFXNSUPY[(FI,?TS]K;VA]!
MZDLQ8K/9[4)S&*BL/#!<A?)/* PGU=PGB=Q'D@N_W2BNXT1$1RSU"]F3I3U#
MZH:ORU[$ZE&2;QMYB]C\V*5*.7W=I;NPS-(+F-9N\,X[GRX;';4_<;>SVVW/
M4DU-D8KM>)TT]9^L9!)"QK0YSG-[G@-!!)] #NKXUQTMM:VSKKCLE2QT(J3U
M&2UZ#O>WLEA?&8Y9>[L^(.?W.' >6M\@C<PF;H[F\IF)<$7NKZ;BBR?"[8IQ
M<B^VT;[%MASI!R<\@%D>P !).R*KW[C?V>30BO?Z49#W*68UX['^F$O;?* "
M6!W<V+MB#MZ^4P?L:= =1BV<?G,U/[I-/!,!JF?=KH2!+XY^C=QN?38C[5<6
MNNB&0U;/F13U1)BJ>5Y]^JR&8-!->&%KCVIX^9;VB0'[M/<.[3L"LG*=(\M8
MDO24=05*CYYL@8S-CG2\(K@:9&D"9N[FN:"UW@;>"T^J"D['L=>SO4,HGU5>
MA,3FLD[FL9&\'.!+0=Y/!(!('V E8VL_8TZ-Z+EA-BMJVU7=0MY&62#4=C=L
M5=K"0T%XY.<9&@#<#U\JYK/L_!]&E%#FMIH+$\LA,<\4<T<T,<3V.$,\;B=H
MF['GML2"/K6YUWTVFU-\FXNL&5\5\BW\/+./C]W$S(0QW!SMWCYLC;??R-SZ
ME!SYIKV0.BFI,X<**FML?E6,E?-5MY^;>+MB%Q#G,E<T[ML1N'$D;$[[$;+P
MI^R/T9LZ+MZHEQ&O:F+B:'5Q+J![Y;O)W%HA8R=QY.=L '\3NX?EVZ4/3 X7
M.86_I67$Z?@HUIZTM/Y*YQS"5\3G/';ECXN^:]2';[_D4>T_T!&+P]#$V,I2
MBH5;;;CWX/&NQUJU(P/[;IIA,XO+7/#M]AY:$%*Q^QWT5NY#!T\94UIEI,M3
M;D(W5M12-;#6):.X_N3,W +AN&<G#[/3?*T?[$_2'6.%?EH\9K?&X\MYPS7=
M0R'WAGG=S&QS/('CT<&GR/"NI_16U#B,9AJV:K_)N.ONN5+-JB^7(5&F42<(
M;'>'$_39R+3NUVQ! \[OI9TW?TTPL^/;+B9B\@MLT,5[G+(=W'E.>Z_NN^(>
M?A^O[? <Q4?94Z&SXK'Y2Y4UMBL;D(I;-6U;U#(YDD$<1E=+\W.\M'$> X!V
M_@M"97V3.CNGM,SY_,Z>ZB8G%QO@:V2QG7.?()9 QKA''8<\ <@7!P:0/J)&
MROAW0(Y._>L93*U8X;O?[M+$4#5@!E@=$Z5K72OXR.+N3G>CBUNXWW)R9NC.
M1R^<;ELOFL;+< JMDDHX@UW61!9CF#I29G<G$1\-_ '(D#ZD%(V_8XZ'5*.?
MN;ZOFK84Q&U)#G[#@6OC9('L^<\M#) 2?R'U6++[)70F+)Y['_\ ZXOLX>:K
M!*UF=L[3/L.#8Q$>Y\6SG!I]-BNCM'])*^EL?JS&R7W9#%YN4]JL^+B:E<PM
MB$'+D>8: 0#L-AL-CMN=1@>A?R38TC9L9U]ZSB'327Y#5X_*<CG%['.^,\.#
M_B ^+TV\(.<ZWLP]%[;V.BT]U#--^-?EQ=.H0(_=F_2?M[SSWW\;<=]_R>5M
M\I[(G0S$W\;4G;K(RY"&">$LSM@@-E?Q;O\ .>#N/*Z#Q_1WW'#QT#ENX&:>
MEP//W;;?F[?N[<_J_P!W_P":U[O9ZP]3*8RYB#1PHJPU8IHZ6-9'[PZ&0OYN
M+7#R=]O.^WVE"J)T;[)70C7-7 SXPZQVS,$\\+)\[98^+LE@>R0<_A=\XW8#
M<'UWVVWP8/9?Z$&3)BW5USCX:4=J9L\^=F<VTVO-V)>T(Y7.W[A:T!S6EW(;
M ^=ND-(]%F:0U1@<M7RY?%C\1\G6*GN_%MF;A$P60>1X'A"UI;L[?9OD<?.F
MI^SI#!;STSLI4KNR8MGO8W&"O8<^6R+$;[$AD<)S$X ,W:WP7?[R%4<?90Z+
M4O>6YC$:^P$U9L,TT5_/2$QUY'E@L%T4[V]MKAL[SR9ZN:!Y6=I[V-NC6IL[
M!2I5M6FE9JSVJU]^HK(9.V*5D;G-;RW+"9 6N_M $[;;$W[=Z5YG4MNU9U%J
M*M8?:K,QT\>-Q[JS'4^9?-&.4SR'2GB'.W\-!  )Y+)TEH/(:5U7CF-G-O!8
M[&6J=2639KXHY)H'10'XB7\&Q.',@>.(\D$D54_WO'I+_O:H_:&U_P"9/O>/
M27_>U1^T-K_S+II$*YE^]X])?][5'[0VO_,GWO'I+_O:H_:&U_YETTB%<R_>
M\>DO^]JC]H;7_F6@US[!/173^G)\CDJ.JLI7@DB JQYV9[WO>]K&<0^1K=^3
MQY)&WVKKE1_7FF)M8Z7LXJO<9C[$DD,L=B6 S-8Z.5D@W8'-+@>&WTAZH5R-
M4]B'V<>Q;=EZV:TO8J3MKV*N;S[H'QO<WFSXA(6.#F[D%CG#P?K! ]&^Q)[,
M GR<,N3L5G8ZT*=DV-2OC#)2P/#=W/&YXG_Y.^PJ^=4]%,UJF+(2S:O->_DP
M^.\ZK6F@KOC[1CB:V..PU_P;O=L^1[7%[MQMQ \LOT%M9+)>\MSS&Q!^XA,-
MB,/:ZK%7E:]T-B-Q!$+'#SL-W AVX("M6_R:/0Y[0YN.S;FD;@C-3['_ .:_
M?O9_0_\ NW.?KJ?_ .E=18^E'C:%:I"T,AKQ-B8T;[!K0 !Y)/H/K)60A7*O
MWL_H?_=N<_74_P#]*_8_Y-'H<R1KG8K,RM!!+),Q.YKOR$;^0NJ40HB(B"(B
M B(@(B("(B B(@(B("(B#6:HPM#4FFLMB<K%W\7?J35;<7GXX7L+7M\>?+20
MN2-/^QST5S.$H91U35V(Q5S=U6QD-4]MDD(B=)W6AMAQX\6GP0'#R2T $CLA
MX<6GB0';>"1N ?S*G,QT(GR=+*R6LG U]J62T:.%Q_N\)D-::(N;'),1W'F4
M.<XN =P .WER"H?N1O9O-46?],;7NY>8Q+_IH_B7@ EN_=]0'-)'U!P/UK[S
MGL>^SUIR'*/OZBR\+\97-JW!_I7,98HP >19SW_M-V\?VF_:%;6E>EV;SF6S
MN>U%+'1N7_>H(X138P\):M>#F6MGD#=NP?'-Q(/DM]%^NZ!9*S8LNN:NEMQ.
MQUO'P,D@F=VFS1,8/@,YC 9P]&,:7;^23Y15:-]A_H0ZE[X,UF/==^/>.JYN
M /;[NV_/;?M_'M_N^?3RO''>Q7T S%V"G0U%E+MNQ&988*^KI9))&#?=S6B3
M<CP?(^PJW<[T7RVH#:BGU%4BI6YGW)XH\8XO,[J+JAXN,VP9L>?$@GQMR^M;
M'$]'(L5K@YSW_P!YJ]V*RRI(; [4[*PK\F!LXBVX-_M1.(W<-_(V"AKGL9=%
M*.0GKR-U<8X;\&,,[-06"SWB5H=Q^GZ-#F$G_I?D*](_8UZ VJHM4\[E;U03
M=F:Q7U@\QPG@YY+CW?\ =:3L-SMYVV!(NW4G26YJ>;*8V7(Q5,!<R7RH_MQ%
MUASW0AA8UW(!FSF\MRUVX=MXVW6%DNA=S/5Y/E/4%9UHU8J3'U,:8HQ#'!9B
M;NPRNW<39<XG<#9H  ]4%+_<C>SJ^?%PPZFREIV2M&E5-;5DT@?,&%Y9NV0^
M>('_ .4W[0O'4WL?]&M-Y&]4;BM>988ZNVUD9\=G97,I1.W(+^<S7./%KG<8
MP]VPWV\C?HM_2Z:'453+4\G%$^"U6G[,E4N:615I*[F^'C8ELFX/U; ;%?6I
MNGN9OY7.6,)GZV*KYVLRO?CLT#8>TM:6=R%PE8&N+#M\0>-VM.WJ"*HNM[$7
M0>Y'6DAS>8D;99+)"1JN?YQL?\Z6_'Y#-QR_W?KV6/![&GL]VIK44.I\A-+5
MC=-88S6$KC#&W;DYX$GP@;C<GTW"M7(>SA5GFM"GFY*58OB%.$5^1JPF/MVX
MP[F.7?:3N=AQ.QV=LL_4G0>'/XAU&/+FB/?+MUCX:Y:0Z>02-;NV1IV:6M!V
M(+@/!;]04O+['?L[P5Z\\FJKS(+#'OAD=K&0-D:TD.+3W/(!!!(]-EEX?V'>
MBV<R5FG5FU-*8X(K44T>I+#XYX9-PV1C@_8CDUP_X?E"N*IT2BKPVWOLTY[5
MJG)7E[\-F5CI'S,E,I<^RZ7?X&^D@((#@1MLMYHK1>2P65-O+9-V5GKXZ''1
M6G@A\P:YTCY' EQ]7-:-W..S-R23N@IK[WCTE_WM4?M#:_\ ,GWO'I+_ +VJ
M/VAM?^9=-(A7,OWO'I+_ +VJ/VAM?^9/O>/27_>U1^T-K_S+II$*YE^]X])?
M][5'[0VO_,GWO'I+_O:H_:&U_P"9=-(A7,OWO'I+_O:H_:&U_P"9/O>/27_>
MU1^T-K_S+II$*YE^]X])?][5'[0VO_,GWO'I+_O:H_:&U_YETTB%<R_>\>DO
M^]JC]H;7_F3[WCTE_P![5'[0VO\ S+II$*XNUE[#G1#"YYE.?36M,[<-)UR6
M6GF7RF&NQX:20^9KG;%Q(:P./KL%\7O8C]F''4#;L9&U$SW'Y1$;M1R"5U?A
MS$@87<MBWSZ+J#56B<QEM3QYC$9VKB7''28V5L^/-EW%[VOYQN$K UPV\<FN
M'Y/J,4L]!+$N0K-9J:P,+2K.JU*,K97F%AHOJ<=N\(CY>9.7:Y$DCEMZ!3&-
M]@CV;LQ:IU:=JW8N6X&V8*K-22&:2(CD'AG/<C;<[[?45O/O9_0_^[<Y^NI_
M_I5MZ;Z-S8C5L6;O96/($/BLN@#;,;66&5A7YQL]X,8!:W^U&XC=PY>1M9Z#
ME7[V?T/_ +MSGZZG_P#I3[V?T/\ [MSGZZG_ /I752(51'2+V*.EO1+6L&J]
M,XR^W-00R00S7;\E@1M>-G%K7'8$C<;_ &$J]T1$$1$!$1 1$0$1$!$1 1$0
M$1$'&7\J_P#U7JOZ0U/\*==E1?S3/S!<0?RG^I:&J]$Z.Z48>S%?UQG]0U75
M\7"\.DCCXR,#W@>6@OE8!OZ_$1]$KN%K>+0/L&R+Q^HB(@B(@(B("ISK][)G
M3KVD8ZLFK<9-'EJC.U6S.-F[%N)F^_'EL6O;ON0'M< 2=MMSO<:(.,/O5?3/
M\-^HGZVK?PJ?>J^F?X;]1/UM6_A5V>B+=<8?>J^F?X;]1/UM6_A4^]5],_PW
MZB?K:M_"KL]$+KC#[U7TS_#?J)^MJW\*GWJOIG^&_43];5OX5=GHA=<8?>J^
MF?X;]1/UM6_A4^]5],_PWZB?K:M_"KL]$+KC#[U7TS_#?J)^MJW\*GWJOIG^
M&_43];5OX5=GHA=<8?>J^F?X;]1/UM6_A4^]5],_PWZB?K:M_"KL]$+KC#[U
M7TS_  WZB?K:M_"I]ZKZ9_AOU$_6U;^%79Z(77&'WJOIG^&_43];5OX5/O5?
M3/\ #?J)^MJW\*NST0NN,/O5?3/\-^HGZVK?PJ?>J^F?X;]1/UM6_A5V>B%U
MQA]ZKZ9_AOU$_6U;^%3[U7TS_#?J)^MJW\*NST0NN,/O5?3/\-^HGZVK?PJ?
M>J^F?X;]1/UM6_A5V>B%UQA]ZKZ9_AOU$_6U;^%3[U7TS_#?J)^MJW\*NST0
MNN,/O5?3/\-^HGZVK?PJ?>J^F?X;]1/UM6_A5V>B%UQA]ZKZ9_AOU$_6U;^%
M3[U7TS_#?J)^MJW\*NST0NN,/O5?3/\ #?J)^MJW\*GWJOIG^&_43];5OX5=
MGHA=<8?>J^F?X;]1/UM6_A4^]5],_P -^HGZVK?PJ[/1"ZXP^]5],_PWZB?K
M:M_"I]ZKZ9_AOU$_6U;^%79Z(77&'WJOIG^&_43];5OX5/O5?3/\-^HGZVK?
MPJ[/1"ZXP^]5],_PWZB?K:M_"I]ZKZ9_AOU$_6U;^%79Z(77&'WJOIG^&_43
M];5OX5/O5?3/\-^HGZVK?PJ[/1"ZXP^]5],_PWZB?K:M_"I]ZKZ9_AOU$_6U
M;^%79Z(77&'WJOIG^&_43];5OX5/O5?3/\-^HGZVK?PJ[/1"ZXP^]5],_P -
M^HGZVK?PJ?>J^F?X;]1/UM6_A5V>B%UQA]ZKZ9_AOU$_6U;^%3[U7TS_  WZ
MB?K:M_"KL]$+KC#[U7TS_#?J)^MJW\*GWJOIG^&_43];5OX5=GHA=<8?>J^F
M?X;]1/UM6_A4^]5],_PWZB?K:M_"KL]$+KC#[U7TS_#?J)^MJW\*GWJOIG^&
M_43];5OX5=GHA=<8?>J^F?X;]1/UM6_A4^]5],_PWZB?K:M_"KL]$+KC#[U7
MTS_#?J)^MJW\*GWJOIG^&_43];5OX5=GHA=<8?>J^F?X;]1/UM6_A4^]5],_
MPWZB?K:M_"KL]$+KC#[U7TS_  WZB?K:M_"I]ZKZ9_AOU$_6U;^%79Z(77&'
MWJOIG^&_43];5OX5/O5?3/\ #?J)^MJW\*NST0NN,/O5?3/\-^HGZVK?PJ?>
MJ^F?X;]1/UM6_A5V>B%UQA]ZKZ9_AOU$_6U;^%3[U7TS_#?J)^MJW\*NST0N
MN,/O5?3/\-^HGZVK?PJ?>J^F?X;]1/UM6_A5V>B%UQA]ZKZ9_AOU$_6U;^%3
M[U7TS_#?J)^MJW\*NST0NN,/O5?3/\-^HGZVK?PJ?>J^F?X;]1/UM6_A5V>B
M%UQA]ZKZ9_AOU$_6U;^%3[U7TS_#?J)^MJW\*NST0NN,/O5?3/\ #?J)^MJW
M\*GWJOIG^&_43];5OX5=GHA=<8?>J^F?X;]1/UM6_A4^]5],_P -^HGZVK?P
MJ[/1"ZXP^]5],_PWZB?K:M_"I]ZKZ9_AOU$_6U;^%79Z(77&'WJOIG^&_43]
M;5OX5/O5?3/\-^HGZVK?PJ[/1"ZXP^]5],_PWZB?K:M_"I]ZKZ9_AOU$_6U;
M^%79Z(77&'WJOIG^&_43];5OX5/O5?3/\-^HGZVK?PJ[/1"ZXP^]5],_PWZB
M?K:M_"I]ZKZ9_AOU$_6U;^%79Z(77&'WJOIG^&_43];5OX5/O5?3/\-^HGZV
MK?PJ[/1"ZXP^]5],_P -^HGZVK?PJ?>J^F?X;]1/UM6_A5V>B%UQA]ZKZ9_A
MOU$_6U;^%3[U7TS_  WZB?K:M_"KL]$+KC#[U7TS_#?J)^MJW\*GWJOIG^&_
M43];5OX5=GHA=4%T']B+IA[/F<=GL'2OYC4A:YK,SG;(L6(FN\.# UK6-)'C
MD&\MB1OL2%?J(B"(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(
M@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(
M@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(@(B("(B B(
2@(B("(B B(@(B("(B B(@__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>xlo-20250610xpre14a_bg002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 xlo-20250610xpre14a_bg002.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1, U$# 2(  A$! Q$!_\0
M'0 !  (# 0$! 0            <(! 4& @,) ?_$ %40   & @$" P,%#08%
M @,$"P ! @,$!081$@<A"!,Q%")!%1E15],6&",R,U9A<7:4E9;4"3<X0K.T
M%R12@=%BD24U4S1#<G1UH;$F8X(V@Y*R\/_$ !4! 0$
M   !_\0 &!$! 0$! 0               !%! 2'_V@ , P$  A$#$0 _ /U3
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M&(XY.*UCMMQXZJU3+JGY"I"B>0Z2F_+0EO@9*2I)NFI1K2:30@B2OF9HRP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M&D5]LF<EU<MQQ')U!LD1*02#[;/\8=@"
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MHPJXHL%MG*G(K1J*T[-<BH<<84RM?)"/:"-)F:.QJ[:2H]=T[FXCV1&9:/Z
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M9U8U+#5':U<2Z@N6-3-GI:2B:R@T$LR2EQ2T'IQ!D2TELCW^@2,
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MG(:2E^0RR;*'%D7O*2@U*-)&>SUR/7TF,H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M  !".3^*>-C&1650KI;U2M%09"XYS:S$GWXKYI,RYM.$>EH/6R478R[B;@ 0
M/5^+6+:642&72;JU%]H>0SY\K#GT--\E$7):M^ZDM[,_@1&)&ZI=3&^EM%&L
MW,:R7*2?DE&]DQ:K782$;2I7-2$GLD>[KE]*DE\1V0 *_??AQ?J>ZP_R6_\
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M7#F/Y!DJ3?0Q[#C5:N?*VHC/EY:>_$M=U?#9?2(I^_#B_4]UA_DM_P#\BP(
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M].NHV1*82A1S\>QEZ;#7R22M)=2>E&6]'KT,C+X"70 5^^_#B_4]UA_DM_\
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MU#YO[P_?5Q#_ 'V7]J+"@!5>OF_O#]]7$/\ ?9?VH?-_>'[ZN(?[[+^U%A0
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M8> C^^?Q2?ML]_N9@+BYX  (
M
M
M    IE_:O_X7HO[0Q/\ 2?%RFOR2/U$*:_VK_P#A>B_M#$_TGQ<IK\DC]1 N
M/8  (       *8> C^^?Q2?ML]_N9@N>*8> C^^?Q2?ML]_N9@+BYX  (
M
M
M                                     IE_:O\ ^%Z+^T,3_2?%RFOR
M2/U$*:_VK_\ A>B_M#$_TGQ<IK\DC]1 N/8  (       *8> C^^?Q2?ML]_
MN9@N>*8> C^^?Q2?ML]_N9@+BYX  (
M
M
M          IE_:O_ .%Z+^T,3_2?%RFOR2/U$*:_VK_^%Z+^T,3_ $GQ<IK\
MDC]1 N/8  (       *8> C^^?Q2?ML]_N9@N>*8> C^^?Q2?ML]_N9@+BYX
M  (
M
M                                           IE_:O_P"%Z+^T,3_2
M?%RFOR2/U$*:_P!J_P#X7HO[0Q/])\7*:_)(_40+CV  "       "F'@(_OG
M\4G[;/?[F8+GBF'@(_OG\4G[;/?[F8"XN>  "
M                                  JSX\JN1B&'4G5^CMRI\FPF:T\T
MVX\:&K)A:R2N*I)?C&K?8M?]7TB'\+L9O5GPX==.NUM:FN_OJZ;!A5L>2I2:
M2*RG262+MQ</1*,]$9EH_B8M)U@\/9]:>H6$VEYD&\0QJ1[>K%TPMIG2RWY;
MCKWF?BI[:1P/_-W[]N.L/!PIFYZL%C^8?(>,=0X#C4RA.L\YN+,4G1RFUD\G
MUVHS1Q+>_P 8M%HJ$L$N)[G5?P<(5-DJ1)Q24M])NJ,G5>S>JBW[Q_K$I>(B
MSE0O&7X>VFI#R([B;,W66UF27--;+9>A_P#<??(?!AD#BNDLW%^IR<9O.GU0
MNKCV"\?1,*3R225.>6M\DH[;+B?+U]>PZ*-X9,JM^HO3;-,QZE(RBYPYV8LW
M$4#<(IJ'TDE*--N\6^&C[Z5RW\ $)>';H_6^,RHR_J1U.M;JTGR+J5 JH,2U
M?BLT[+6N/E(;41<O>_S$9'K9D9F9B4O CG.17..9[AV16\C(7<)R)^FBV\M9
MK>D1T[X$M1]U&6C[GWT9?0/ZOPDYC@F2Y++Z1]5W<"HLCE*FS:652M6#;#Z_
MQW(ZE+2:#/Z-?1W[%J5.@/0FF\/V#'C]5*DVDF3)7.L;6:9&_-DK_'<5KT]"
M(B^!%ZF>S,*E>)KPZX?2>(WH_7P_EAF)FMU,^6FRN96GBTE>D_A/P9;4?XNA
MG]3[*)X;/%QTAK*&CRK(J"NQ::VW2427+*:[S<?/EP6LC7Q-1F9F?8B_0++]
M6.@W_%#JATRS#Y<^3/N+FO3/8O9/-]L\Q*2X\^:?+UQ]>*O7T']R/H/]T'B.
MQ/JM\N>1\@U,BL^2/9.7G^;S]_SN9<=<_3@>]>I M55QGJ=-ZB^(CQ"6I5.2
MXJP73Q1M5&21SARF%):27/RN2B3OU(R/N1C \!%'B%NW@5M(P'J8>7>2\\O+
M9923H7%EYA;)9OF@R-/NE[GXW_N+067AD^4>KO4G./ND\O[L<:^Y[V#V#?L?
MX,D>=YGF?A/3?'BG_P#$-'T$\-O4OHA'QRC_ .,[5UA-.2D?(/W)L1U.MGR/
MC[1YREI]Y6]]_30(_/6OMXDJGMF:I_,JWJU/S5Z#1Y"W8NQ:AM/G)_!..K<)
MOD1<O=(M]T_#L+N>-;*9TZ@Z;='UY"BHNLQFLIM[5M\F"8B,$2GW249D224L
MBUOUT9#:'X$X;_0;*NG,G+5.R;;(',BAW:*W@JO?4M*DD3?FGST25%OFG?+T
M(;QWP;56:=4CS+J?:1.HA-4D:GB5<NJ\EAA39$;C_=U?)2U<E:T7'F9;,%J&
M>F'5";?>!/JQBL^T.5DN"1)],]+;?YJ=:22C8=)9'W(T[(CW_D$7>&MR=*S?
MI+(Z6KS93:JQ:\\=L523J%EY7<TF[[IJY<M<>V^/'XBT$OP*U-5D'4%W#+YC
M#\:S+'SI96/QZOS&6'M:3)0KSD]R[^YQ[\E>\6Q./3#IY_PXZ4X_A?RA\H_)
M-:W7>W>3Y7F\4<>?#DKCOUUR/]8%?GWX&:G%,B=Q:QN<#ZF7.5(NW5M97%]I
M51M&ATS;\Q9/DC2=$2B-!]^Q[%BO!S829G6'Q(-R)+KZ&,LXM(<<-1-ITYV2
M1^A?J&9T*\*?4GH0W4U%5UK:DX;$L#F/T9XBPE4A"W.;K?M"GU+1R[ER+>M]
MB'VR7PGYA4=2\OR[I;U17@A9<:5W%?)IFY[9ND1EYS1J6G@KN9^GJ9]_0B(@
MSH+TIH^LOADSRTRAVTF3:"^O7Z]UBS?8-"B;0HM\%ER(C06B/9>OTC0X/TKI
M:;^SRO>IT9ZU+,;''Y#4B:Y:2%I,O:M;2V:S2D](3W(B/_W%R^DWAPJ^D/0R
M;TYK+21+.<S**7;RFR-QZ0^DTK=-!'\-EI._0B[_ !&BKO"K\G^$EWHC]U'F
M>9!<A_+OR?K7)XW.7D>;\-ZUS_3OX M5_.9<]=.H71?HS+R&SI,.3@T6_N$5
MLI3#]HKRR(FE.%[W'L1F7Z5'ZD1EV'B/\,L[I?T)LZ[HG OTL3;.+(NZFOMI
M#TJ3";)9.(CJ<6I1&KDGDE)]]>A^@[_-O!VB]KNGMCCN9S,1Z@856M5D+)H<
M1+B9#2$$DTO1U*TI)]SX\NW(R/D0W#72OK@K$ID9_K?$/(ERF7HT]K$XZ666
MDI62V5-^8?,EFI)FHSVG@6B[@5S7@FNND$^HR*-TQBW5%8M.-%<X_D,A]<N&
MZ1*(C-+JUZV?+9I/6R[D7H+$90HTXS;J29D90WC(R^'N&*NJ\-74?IABO4S+
ML>RQS-^M.7MQXR;4HS%:Q%0E:2VALU&@N*-GLS[\2T6][LM4T$UK!8M+96+D
M^Q^3TQ9-@Z1&MUWR^*W#(M%W/9Z+0)U^7,N+D.<^%#P^TU=>S(%O;Y?/AM3B
MD+Y$LW%DCD>]F1'H3-2];;#JEUL\-LJP<>AW\!=Q59%7)6:>$V.R27"4GX[[
M++?_ %"6L8\#_P!SF%=)\?\ NT]H^X/(7+[VCY*X^W<UFORN/G'Y>MZY;5^H
M;6Q\&-<YXK*WK16Y"JM)E2GY= 4+FW)D*:4TITG?,+@:B-)G[A[-/KW[%1'X
M>.E<#QHQ\LZD=4[.WNVUW4FNJ:&/:/Q(E8PT9<>*&EI/G[Q=S/OK9D9F+L8M
MCD3$,;K*2"I]<.OCHC,JDNFZX:$D1%R6?=1Z+U/U%=F_"1EG3K,,@MNC_5)S
M!*J_E',G4,^F:LHJ'U?C.,\EI-'ZO^V]$1%*N%=/LWH<U^6;_J.]DM6=2S"5
M3G5-Q6SEIX\Y9*2L]&O1_@R+1<O7L"=20  "
M                                 IE_:O\ ^%Z+^T,3_2?%RFOR2/U$
M*:_VK_\ A>B_M#$_TGQ<IK\DC]1 N/8  (       *8> C^^?Q2?ML]_N9@N
M>*8> C^^?Q2?ML]_N9@+BYX  (
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M0LTD2W>9.F1[,^.^^M L?IQ,S;':Z]8I)=_5Q;E_1M5STQM$AS?IQ;-7(_\
ML0_MGF>/TLAYBPO:V ^R2#=;DS&VU()9Z1R)1D9<C[%OU/T'Y5Y11-2,FZL4
M'4')<0Q#+9F1NR6I^0X_,E72F^9''<@R6U=D:(B2E!?KV1D+"4W2JFZB>/&S
MK\UCMY(55A5;+,GN26G9:."2?-&_4N2S+?IR^D$BYC>=XT[D)T",AJEWI;W5
MIFM'*+1;/\%RY>G?T&]'YO\ A\L<>Z:^*2LQG#I.,]68%]:3ILBZ*E6W?4"C
M)1*-V2I/XG<TGL^_?LG??]( .@  (
M                   IE_:O_P"%Z+^T,3_2?%RFOR2/U$*:_P!J_P#X7HO[
M0Q/])\7*:_)(_40+CV  "       "F'@(_OG\4G[;/?[F8+GBF'@(_OG\4G[
M;/?[F8"XN>  "
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M?-##3;BW$MH2XO7)9)(C5]&S^(^@
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MV                                           IE_:O_X7HO[0Q/\
M2?%RFOR2/U$*:_VK_P#A>B_M#$_TGQ<IK\DC]1 N/8  (       *8> C^^?
MQ2?ML]_N9@N>*8> C^^?Q2?ML]_N9@+BYX  (
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M.SXR$D1NHDJ+3:4I[;(^Q[UQ%]@ K^)WQ+9:/7<B']  0
M                        !3+^U?\ \+T7]H8G^D^+E-?DD?J(4U_M7_\
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M/SBFKTUB_;$26[&P^2V'(IDZGVCW]H,R/MHVUD?T&6C&^
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MP$?WS^*3]MGO]S,%SQ3#P$?WS^*3]MGO]S,!<7/  !$9]1/[V^E'_P"<L?\
M9."+LPI3AN=:LLCV5G&MJFVC/P?9I[S+32T0XAF9MH425\M\5<R5LNWH+.@
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MH]Y7NGV[GV[C'+$J,HTJ,5-7E'E1T1)#/LJ.#S*$FE#2RUI2$D9D23[$1F1
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MC]2T7T (3BO7.%6/4FPB9)8R77,TJX9MRD1U(2V[[ E>B2T1[-#AH]?0B/\
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M)*B)1:T:2WWG_)I;L#'+62PORWV8CKC:]$?%1(,R/1_I(<[!Z6X>BOC-4U3
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MVV>_W,P7/%,/ 1_?/XI/VV>_W,P%Q<\  $
M
M
M              4R_M7_ /"]%_:&)_I/BY37Y)'ZB%-?[5__  O1?VAB?Z3X
MN4U^21^H@7'L  $       %,/ 1_?/XI/VV>_P!S,%SQ3#P$?WS^*3]MGO\
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ME]_VHJ W3A_C'PX>;[_XO'>_CO78=$"
M                  IE_:O_ .%Z+^T,3_2?%RFOR2/U$*:_VK_^%Z+^T,3_
M $GQ<IK\DC]1 N/8  (       *8> C^^?Q2?ML]_N9@N>*8> C^^?Q2?ML]
M_N9@+BYX  (      #^$1%Z%H?T
M
M                                                           4
MR_M7_P#"]%_:&)_I/BY37Y)'ZB%-?[5__"]%_:&)_I/BY37Y)'ZB!<>P  0
M      4P\!']\_BD_;9[_<S!<\4P\!']\_BD_;9[_<S 7%SP  0
M
M
M                              !3+^U?_P +T7]H8G^D^+E-?DD?J(4U
M_M7_ /"]%_:&)_I/BY37Y)'ZB!<>P  0       4P\!']\_BD_;9[_<S!<\4
MP\!']\_BD_;9[_<S 7%SP  0
M
M
M   !3+^U?_PO1?VAB?Z3XN4U^21^HA37^U?_ ,+T7]H8G^D^+E-?DD?J(%Q[
M  !       !3#P$?WS^*3]MGO]S,%SQ3#P$?WS^*3]MGO]S,!<7/  !
M
M
M                                   %,O[5_P#PO1?VAB?Z3XN4U^21
M^HA37^U?_P +T7]H8G^D^+E-?DD?J(%Q[  !       !3#P$?WS^*3]MGO\
M<S!<\4P\!']\_BD_;9[_ ',P%Q<\  $
M
M
M           4R_M7_P#"]%_:&)_I/BY37Y)'ZB%-?[5__"]%_:&)_I/BY37Y
M)'ZB!<>P  0       4P\!']\_BD_;9[_<S!<\4P\!']\_BD_;9[_<S 7%SP
M  0
M
M                                          !3+^U?_P +T7]H8G^D
M^+E-?DD?J(4U_M7_ /"]%_:&)_I/BY37Y)'ZB!<>P  0       4P\!']\_B
MD_;9[_<S!<\4P\!']\_BD_;9[_<S 7%SP  0
M
M
M               !3+^U?_PO1?VAB?Z3XN4U^21^HA37^U?_ ,+T7]H8G^D^
M+E-?DD?J(%Q[  !       !3#P$?WS^*3]MGO]S,%SQ3#P$?WS^*3]MGO]S,
M!<7/  !
M
M                                               %,O[5_P#PO1?V
MAB?Z3XN4U^21^HA37^U?_P +T7]H8G^D^+E-?DD?J(%Q[  !       !3#P$
M?WS^*3]MGO\ <S!<\4P\!']\_BD_;9[_ ',P%Q<\  $
M
M
M                       4R_M7_P#"]%_:&)_I/BY37Y)'ZB%-?[5__"]%
M_:&)_I/BY37Y)'ZB!<>P  0       4P\!']\_BD_;9[_<S!<\4P\!']\_BD
M_;9[_<S 7%SP  0
M
M                                                      !3+^U?
M_P +T7]H8G^D^+E-?DD?J(4U_M7_ /"]%_:&)_I/BY37Y)'ZB!<>P  0
M   4P\!']\_BD_;9[_<S!<\4P\!']\_BD_;9[_<S 7%SP  0
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MU\ZGO\,1J<^]N7#ZD1L78S%$&.M4Z(ZRM2DK22/+4MLR(C4DBV>M_'8B_H"
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M^F4IJ5[II7%:AN&Z3)\C2:7$F:3ULR/9"X@(
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M+EKMO>]#X,=$>G<6]<NVL#QINX<DIF*L$U+'GF^DS-+O/AOF1F9\M[V9F.V
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M;P^BH+*61ID3*VN9CNND9[,C4A)&9&??7ION.M
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M
M
M
(       ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>xlo-20250610.xsd
<DESCRIPTION>EX-101.SCH
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 4/17/2025 3:35:19 PM-->
<!--Modified on: 4/17/2025 3:35:19 PM-->
<xsd:schema targetNamespace="http://www.xiliotx.com/20250610" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:deprecated="http://www.xbrl.org/2009/role/deprecated" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:dtr="http://www.xbrl.org/2009/dtr" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:srt="http://fasb.org/srt/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:attributeFormDefault="unqualified" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap-ebp="http://fasb.org/us-gaap-ebp/2024" xmlns:cyd-af-sub="http://xbrl.sec.gov/cyd-af-sub/2024" xmlns:xlo="http://www.xiliotx.com/20250610" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:ecd-sub="http://xbrl.sec.gov/ecd-sub/2024">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.xiliotx.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="xlo-20250610_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="xlo-20250610_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>xlo-20250610_lab.xml
<DESCRIPTION>EX-101.LAB
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 4/17/2025 3:35:19 PM-->
<!--Modified on: 4/17/2025 3:35:19 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information [Abstract]</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>xlo-20250610_pre.xml
<DESCRIPTION>EX-101.PRE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--XBRL document created with Toppan Merrill Bridge  10.9.0.3 -->
<!--Based on XBRL 2.1-->
<!--Created on: 4/17/2025 3:35:19 PM-->
<!--Modified on: 4/17/2025 3:35:19 PM-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <roleRef xlink:type="simple" xlink:href="xlo-20250610.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.xiliotx.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.xiliotx.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType_638805009189827181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_DocumentType_638805009189827181" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_638805009189827181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityRegistrantName_638805009189827181" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_638805009189827181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_EntityCentralIndexKey_638805009189827181" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_638805009189827181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="dei_AmendmentFlag_638805009189827181" order="4" use="optional" />
  </presentationLink>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended" xlink:title="995443 - Disclosure - Award Timing Disclosure" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures" xmlns="http://www.xbrl.org/2003/linkbase" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Document and Entity Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">PRE 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">XILIO THERAPEUTICS,&#160;INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001840233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th">
<div>Aug. 03, 2024 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We grant stock options to our employees and directors on an annual basis. We also grant stock options to individuals upon hire or promotion or for retention or recognition purposes and have also granted restricted stock units for retention and recognition purposes. We currently do not grant stock appreciation rights or similar option-like instruments. During the last fiscal year, neither the board of directors nor the compensation committee took material nonpublic information into account when determining the timing or terms of stock options, nor did we time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">While we do not have any policy or obligation that requires us to grant stock options to employees on specified dates, annual stock option grants to employees are typically approved in December and granted on January 1 of the following year. Stock option awards for new hires are typically approved with a grant date of the first day of the month following commencement of employment. Our annual stock option grants to non-employee directors occur automatically and without the need for any further action by the Board on the first business day following the date of each annual meeting of stockholders.<span style="font-size:12pt;"> </span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:12pt;visibility:hidden;background:#00ff00;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;">The following table presents information regarding stock options, stock appreciation rights and/or similar option-like instruments granted to our named executive officers in the fiscal year ending December 31, 2024 during any period beginning four business days before the filing of a Form 10-Q or Form 10-K, or the filing or furnishing of a Form 8-K that discloses material nonpublic information (other than a Form 8-K disclosing a material new option award grant under Item 5.02(e)), and ending one business day after the filing or furnishing of such report with the SEC. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Per-share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Percentage</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">securities underlying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">exercise price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">fair value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">change in the</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">the award</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of the award</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of the award</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">closing market price</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;">Christopher Frankenfield</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">August 3, 2024<sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"> 52,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"> $0.8950</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">$ 35,578</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">+0.69%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Granted in connection with Mr. Frankenfield&#8217;s promotion to chief financial officer on August 3, 2024.</span></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">We grant stock options to our employees and directors on an annual basis. We also grant stock options to individuals upon hire or promotion or for retention or recognition purposes and have also granted restricted stock units for retention and recognition purposes. We currently do not grant stock appreciation rights or similar option-like instruments. During the last fiscal year, neither the board of directors nor the compensation committee took material nonpublic information into account when determining the timing or terms of stock options, nor did we time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</p><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text">We currently do not grant stock appreciation rights or similar option-like instruments. During the last fiscal year, neither the board of directors nor the compensation committee took material nonpublic information into account when determining the timing or terms of stock options, nor did we time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardsCloseToMnpiDiscTableTextBlock', window );">Awards Close in Time to MNPI Disclosures, Table</a></td>
<td class="text"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Number of</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Per-share</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Percentage</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">securities underlying</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">exercise price</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">fair value</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">change in the</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Name</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">Grant Date</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">the award</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of the award</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">of the award</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;font-weight:bold;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"><b style="font-weight:bold;">closing market price</b></p></td></tr><tr><td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"><span style="font-size:9pt;">Christopher Frankenfield</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">August 3, 2024<sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;">(1)</sup></p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"> 52,000</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"> $0.8950</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">$ 35,578</p></td><td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">&#160;</p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;">+0.69%</p></td></tr></table><div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"><div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"></div></div><table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"><tr><td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;">(1)</td><td style="padding:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;">Granted in connection with Mr. Frankenfield&#8217;s promotion to chief financial officer on August 3, 2024.</span></td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardsCloseToMnpiDiscTable', window );"><strong>Awards Close in Time to MNPI Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardsCloseToMnpiDiscIndName', window );">Name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Christopher Frankenfield<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardUndrlygSecuritiesAmt', window );">Underlying Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardExrcPrice', window );">Exercise Price | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardGrantDateFairValue', window );">Fair Value as of Grant Date | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,578<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_UndrlygSecurityMktPriceChngPct', window );">Underlying Security Market Price Change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardExrcPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 2<br> -Subparagraph ii<br> -Sentence D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardExrcPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 2<br> -Subparagraph ii<br> -Sentence E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardUndrlygSecuritiesAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 2<br> -Subparagraph ii<br> -Sentence C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardUndrlygSecuritiesAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardsCloseToMnpiDiscIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 2<br> -Subparagraph ii<br> -Sentence A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardsCloseToMnpiDiscIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardsCloseToMnpiDiscTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardsCloseToMnpiDiscTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardsCloseToMnpiDiscTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardsCloseToMnpiDiscTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_UndrlygSecurityMktPriceChngPct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 2<br> -Subparagraph ii<br> -Sentence F<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_UndrlygSecurityMktPriceChngPct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( ,E+DEI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( ,E+DEKU>R,A[P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DE%+PS 0Q[^*Y+V]IE49H<N+8T\*@@/%MY#<
MMF"3AN2DW;<WK5N'Z ?P,7?__.YW<*T.0O<1GV,?,)+%=#.ZSB>APYH=B8(
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
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MOPH@C0.>[X30)\-<T'YGXC]02P,$%     @ R4N26@A*4*V*!P  @B   !@
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M8EB[R=Q)Q0WI2. .(Q*/PWN;)%B2T+;B;;AA6>F&^3<>E;3-[&#&Z*0BXV2
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M"!&(O(P?(R>>2@;@Z?S(_CYZ]U[VU,*5%E\Y<TV!WV#$X$ [X>YT_P%&/\O
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M-O[] 1,2_/Y!:W<,0H'I12M_ 5!+ P04    " #)2Y):D.M2:P4#   O$
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MW7&@I]P^402[BFG#GF <21(,@5YT]V@<(]6)X>/>'^PIB:(D<2. N15$$8;
MTX@CF +0@"%1U)V#!^=1L#FG@NV_"&:_ %!+ P04    " #)2Y):EXJ[',
M   3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!
M5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]I
MSI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z
M3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=
MQ_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( ,E+
MDEH9M*93? $  'X#   /    >&PO=V]R:V)O;VLN>&ULM9)A3^,P#(;_2I0?
M0,<XD)@HTNEVP"1T3,?$]RQQ5XLDKIR4'?SZ<U-55$)"?.%3Z]>6\_BUKX[$
MSWNB9_4O^)AJW>;<K:HJV1:"22?4091,0QQ,EI /5>H8C$LM0 Z^6BX6%U4P
M&/7UU=1KR]4\H PV(T41!^$)X9C>\T.H7C#A'CWFUUJ7?P]:!8P8\ U<K1=:
MI9:.=\3X1C$;_VB9O*_UZ9AX LYH/\B/ ^3.[%-1LMG_-0)2ZXN%-&R04RX5
MI;\1QA>0XC'J,]V@S\!KD^&6J>\P'H8V,D4U&Z/X,'U'$U?\%1NI:=#"FFP?
M(.;11P8_ ,;48I>TBB9 K:<29:)3OV,6D]0FCJVD=IA4GMZX<>HLN#,/>862
MX(TKX-\'^?-HV*F=["L>U!J3]91ZAAG<\A.XY??";6)"!ZQV;-S MR6/%B$5
M1[<\@SS[!/*LK'[:MX,&([@_\D 276[/;ED-G[*)Y8_STTNYL=[[7Z(]Q'LR
M;CJ?Z?2O_P-02P,$%     @ R4N26KMLZNRZ    &@,  !H   !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<\63.0Z#,!!%KX)\ (8E21$!51K:B M8,"QB
ML>69*'#[$"C 4HHTB,KZ8_G]5XRC)W:2&S50W6ARQKX;*!8UL[X#4%YC+\E5
M&H?YIE2FESQ'4X&6>2LKA,#S;F#V#)%$>Z:331K_(:JR;')\J/S5X\ _P/!6
MIJ4:D86325,AQP+&;AL3+(?OSF3AI$4L3%KX LX6"BRAX'RAT!(*#Q0BGCJD
MS6;-5OWEP'J>W^+6OL1U:"_)]>L UE=(/E!+ P04    " #)2Y):IOQ*6R,!
M  #?!   $P   %M#;VYT96YT7U1Y<&5S72YX;6S-E,].PS ,QE^EZG5J,H;$
M :V[ %?8@1<(C;M&S3_%WNC>'K?=)H%&Q30DN#1J;'\_QY^2Y>L^ F:=LQ[+
MO"&*]U)BU8!3*$($SY$Z)*>(?]-&1E6U:@-R,9_?R2IX D\%]1KY:OD(M=I:
MRIXZWD83?)DGL)AG#V-BSRIS%:,UE2*.RYW77RC%@2"X<LC!QD2<<4(NSQ+Z
MR/> 0]W+#E(R&K*U2O2L'&?)SDJDO044TQ)G>@QU;2K0H=HZ+A$8$RB-#0 Y
M*T;1V329>,(P?F^NY@\R4T#.7*<0D1U+<#GN:$E?7406@D1F^H@G(DM??3[H
MW=:@?\CF\;Z'U Y^H!R6ZV?\V>.3_H5]+/Y)'[=_V,=;".UO7[E^%4X9?^3+
MX5U;?0!02P$"% ,4    " #)2Y):1L=-2)4   #-    $
M@ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( ,E+DEKU>R,A[P
M "L"   1              "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4
M Q0    ( ,E+DEJ97)PC$ 8  )PG   3              "  >$!  !X;"]T
M:&5M92]T:&5M93$N>&UL4$L! A0#%     @ R4N26ANI3N=R @  <P8  !@
M             ("!(@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4
M Q0    ( ,E+DEH(2E"MB@<  ((@   8              " @<H*  !X;"]W
M;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " #)2Y):/*4S.!$"  #=
M!   &               @(&*$@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
M4$L! A0#%     @ R4N26I#K4FL% P  +Q    T              ( !T10
M 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " #)2Y):EXJ[',     3 @  "P
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52P4&      L "P#* @  V1P

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>17</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="xlo-20250610xpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.xiliotx.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="xlo-20250610xpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="xlo-20250610xpre14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>xlo-20250610.xsd</File>
    <File>xlo-20250610_lab.xml</File>
    <File>xlo-20250610_pre.xml</File>
    <File doctype="PRE 14A" isUsgaap="true" original="xlo-20250610xpre14a.htm">xlo-20250610xpre14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>xlo-20250610xpre14a_a003.jpg</File>
    <File>xlo-20250610xpre14a_a004.jpg</File>
    <File>xlo-20250610xpre14a_bg001.jpg</File>
    <File>xlo-20250610xpre14a_bg002.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="13">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>19
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "xlo-20250610xpre14a.htm": {
   "nsprefix": "xlo",
   "nsuri": "http://www.xiliotx.com/20250610",
   "dts": {
    "schema": {
     "local": [
      "xlo-20250610.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "xlo-20250610_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "xlo-20250610_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "xlo-20250610xpre14a.htm"
     ]
    }
   },
   "keyStandard": 17,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 2,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 114,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 13,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://www.xiliotx.com/role/DocumentDocumentAndEntityInformation",
     "longName": "00090 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xlo-20250610xpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xlo-20250610xpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xlo-20250610xpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xlo-20250610xpre14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xlo-20250610xpre14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "xlo-20250610xpre14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r15",
      "r25",
      "r56"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r18",
      "r28",
      "r59"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r52",
      "r60",
      "r64",
      "r72"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.xiliotx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Document and Entity Information [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.xiliotx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.xiliotx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.xiliotx.com/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r15",
      "r25",
      "r56"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r12",
      "r22",
      "r53"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r60"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r60"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r60"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r60"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r60"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r52",
      "r60",
      "r64",
      "r72"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r1",
      "r76"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r1",
      "r76"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r1",
      "r76"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r9",
      "r19",
      "r29",
      "r52",
      "r60"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r17",
      "r27",
      "r58"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r20",
      "r30",
      "r61"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r20",
      "r30",
      "r61"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r33"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r12",
      "r22",
      "r53"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r13",
      "r23",
      "r54"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r4",
      "r14",
      "r24",
      "r55"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r21",
      "r31",
      "r62"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r16",
      "r26",
      "r57"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>20
<FILENAME>0001558370-25-004996-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001558370-25-004996-xbrl.zip
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MCP 4-G:AXUVG+=A3Q:C*6?K\P.5?@=D8O":D/DUB!T0Q-6=C:O8Q&4Z'4P5
M7$5;ZQ$F(!%5@-=GHG+P"J:J+YEJI-5C%6O!2#^3334=RNXT2]G.,FGX2C#L
M:$P3"VO"X*E;$WTB7?,,M&- (FN2<&J&G?-03&;VM9X%RK[XQYGJ)BZ?S^>I
M1P^<'IFA@!SW]!$_\@;@U,%.9HJS&9[E4>_RP=Z]:7N7[X-=7S*D'>U@'0PN
M@KC$.[H9SKE#3M;+2#U[*!*X8%ON4\'/-#*7QA))V7Y]\M?7)SZ6ZL87L]7X
M;#LPBH&^%)B4V#2KD;'I\4AL)]0%UTE7 EJ,5( 6<:UH,>Y(![8"RW<(^9N.
M2*FLGTQW% [KFLM2M2=PYMI_X<KW!3H5N8\_GCZ-NN];[6-WU8??'V7QL[3<
MOGP"Q;KR%B>(0V 7,8,KP9F"E5QR[W8&[9TAC(+\X2>1!6J5H0-MM^FQCB/M
M#3PT?I-+_PW7F@%57M!= IUP1SDC2(F@C7B[W-ZM4;'N,%0DKE-8ZD^L1'YQ
M+=Q^N9L87M7"];H_V_@K%+H0AV[[$R)-H(\"PVD_,W*^RL?)Z>P&%433$RTG
M>Q64J)IIRV$Y["^D]#\*2I#56X,"$2;^EVANTZ/IZ@ZB&?03"&$I;9$\>7J.
MO._:!^N#HEY-RS9C=/?A,G25@*G.N?-6SVW<(=.#(NY?OW.Q.\+Y%.Z[B[T8
M?KU=:#\(.,/7;S-YNFXO2G>@^\W[IG2/[^U_8!ED_T6Q!]\G8TZ\)NG_F]Z1
MMOM;9<MO4$L#!!0    ( ,E+DEJX80, BP(  &4.   4    >&QO+3(P,C4P
M-C$P7VQA8BYX;6S-EU%OVC 4A=\K[3_<9<^."6FU$0$5L$VJ!M/4=E*E::I,
M8D*TQ$:.*>'?UPXQ(S2AC(HI+RCD'A^?>_-AE.YUEL3P1$4:<=:S'+ME 64^
M#R(6]JREG*%/UG7_W47W/4(/P]LQ!-Q?)I1)\ 4ED@:PBN0<[OEB01A,J!!1
M',-01$%( 9R6W;%;M@L(]7.+(4G5$LX@]VK;CBF,"C?./+C$SD?<;K6OP/7<
M*\_IP(^)T4U4LEGTFC".V!]/?TS5?J Z9*F7I5'/FDNY\#!>K5;VRK6Y"-7R
MEH,?)N,[?TX3@B*62L)\:H'2>VE^<\Q](O/Q["S/IB(V!B[>[E6KT-^0D2%]
M"SEMY#IVE@96$5&7C]C$R'4UD-L%N^(KO"ENI2^LB_:=3J>#\ZK5OP H)D>F
M-!ZK*\@KGEPO:,^BF:0LH#IM?E?PF!Y(J\MX:ZRMN5_RB_58N3!V<T%G&[O4
M-)-2WP[Y$PYHI!_SI;Y ^D(/[8/Z\CCB"MW!-)6"^-(XY?%[5E5=#^.H"6,3
M6GL-1#DY$;[92UV^,H="@7VNL%I(E#N:Y3/!D^JDF^UX1?$QGL8GMU+J0]"4
M+T4.^_%/=#=^W:2W$95"GR.4H9]W_Y"Y_]F<,H0%\(7)2*[AALVX2/)?(OPR
M._WN;A*=D3&3Y5XY5C2^5VXN855]&,!V:\WDJS+AF_'2;N<G: /P+0TC#2V3
MWTE215*-K+E$'>K+D%6E:29A!Y.>2EIQ=OUU!6W[OY ;*<8%B6_4WW;VC:YK
MFWZI:SIT-9V5J=L3-1F[NJAOY*ZPA=P7E/'YR1NH@S70A^O7F(05_>[7FTM:
M92>&L%*QF6151SR5J*T;:+L=CKJX_-*@WK]PZ06L_PQ02P,$%     @ R4N2
M6C"@(&H! P  O@T  !0   !X;&\M,C R-3 V,3!?<')E+GAM;-5776_:,!1]
MK[3_X&7/B1,"+8F BK:;5 VFBC&I;Y5Q#%AS[,@V)?WWLT-"^6H;NG5;7]K$
M]_KXG'-O;-,YSU,&[HE45/"N$WB^ PC'(J%\UG46>NJVG?/>AY/.1]>]O1@-
M0"+P(B5< RP)TB0!2ZKG8"RR#'$P)%)2QL"%I,F, !#X7N3Y7@A<MU= 7"!E
MI@@."JR&%U2!RQ)-\!@T87 &&WZC!<(X;,5!!&Z&5=[0,)O2EQ(9Y3]C^V=B
MU@-&(5=QKFC7F6N=Q1 NETMO&7I"SLQT/X"WP\%W/"<I<BE7&G%,'&#R8U4,
M#@1&NK!G8WH^D:P"".%ZK2<S[)M;I;EVR T:;AAXN4J<DJ(-UUBD2K=1^DS^
MAI95_AY^Z4$011$LHD[O!(".%(R,R!040[%^R$C7433-F(4JQN:23+M.SH1K
M[?=/3:&-CD]797-4__L\^<PUU0_7?"ID6KCH  O_8W2]S9PR*G3N89%"&X?U
MH IAM2R#1RFS@,H@%FB*8&\F[B'!B>VVIGVPNIN%YOX2R61,4_/!7%&%F5 +
M2?9%[B$5*I^8_!_(NN:*)D2.););P8U@%%.B;J3 =;4]AW"LP$P299J@J/K
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MV.Z?<+@"SJ^*K&D8)],PX#H^_(((1_5JNBP/%&U/#5R$IS>1OPJP!JZ$-@)
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M=JPF5;\@&4=A>CFV?O9*XMX>G$[/ ?I9VIGY\UOO7=TZ]<EP=>#.48K^4,R
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M!DO*+K/7^ZW5.$FF\>[;MUY4OT%5)[E9GB9Z3)[P>2><SM0@2_??PJVOL>%
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MEBD=K /3VWH8<'$UJJ5G69K,:3J$UUL]1B; L_@!CM+*J-)184H4Y#:GU8^
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MM?_K;Z9M_8W]7Z=VZEN_U+%4.G!F*VUBO@R2>.%*V69[K92MOE*&.6*V%RG
MC/=80_^C*6H%1K4_IO+[P":/F/>P"6%K?]@/K,YU=M8:VDO7T'Y$?U@O]$;
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MJ9]?KG(![Y@!R1*U _XX#*Z\JYG+6V^]1@1R$6%3YIYK7Y9VR7LCY6PBG'$
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M_$CO._G\&9X<P''[]2%U1J,)$A^8A]+77KU[K[DS"=25&308%VC[V/$W4@?
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M0[,*VD 49-YJ@!!U#V'HDE 28(UX/LDT*BV9H=RR&R9.1P=;!C\>-$T$B9Q
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M.>N/Q+9.)O@1#GX6/RS+[[AG(ZW[#]&B;)#KH"P7Y&$#+DV*B'&6K/:R.]K
M^M+8CC32[C?*7KE6]+ZEM+;>5EE:["849)#TJ0*3RWCH<3:2G4BC.$P<S&8U
M&&DP<HT8N8B$FBD1)8XC3!'*+D%7B4$^@WRER#<"D\[#P2P7><N9'"!%:J&<
M/NGQ%5S2%*H9I+M[ J9L9[2<A[F,6#L;,[NO=?<$H;1[;JD"53;;DR?3-'DR
M)D]FA_)DEOVFA9W$T6]:.&U1^$T+^Y*3W[2H6D[X3=OK]YL^V$OZ1LFK=%;C
M)Q51H%Q!BC:PIQ[;>'M%+RI]%SXL*62*.\6X#I-AA339EJ7;QVB16$;&EC6Q
MA*<5\F.<X.3/Y;>A:S+"0$*1<_)M]H^E48LEQ:=B7Z)D6$T^"RD[P,4IZ7+N
M:@_XG!(^JM7YQ44HQ!1\\-S5)CW% 48GLT'6:6!HPKUT)FO!5I[+LT@/EQO(
M$(L8^B[V1A[AD4B]4+]\(1(\W'OM >>OZ#,52@&$\4?J)%6PC>4=1V5;?E%6
MREI8L$JD7C@T@$B]L/R52+THX")(O5,A4D\I_#!'%8="E95DC]=PJDT$WB39
M%ZIO6D\R%3G/C62+*!22NOU!K(U31I"VF<@-[%V<W%ZSWLE ^>KGD$0%T4?N
MC<)ENAQM,Y14@+_U-517N"I"K3CNT_4U7B5S09:QMC!\1UA;6&9-6%L8#"2L
M+1)W FN[%<+:(]EL\XUJMGFD-=L\IF:;Y?&]]RFR; J/?^=RYNLHF-%XE6QN
MS.U=1 5F4Q>$S'6AIWKIZ1MI"[3%1"7I_:#.%4O)2MF765>&@B^UEB J)4R,
MAL..J1X^B_)+!DBTM)S(!1BS,&UJ*9IA$$3DZ!NV-#5'F)LCOB53<7*30*\Y
M)2.(N ^>4,T.ETN3!-2Z&LL;#GDNW]9CUPC/A?G/U$@#V$>DC^2CR6;H_!+F
M--8EXTA/YJ*[@HQ1,=^5>&64RY*Y%?VJV,5%#!N2Q'2;@,CGD16L*)MSY&8L
MQY$:QBE<# OQ8QG3$[-2Q3RW*$XS4'+-%]34.:K/S0F8PP5D7WT,S F[8D!'
M9*1M U%L"G'^-<R]4Q<Z.*R3&N5;9R$CWGA"%:'_>CE<YY2Z^VW7O0$;W/^<
M3&$MA]@I_/PKVO)@5)!CZ[P!_P^U#)#/YXWF>4O^ZY>? _;+X<GT\MNO1W]&
M_[O\_.'JV]?K9Y;(,OOW,_=&NH@/XC#ASRA[^-_/N#-Z)<%P%HY.9/'N21@X
MAX*DWGGLXAGI Y]9&)Y_B][]\<?9J/GY\N_?O9O3HW>CC^^G%P52#8<."NC&
M$KHS"=W<$7^2&)ZJ[TGH %4#<D7,H[R[EVDV*'!)9<)'*IT4*2K*9LC+3. "
MB6AK'4&)!.7HVBO1YTH(JH7&3+SD#(CR(6?P"R! G*T<P>V*CEJ8)1[$7.L0
M+N)<BPL!0X<M9>ELFN/2UA/>EEB]SBI$XZZR'8Y=3YAHQS<3X%: 9P.E,4@-
M_ZLH^0#*?H=.ST;]X-<TXW(,(@D>F7.0U<(R?<L=8<6V&K8P=!\E!^Y>%'RB
M5YN?I-7F7V7[09G4^1ZKR\F9Q4/*6#X6N;"'UPC1E-[73WL9C=&KSJ87G_R9
MB]679[#T&V";EX*VSH;G;Z/+TZNW[=Z?]<3].@QNWK3^OAC!&K@/UT_XZ#!>
M\=PY/M9X9G&XM1F\DVC\B8X$ND$P6C[0U?3HO]>SBS_";U\^_!7]]F?=OWC_
MY\72%O>%RRIPG0"_B<.IO\A9C]]?_?+GN??G?[_Q^(K_/'KO]MZ>'!)GI>X(
M0F&P@EDNE)YG:CEW21:4&C)0>8BWD;)4LISK8\[Z"'X0B8J)B1M2K$/P-%>X
MI) _:'V/0^5WHW^FF<XBY_M*?R'-R8UB #C^*=Z>^*Z,^&1+J@#NXII@ S\%
M-O\<7".-'OG1*"Q ZN;7\WGTKGX3'4\_?_CM[//)?[[^]O;P">AN&<'& -M"
M#,OVOX!B9W[CR*E__G9R>7#UV\7/?UR^FPWF0GA+DPNE64"9[CJ28#2+.ZX<
M%8[\EZI6E"DG<.C <R])8 ((9#>^15F_&;"D+!<8R @$'5;"_\:\!=A$I_/V
MY\Y-V_LV__CQK_'9V9LWGZ\!-F\SUZ*'%6F:7+0MG[OIU/H"8\+7JA<*DN%I
M /SJIB9H1@3*U@9]F_M+E6*JETI(96U1ZI-2I&W3-D;N"$U1$8:<<'W*R:V=
M55*=0)(B5>B-QV+((7V!06_9";&HYTIM"1%N_?=L^;,G$!3HGIF VH2@DG0@
MN!C:RT*QHF(G^+EL4H/&NC34(VRG&I>RUXQ3HS-:#+G%@48X0MA6G%K_E6J*
MD_LM.@;B^0PS*H!6]?ZKJ7J&#%1Q7%CE%P8KAW.KH<R^<>!Y 65J(1+7A'-7
MO9.12D0W[@-,)W2NDI>*CISRO",9@A"Z8QCA)ZD].X4[F&@O%NDYCFQ2,=:Z
M8\K1JRNA45CD"6!U'&H_&@>(MG*O_BBM7*&4=2[3<_%&QTDHJLR$=2LC(C+^
MY6LG23TB(\H/4*<@.I+'%OU"5WN1GWQ ^FVX?K]:DRR>CY'\\;A>+RX_6:+E
MK4EH:)F$!I/0L*F$!@W(=%'BX(^4X_"S=]EHU?N-YE((J<5ZHW&W,SROLWKC
MO%UGK7,VZ+/SP:@U8O7AJ-%KC7._.'/.!V_^./?>7[7XY='7*__-;W_X[>OX
M$!2Y]N*3T_;O?PW_O/J-73:GW\X/PIO9+Y.+"WBRN_ADT J/KJZ3=W]^^[L7
M?CJ8_O+W&?^ :_87G_SEZ/>W;';^W[??NF?-2V_\KE'_L_4?5"3KBX^./_S6
M^WC\W^G_ZK]._^H,OYT-WKT[^<]Y<WFCOY]=WQQY?R2]RR2Y=F;CP9_MOT\O
MX,FEC;9^<?_[Q_N_DK-OIW_7HY\_O3W]]? 3/KFTT4_AER09?#CPZ[_^,OOS
MX-OA\4D<'L*3RQN=#[^,W@^'[=\O#XZN_CHY:W=^_YA<G+?.EYX\_U^KVW N
M>N,ZOSH+G'DK\M_]\1]XLKGXY.ROJ_\F;P[#_WR;3V97P?Q+NW[6O(8GEPY_
MZG4ZYU\^'OY2_[4S_3IKLJNS9H!O7SK\97WZW_^=O?OOQ3%O=:9_#=[,ZS_'
MN.;2X0_'X_9O[D'S_/A7MW/XN<YOWAX<XY/+A^]_F,S#H\_3_C?WY_-??_LR
MO#@[.KXX;Z=' @$CO2)225[E09&>D:>2J6<Y#4LD"<N*TBBG5&<EV@OJ>KG-
M);VAM]A=J?(G702E;2)<O\C3ASM:<O6I_!92A$5.R)##H<D*&5.:JZ8C1?#E
M&'-4Q/)>V@]$N1G_@VITZG.D )7^*$8'0U^.>,I^V#_X547VR7B!>[O%<'FN
MU8MKB\C?TX&T)0 '="U8*K8B6?-#S*=6IU9O/N<O7@@/K805)H3F%$02]BO/
M0Z%^V6^'E&A\^/3X2(;Y']W-$1TA],Z"U#)&+%WV=4P.O_U1?_]+YZA^^NO?
MHZON5?CG\=%C.?#*%=,[5CW?(Q]?O!4U&REP46P[0B_(ZU'+4G99.8U#]58E
MOF5V?9JHOI #+_3<\@SX9KO6;OZH0V0ATUU3"K178BAC#'Q'04G]^P"7?B44
MT6N RZT*H%9OD#[*AA&VN5A4)QY%\0.%J).I?B4VRMW+X77[8Z&"X)X7TZCU
M.^9>*G@OS5K?$$P5+\803#7OI5OKM,S%5/!B#,%4\U[JM5[77$P%+\803"7O
M95 ;#,R]5.]>#+U4]%ZZM4;/7,RC70Q5V>?['3S,*Z-'0<?T?RLN;6.@&A15
MV=P5=FM@,$\+I<%M0%J50BJSWI?^FZ:%KL4W8=#&H,T#+/0M LAG5>2[+@@8
MC"@R0;<(("<\/(@F+.0&(QX%(X2-M47P>)]F"AJ,>"RI@5;$%@$$> 3FXK&+
M!90P^OH.*UY;""6CQ1MD6AN4MDZWURIL*1W*F\/6MEB&;R'.;)WVG[90F(6N
ML\T*W_8AR]89!F.<*D%%9 9/GE80;9FY((?MB<SEI[,89#JI:O\]N\%Q:.[(
M4@5 50779S8U%%4-.V%;44CX;-YNM\]F"Q&IU$;85D2B-HM8?6#PJ!)VP[;B
MD>I[:U"I*E:%P22#26NR.[85E50Y(2QPR>,BE\>CF">.P_FFD:N\6O$P.O\R
M/N]C+3(6)_YY^/[/@Y]__>_AM].+S_5!R[V<-OZXN+4X\8,_0C/FF:H.GOSG
MT]>D 2#XEG1YN^5>??C3"[$ZN+X2TY_]=#0)W2@.9E@1^@ZTVDONCUWN92-^
MBGK0K)D;//Z%W8;&*M[X&*;.YD]WF%PD46RU1-7ROZ)DMHP-7='! CNI9@T7
MZC^^5D.5%B<6!3-8^'GC!>!),C-H<7_#9?.G4ZWCWH6RUP\VGB,>]0W^.#^5
MS37/9TG(SP>#RW'[4^?#_/)@VOG/AS>]QOQ-\_#90UC;B#ONE'G1OY_5\ZW*
M_&1Z, KB _G $A/\YH]";WYQFL9=#J?Q,POK]#FM)7EA]_#FPOGMX^FW;[]^
MO?DR/__T^VDRN 9>V'[V4Z=I@\147$V=W.#O_0VFS9_.^L=J!'Z+C1OY^;?3
MM^>4<!6=.X.;;[_UG(_C;^]'OUX='[/__1J%%]^)Q.W[(?'Q3>B<H"94@+E_
M#4_JE\G9U[_K[/KW#T?A_'KV=HI2O/OLIWJM/^@8S/U^^VSSA_O'73DOHNZ7
MCW/_S=715>_R_5MWU!J]?__[FXOKIV6\Y.Y$;^<[YH:_842J 'G_F-=/DO]]
M_NI>-L_^=G\[_?.#_W:&;+?_[*=6Q^[T^@9YO]\DW/SI_F_C:D/SSMB;UQCF
MGRYC8KU'$__BQ"G2'=YT!O%L..N<'[NG[SY&O_1^Z[4^(@?&ADSU6G>PA,,_
M+EBS!4,K'WP3>DLU?=ZIUA2MUACPZ:T-SN[2KT\KH%I>CLR 6A=>)<WN3BT;
MG K@X"G*4*])JVYA'\1<Q='.C89]Z%;[!>;40P; DO7UZ,-?^[,[SWY]+UML
MN=C/U_?E? SJY?0IK.7<"^E(]:R--F"-,W'Y>'G"#O8=S=NP*X;%%C71U?NB
M/7YK)NW!XIZAA<[#I3%6W<)IBC3&JE7T#8VQ*IS-2&.LBD:YB3%6ZC=5&&,E
M^LQ^Y Q[PT[<F74:AXD3)^%&!RO>:\):?.\!NV"=>)[L(*=:]$81=DXK;J$M
MB<?R,C!%"DSZ5*OK"4\;<0M2$A-"B,J66M^)G4XPZ:A\X& T"1*<40B;YC.&
M1Q*]B0N!4;@"L8.QQV\D42#=J^[=/+?E^#JPP@!G@61O!: -79PJ@AW_Y Y&
MV,H?_DOM^:FW'^<C.8%H)?P$D%6[96RZKT%T:4 QC0J0_:^SQO"B$S;]4!O0
MG(VV@TT[+(D$.%+H%H_ QODD^AH(*MF.<,J9+_ODX3\7YJ#0Q)2-31/*-<I7
MER)&6-/M?1_*V>ELJ/L1%3Y2 &(UQ\:-:5Z4/I%:3C,LVVLZS8KF>V:S2TO&
MF1-9E*U%HW+RHQ<C'J>=XX&:84<7KB/74^WF%R=FB5[;<] <#K#'HH:]^*V<
M+Z>FO6H_IB%5WMUP$MMT CG#-0*0LU&E*^XK8T#9P9'0U(2B5?<L]RS>%M&0
MR,718C7K5.!8VFU<C"%34\+H/()Z"[XLP4-L31K==OWCP$DB-:E.@[MJ=*G
MRO1>Z&(_\&MB$>4#UFCF!VCE.*4.Q\,B[>!#@IT2TH^N8"<TK<W/,YL,6#2V
MP&<77+2-/Q4=]4FFV/)XN)TP\:/<78JA2<OL"\XT9@Y"'COR$WF!N>>(F4Q
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M!>74F$/?]"P9>M347Y0>B;(CRLITV,P5I0DX\"#24I+]D2S5.0A\"TM!8TS
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MR*""TN294?E/;-72(4K5 GI;UBV$WJOU05G6W](6>/ T5HJ )I&$V?B:2*N
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M#A^8</@>A\.[9CJZB8:;:+B)AIO>[8_F*'@9LZ''?_K7R+WZWNWW:]D]'@@
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M1PA 3OAQ4 I0"Z0$^"BL':!O)YRB%KQ$!K90G[ W&0@=H3ZAP (Y.,5]XJ4
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M@!"]2;$:E 3H>3O.^82%!T/C#ZY_%7C ^=$#IAG%J85ZI\8RI!]&3N@.<;_
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MC3YLA&&0=26\G)3JR_-&TL_P!"]58B6JI7JS6(@M6 B]75J86E(LQ.,68OD
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MX12\Q.@[8Y%LC.=3KCAE, _F#/W2A=:G+YHKF!CH1>CE9S.F3S),:)#,\ME
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M+!J$F9&=[YIFB*]:KB=7VYN*U<86$F,N,>24P1VA^+SF+!$VFQE%9L"B6]&
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M54P2E9V#>;JB?K0Q=WI4G$]\U@CBB)HE0]P:)IX+;#/&VR9 /(U;$F[Q/0@
M#W!,J1)Z5(.2FR,'X/SM5)QN!WY&H#2W2-XC!O_X\GEJ8OGE\S+"7=.JM:;6
MJBRL.08-2.H]LFA>I03J<@5%\\#NBXOF==+W.^&53VF":&JT6"(L6^NL5:I%
MY<$ ]U'M*KH8+%]=&O25*"%4%37'ZR7 V'H#(?:&T;:8YNLI5C:?LQ5[OJ)B
M97+*KZ%8V=,+#&\O-BZ&^>2PRA..PFYU3:U:N:BIQ8N:6O,9= ]J:F5*W%=:
M"^Z3R!2RK_%68]"JE6]J]6;]IE9IEV]:Y8IY4X7OJXT!X-=A^HT>+-:?%]_.
MNU>]SZ>7G?.3J^[EQ=7UZ?GO-W6]WE3WN*R_&OZ,M&>U*XV414-E,%86#79C
M*G]AVO*S@.[JSLT\?EI?';H_D)#1O2A&3'>1R5+_ZB*(N079DF@\B_[PU6QI
M8D6;V3)M.28%H/D-W5F];K]X<9/@X^Y3(2@O;B$A-P5N_,1'B:R<Z)*2^Y&+
M1LMW!^]W!CX43K8^SV5(; 1O5?'$+2L2U^?;P%FF?4V1G()CG\"QV2N /A0,
M4S#,$@PS]P9#V_*#^$[.7C@F/T;RJD&Y11M]%]!F<3]OP7*+;BFS[1D5)8MR
MS]Z=B?YEVG9W[ZK=CWD@U,)[K81_44B489K 6P9>IQG[_/">'^'7%F[ZV] V
M$E=X@@QVC^5%FECG'N9PYU+4CNY#0[\M>30G[CWW9@#R#)Z0!^ES 7+"A2NB
M(;*&,880P/KPH!M[FKIO!(:0_"A#M8VRF _%:X6G-8.ZJ45YFQC>>I3 0CC3
M&$'AC7(43) !6GFO'%8X5I%4-=2AO!!L$GI@%!/.0K,[5#'.$1>C@B;0/L3[
MFE+V DU5MM\/ [H%Y;EMTB5]Y!(6#9=8]X?)@6N,I$$$/>$-9?'\I(BHO'#2
MQ<!,0IN2X]EWX2_)!X(WD!&H#'XN'T@Y3,>G9QA@+MW'J6MB\)W006,4@W.@
MNZ8,+\A&6(S7ML77K)78IHS.:Q'L"\=.'%F0(:/+Q%JINA() ]H6)O9 Q8:
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M #,L)97(A,'Q>_PV1(Z7V9K#T',L?\1":4F8[L02B(1,(+3@Y"S 0'6IB^\
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MUA2)(3(Y1G;]N<MZG2]=UCDYN>KV7E:-)<;FCH$U#><[B'7?<[\K61;<[+@
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MEG(TDD0DDBB& J[V"K%VTC()A&76=V%9<;WB6ALN4IOLJ:1RP--W3I9W^F$
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M32O:+18'<22=,8HC#PF'MHT9V[* ^81[8RS_%NTJC]]F'3<^O8?_/]]#+@)
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M_=4Y.ST1OP)R.J>9=4^HF1,,JY0._FKJ]5;YZ++2AE4^^'\8_-_!)T#&!QW
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ML?:XX8O2T5AB 54",!G0'/^B03LE]HU*GL [5$T!RU3"H!T^53=)8,'U V,
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MKU)CE5EWP.PU,,LE-:TV_=-SU97SETO6LY_]M@L+6KRN?: X7@RW8YR>"QV
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MZFL&#+P_A,.MW^;<)+$MVS KJ*PCH,\BT47/!*B[>E25U?+?=ZRMGKA;N5)
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M]2KEBY$R&,I<FUKU;CFGHQ0?F(CB(>FVUUPT7P:KS0XNSL\ZY5-LF .Z^^B
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M;\?_+".?@EU#U\1:OWMS$2^L_*I&<^]&OM@>QU;($GAR=?%WQ<+9VG3VS:;
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MNWZ6P@1N%=4>* 7%XNW^).5>PF.3*1H54'< A[;2CE)Q'59[BU#I5ZP-J!A
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MA$ZUY+7B]2CL*K#\=>Z:<C[S/V**/OD?4$L#!!0    ( ,E+DEKITZB,, 4
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M%;)^[#J5-GQ=&LS_;P( 4$L#!!0    ( ,E+DEJVD19WG[0! -7@ 0 =
M>&QO+3(P,C4P-C$P>'!R93$T85]B9S P,2YJ<&?L>V547$_3YQ @A. 07(:@
M2;#@,F@@2+"$)+@$=W<=) $2'/ZX.P1WEP09W&5@&&QP&)Q!!Y9G=\^>?3_L
M[O.>_;!?MFZ?^M"W^W:=NE6_JNK;]P'ZL H@_B"O) _ P   ,!XOP ,,( O
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M^?9=&'K>X,6=]:[Z7!SX/*>)Y O8??Z]%(W/YXL"(_3K2P.WSR?%A5*Z[Q\
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MB+J/*T9C^/B9,GN6ZF+%OR]6.DS+W;:5]*:^(.PJK6K\:]J6N;)5X=WRP@^
M@MP%\4HVB%;UY)[?6$K%1ZM(K#@"XX0N0V'QOZ)4';-(;N^;:R^CF2UYZ+6S
ME2/SP('0$KIL]_FJ6J-5IB^1SJG$JRE*N]DI QUWOYJA/@[XJ=XW(#)/2A*S
M.QS9?"/M;_/YP%_=\(+L-R4?7(;LKX^M].[S$3[0C^$@2(=53$7_2ZJ5\6FX
M1U!4(=+;BL>*422&&?S%SM[8V596.7K;N'$;^4H+"SJ5J3M[/^7_6/MK^<";
MGP<C.1W4.B9V:0FL;<)H!?L? /@CZ]+G*]E5/SZ;7FC:&KGA%-*_ZF_[8F&G
M?)KE*"R495IN9,>[D/4&=B>[QD^LMCV9"_[RZ?F]G0W9CWT<-3'9DKKFVT3W
MLX9,@I>_%V\;7R9N,>ZLT,7]!%C[ZD)( :"$31]?V=7ZRA^HK*HB\Y:BZE:3
MZ(2JPT1W#SUF<LWVA=@LHF U1,%I0!SSHTDQW<?ED=_5[H7P3;@G&]DL^>>K
MJZX*/LVVSY2-[K!:Z/L:3W7I1QP6OO$3!D"P;9N(TP]E[E>6FQV32^0>-^-1
MNHB%:-H^;^84$%!*<B"=LTZ<J ?^EI2S;TK&1I/*<5S_2-F35%"X%7;'*_)V
M+7F;5#]F"XSK;?M8/]]Y]V6>2B9@3$IF*8@QKBZXP;_*IS!'#))7/R:KYBZE
MKET<VGFYT+MAV3QBH8K.D>,?U;.4/Q;F7 I\#-TFAS]..%6R^ :I%JC\==>:
MI8[?M8"I9ZEX#;NC9\\%[DVQ\:KY&_'M*%FS9@U=)-D&%C;A=Q@2W9<.LD*W
MY%)W6?XRMF=I"46:,+U7]KVW257SPY2(S9]QM<1[*F#VD5TEWT*/ P*G\YNP
M\V?U)(T]CJK)&\Z-;(*15J8T0@164$#(]7;@)/Q3PTQ$)GT4JMS8QVQ_,8;:
MQSI#3;GUK[.3HOH4?MSX$EG-JLSY)TY#Y0^#.?7N%<"T&0]TL9TY!^2?4L&R
MRA:6?H,*B UE%NP;_N8% ,#@KW6^(3]Q>CS!((T-\V;TX8G#LD^<"E]D=8*V
M"[@P'\"?(PC8)U2)<!K[\Z</^K2I[ Q3"Y-+/VX@*?KLH*#!+8/QG&,E8)SF
M?5\+'?E8->6&*XVF@>PIZFOL?$-\IZL<SA -+9&4)Q?,O\GASO,&9319_ZYT
MQ4YJKVWFZ)80<D]>5(;$SKVAG,C*'O_M@OR%S"#'4"?YU'$[3_?M&\$OBCNU
MI:NE SA:45-!Q\?OONR\ZHL5RH!JWJ)D4'D9#G1Z/V _'(WP[QS]&^+&L\#\
M[IRG(;8,_R9&\UGZB[1DD0> 5[/N7&AHOWIX"@ JF.X%)?60>7(-K B8 5.8
MV!J0[+:OH ]+CI&R<>%H#:5=G0*PF9_L &/,FY-=A?=NEG+50!:K W(_%4+H
M.$@!1&%P?U?;YBE^[XH T[[^^V_OI#\/1%7/=,COHIXTEDS>- %_0H1&\>V:
MA[T\%ETW:^RK4[\7R503)';A ,4EY.]Y+K#W%91ALVA2@;-:=@K)CX7@92R)
M%;3AB.L)8K!+N0GB?^?8E2U';-A@6V$T$6.IIQO"7E)J(4B.5[]@R<V;U\X=
MJG<B_P!((?2 O7])>^@7]>AV?;N0^GZ.LLZ).8'EF+'9T5VQ&_T--C?!94CM
M44<X:@,5TF3?TP_SUN31]3%9KK;"$S->P(RPF]M=O(PC\G3H2RE&0&)O#"I!
M1PC_.V3M'3UW5(<#O:S]/3>-[P8PX3N#U$76 \ SF^<!0/FOW'TF.([>?L8;
M;(-6R"'Z5*/K4"3,+"]&$V!'4F?*BK<'$4=28 9&7GMAA3R&2\,A/:3.K-V*
MREA@U:]9KPXR/=&4^,2#+9,R3AE=MKDD:67#K1AN4[WSL"F=L)R;'O(Y":4*
M@>U/)CVF@@2+'K54.DZ\.GQ"STR_U]2U2NL-EDO*^KG<H#3NB]U^%7]NH @;
M6*ZCM;4N_Z<%9RJM.C49<W^0R!X62X/CFG0+S&]<T250KP-J\&=J[E)(?;1Y
M.A>_C]2M')Y9<WMK%/HZF\[#U/0GEUV4E1,M.D#<+M?@)>K'Z#[8BD"GZ%2U
M@B&A=M]YUUM[C._#'FDM7D8FNE)#*B&@^V]Y0/SY[Q4E'W?)V,)L][W$K;I3
M\;.YJQ(MWXC<'RO4A^$1C3AK\!R"T*'62<.^1:/BI!O?E&X=>WJMHO++6M$_
M^JFNJG[JT3VL=/<,%FIZU^O2%]*HE+W.W(F;V_>K-;K[V-,' >KT\2V6K[-*
M!M?<$F_IFR'"=2:'^QV$]Q+/H>MB"R5G6?U)/MFLVKRM*=;I.O+5<BH2.XC8
M6FF(]^ICM0PL[1F\^"SA/&FG\%$LH=!=S4(L]7GS&T^;R*][*C5T8]7&3*KP
MM<+,;"#N2G();.RRE(9!,L=M7L.:0IMJH(YJ\"2OAXF(&)>9<X.Z><4>+<P0
MS@$V-\PU:\TLY-ZJO""BKX3ZDB29'A<##\D\K@?)?CH? J,ZI0'.=YU,WF,=
M>XOTS*B@&5[U+V;U%AZ;^,I13KH#^=$X;\7!=D?,[8DVY[;%BSW%*0O.-^GZ
M/>6O^[#(=R ,-&)/ZTRQBUT@S8/-B/U=R.GO(WU?5J-94;B.$; *N2; 5MT^
M$ITS'8=83T2Q802KS<9[RRU@V6T(21DNMS&N^*K8T'L6W,C&SJ5):4S]E<+^
ME<WL4-BN9W^[:TNS52_2T='1Z)F9V<4ST)3FL%PW;4 ]LN7.5E!:<A8"%/I0
M\?OJCYJ(WN':060_PZ&>"-FP<^>M_9JB3\4T]"9]"JZ<C]T3$<$;G<S )<1]
M]$VBW=MYR05VL,05+?LAXH9P+.TR_H^0(/3(>ZT3UFNZ#0$/=\(> 'W81JZ5
MEVXQM=R@W]X?1@:WZ(M?;P ->6'1MI\A5+9^_A2I++3('6$]AV3KY>KU.B>]
M>;$>]>T:C]\M*.<97L(R5@XI(@K95[&7S$ J5@08T]&(]I4/<WC+A)@_Q^C(
M71$3)XN(3GE-1_$ \\]RTGH'KS:/,")V$YS?T^==!6D/ (7M/>T9N$Y76?75
MS6&%.I7SQZ^'3P!$=<S>8EKU&#5T?M>@PW?/A&KV4+452/%16K:*7BM]9J#<
M>JGY"6%B:UR\G5TXTL56AYGPP!8G'MF$X\ZSIUFX)P\J]]$-S2H53S.T?,>5
MLNMIZL7#I''ME46GBU.6WA0LFKDH[E-Q<%DB5E'.&'_YT3)"UO="/'+1'%K"
MXLM:OM61AV<()#/<>G*$=>V$A5G;-O%O[1'C\/N:^+Z81=76%%5D:G$GM?PP
MF\1YS@1C,_L1YB#13Q&KL]]R<:Z_<IF.@["['P/?:-S_D\<U3V6!_M&:6M(J
M^KGP\N;^NM[?0H',Y@&05_.3_H49U;I;\#@[;X'P-_49R1QRY?\PE_)+<JU1
M':NZ>4 &?)K8TGS&%3X@Q2RQP/$<D9#2_[3Q[;8=IBE#)2@>S$AIP\3X?_W]
M-3P<CW19-PJ'8J'%L"U$=B!)LS[0H!?(/M$<=#TVS/5.L$J-;8[:YQJ8F*ZA
MZZQ$+N];$E=S2:7'G'GR9-NQN_YJ76?'$XX5;?#Y1VA*$YOA=W>U6[5]3OQC
M#"F*6Q]B\#IE7Z91<&%,14"_+3TVK1I!\$PCPDXC88=JW</Y;@A7*U_+NNT%
MRO*-R+K=N$6& P34J!*/0[AZY/<^-S<G&-Z(XTC[6H"&?&+]Y*OJO6.9__7K
MC8,#]M1^A<STX56K>.E584F:IP\ 78*."JWO^?@:"R,?JUYTC7;JJ=@:;<1@
M94O* (\_W%3AVL?X44?ZC9@A?V\K6$<3I$(L^CTD&=0#5[X::>X80S:<4'N6
MQ0RK [*IWZ )Z= %V8PI3H&ZN%1(.+PS,+B=PPT3GFMF/S./:>SV^4\[5X+U
M(G7;LAD/:WO*^EQ]76#<*E#R28]'P_1HZB0=ZNV'P0[XB##S!NO9F9G+C2%1
MC!&VO^&<"+Z1Z0I_RF(FJF'B$MD_MNIQI^PI*0-%-E4.$0%EURLL@2:=AMK;
MOSK"*U00H((L);6[1=_5MT\,Y<Q$LZE/+LK'+[XZ^-C;1\Z\F]:E6>"8YHS*
M3<S&DA884/]KYGJ?'!]00/KS8BS]]Z60O<RO'Z-1M2VU!E$%O#!G9_AR6(*'
ME"$"J3/OFG)@SJ;?$ENFD=[-52,^:N9PK+C0>^#W!/SV8^XTWLSY; 8Y?J'(
M:[$_-;HZKY6.B,6;VT4D$H0]!9!],() 0'"=NY;ZUKS7$KG?:'/:HDNCK]-[
M$E].D'V$#(N=$ \M<CLYYUR&N:[T^!SY7K-?-Y+"/*&!CD_'U/#RZDJ:W<4O
M!A,)M%DH>1JYVZCP7EU@]LS),&W&CW/4X2>/M^V&*Y[B/W: V">$MR=+)*W9
M.?_^X2,BO*E1; [2^>\ZF7$MDW\-(,VKXL+^T;!LVH.OV#@-LW85^*8G-":V
MEU4R[WB_SM,2A[VTL68R5P)VGZPM)(X%+&/*C[+\F'!P,E7.D+:BC0\H'&[&
MKU(T*KH0T)$0)L2CSQALXN>M"!@NS!I/]45Z(SMQ:BI,[ZU.Z/]T)Y,2*YFA
MXF8J1R9[>G*MZ,K.QJ8]F;(EM_CP3#"-*TW[M#R9W*2)UVF08WWYLXZM6O.[
M/HG?9U.UC&TFJD+\DX2HJ@8%IE*,.(C>[E#-.2XN.;NB_9"U$SMG.;QK05#:
M1%N3NOB-TL4T/<UB?H>]\0X+2XDQ,+OH =UPNS!8_D[T!H=]:@E[F,87FTVC
M3?!%S-,?!S\6C#V]IT1:7Q4E_F4;0+Q>%FH"&[V;^A!N#;8?X*?A72RZCZK3
MPM/M%3P<?[?6N'>8U9S4.<++>[AQ"OT)!6P+FZRUD(T57]S/?ZA/PGR=.#7N
M(<O^;G/0N:(=H_SFPN!;KU&/)1DD]!9 E/V&F2U\*E.JJD2@08(0IOW2D0PK
MQB.GPP4>]I/V<+)>$6^1R58V!*L=</>]--KS]=1]DX6S%V=9@&;SM\QJ:;.T
M)W\D3%BCENBF!_X:[.]>$'O($( ;D.5)I,O*F/DFK8O<_3T>>->NFHKL31RY
M2&(HRQ*$0]E@=]5!^-S0F\B.UBLRH*K&\P/B6T#FH,+/-)ZD3?$B]_!5'M>.
M$<$:S)?B0:[ACA.T5P:>:KQ7HWIQ,?)$X&&;-PT'LQ;RVGW;LTF2?;4RBT+"
M'LT'DLS5GDR;L4O9LIE"RB^/M,P<U%F6"G]5#1NX>T+MXJ 4Z?JC,.,-9N?U
M"<2Y(B@I9WX1M5(8 S&M-)BB*)/Q51O-"-72=[2?$CP3$A%U6K'6PUP:?/:H
MA%Y2BAG?+QN'B-807^H"YSGCR:V>XE"_I1IUT,L;!\ 75]KF<[I!]GG'KU7I
MRFZ>/*')9+[R^M>@UU@SZ#^GNGY5/Y.VJJ>I; >B0N6U8T5$"W.<@41!G--B
MMH77'-?E\F^*3&S2.D&J361'9H22\VSU4$[3 F0O.D+&E6;>01&G)Q!/7<&\
M5A3)'SVP^4JKWZ"!.'769E%(A\HS"?DRFL_/ONNOD*3X3<703_CLU8%D%B2#
MJ&U+CROEQ"VORHJJ+2O#Z-5FKX! O(?SR8[ZCQ^R9=K)?60.JACU] T)O^)0
M^[/+AM,J\:@%B*?7Z60-SAY6'ONKW 7NXH^]>[8I2CL;]#84?TW>2IM=)BLN
MT/<%>E_ID0VR&R/NT0$-^XTQ$U1#U'1]N^O% 2&G7UE_E<=[KCLZ.DT\W=QN
M'4UMW'9%_)'YEE=<RS G(=2OX*!S1A;.$<IP]D9QZP,>PI@W5O+M-(>W_;E?
MPHY6?>=,!RAXIXQ;UZK _:KFI&6698UY(\DJ#979R'M6]8KGG,[OZB5VXZ^J
M<5\%JU%0X!\+SN'XI&B;BHCZ47VW:9'Y[YB<E;:ZRMHTJ\CQF>H-5,&$"8@G
MU*ZBO\?")F>F%YK<OJ-K!,I?'X^*J\81[>G>F-R3EG%@*AUO>!IX"6M(CVM@
M+N7#+1\8TDA9"[64@[*[-D(5V+U_5-YT>]_W--Y:UB\'\BG.;[*%14:9&G#I
MT+ :^R$/JY$G\A*+)H;B@%'TLR6N+U_JT&7G?JF<Y&\:^#\/)C0NCATB"@-G
MHRY6Q%T'Y@-]':.B&6-*0/[-F8TWGHMZQ3?%\ML-\E(\+"F1['9+WA6,L;@
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M@A1L-@U& ?WR8E^_"P>9U20W5/TC.F+-6I!T8N5Q:!LHA1?AH:V6OS@<:15
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M:_1SZH1(K1II,&;(XE_A<Q91I&-,1;>_K=%OG]+B\P[QC)@V^C8WVI/I(-B
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MQ]&A8#<;]<TBZM6E_==AJ=NK<[F N4DONE!E>E MOY*GFMP0$8&K]IA*X-&
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M @"S4(N^;J_R*<13'CQ!<Y>1N<7(8O+-*#H^$EA0MSK"92BW'STJ.KEZ[&V
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MIVMH&Y2,067](+ZE5/>ISJ5I_,#;(D37FG@ U2YF3F*^T>T$\-*6]]91/Y%
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MVBD;DCZ]<,AG4G)>,BG\?(LW"?\]5]SEF4: NE 4BYJ)]/JF.Z]'6RV\NM?
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M$E%5U3DEXU^>GC6)6[-_FG1/!8[[BR?'-'8=H2B1\ KE(O<*0ZEX[!=<*N+
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MY;^PS+TJ-H%:'\Q1FR(S3FYW^4.'&;9:2S)@@_5BPD;?C_*DC>/V.:L%FWP
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MZZNATPL9A .7F:+CP=8U29N#_:-(28JQCFT.QGBN*M%*70&/+.V*F!(&9M*
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MM$*$/QA:WQ*IYR6NHCY1-D_^3(:&835L7/;WD-,H49PF!Q?.W68\X<@"U$Q
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M#QZ0[P? I?QY./X !K$W6W[[^];[G9U2%]B 1J,'(3H2_P;4&F]V;LYK\_\
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M(W?&.-%RT^%]L07>7ZRTQY>=]/XBS VNG>\^_)GS%"*-,LS1)U@)Y8_,,&0
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M+_(G-:#5( =HIKV Z;O^/>YECEYEI\MRP>\ !E>PJ8AV**@)SGB,H'/D3U2
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M;D)1(O!@6&MMO@</ +R3"G\O* D![_;-\^B8B-$P^$K%NDD0V+A:;KQNM>Q
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M8@9.Y ;XW%+NY<AR!UJ9B=/F]\1?T-KD)Q5PB/KR7@V1I'7NWJPCH,L+%^@
MEF2-:0PS"6(Z27>5SC'QTA2G3B"\25NIC<C?E;&%S<WT]T!0VY3@6!"-$\]'
M.T1#QX8KG-S'+@1;B-0<"S=XVTV7M'[B1<6[>A-;>H26QLN/L,,<(U=#Y]Z_
M6#IWK_TP#]6FB+SNYG'8Z3-47&W6-^3"2-/+V@:"Y(X3@82'[735))<(@"C\
MD!#]E9HJT#*X,315& _(+,;$VY.ZWH!X,P)%^(;V.$,"*FT8]28NG3<L[0KZ
MR)+6PH!"4F@K,2'SK;'G(.3U7ZRVP)_^"^,DN51ECNGEH\*^,L=BPZ2"O\$>
M B3I;":J@IZDP QYEC@=P30IF?0PIUGS,C9X *Q8VMDD;Y=HNWK1@?\&@_X]
MH(K,>=,@T8X(_*V?L0=*[[8R]=ZJO=38'0 U^KDJVS0#Z+<IR3=/ I^*,XD;
MIC9V,#,7GDKNNG8=2ER;\N;-IVDJ56P8K'=TH2A6$O:>T3!/F(3Q-?T((9'_
M5/]N-H,A/8EA33%1RM<SU#'<Y0=2#@?V0+'MJ9Y@$>!^0*/CYDAM\[6!V<RH
MD<,GL"!$O"8VQQ^RBYO4?Z"*2N#R);_L\='7-/_=&S +)E-Z2"O*H;'YZ0N_
MPN(A!=V1= $"X=>+M@M[KG$%UYG6NJLLWK5B#CWIM$;F@#",^^*2/%9\4",3
M(V=&4B:0.26,Y[NAZFG\@%5"(B]*JU&#J8OM'Z#M@2OAK'J!&F7"^3FQJN@:
MI-MD>_.V2ED%G.;@M0:IHV[P>FUDRMT2]_H-SMJ%O%1G*1WU$YXJOJP%*.$;
MB%:O!@X\ABW(Q3M1\!L\$-(IML=K7-D"R%D5H3H:@-8S&K+W7Z8A7P%P_ SY
MCDA)?>/RYK 'X/$$FL5:=77>AQTIO4ZTM7?J1P&-O#1JR\%C7LL$0#M+>S[Y
MPBX4I@/UE*"K<P(N2;=,G![@OGHH]3W]"97':%S++<J='-X&UF1-")ED MF'
MB,NS3RPJY5=LID@XFB%>ZT6=/[^C7?:K9'6W&5Z[@G!%'A_R,8D[H'EY9-QZ
MM/O<>S=CFKZZ]?VVBI#C1+355H=OB^%XP ZIR0G8L?1SLG>WP.I#1I;?"],S
MI&8$#OA+]C!A7UT]P!%/I;-Z&)L9C%N8R4JD6A](^^= G&[GB7",!5L4,?>H
MR$D8IYPGEQMX6R.S]VL#8K<%\!W0+S4?5L_^2(I.7*G-&2[N)##LM9$^+IIT
M#SY"6V?XX0<W;83%:T_)36>!<L:(;6;X1MFH1N#Q@F%/K/R)W:_4_'Q[5H)"
M36M.,>')3\O']WVD3YK?]=S.2UK5IEG^\#=,3LFU2#-=7"!?9W7$53L.KEWV
M]'+UGA(O=0:D\Q3R?!YT+CWM?7)A^L*_6KC (NPCRVH+:Q5'U;(+XAF=^3Z<
M6/(OULY!T>1?K N)R_R_6).?99&RUMMRM^M(6:_P</Q 9FZGPU(+)T>N/8;L
MT+!"JB1UD#FO]4J6QH(@W)[ZD/$B1'E)GFTPXB]6"6KY .?A>;@SWU^LYY]W
MSOZ,_9EB^(LE=]8IL\8IO(JY1M]F]P0OBM8]$";\AG-3UJ56P=EX_V+Y/.>[
MR=):XP.'D;+"O98M]UL)17F-0P=L"WNGA]<Q-FMNDB\5'./20Q&)OWQQUMS^
MY3=R20[\LOMM6/M'OFN?&=&S%R:P^&HS*65)^*S_&=GW?H4TZ3@D7NBY+U=<
MYF/L=[=CC,E[;@TDB\R<E=/T;H\CIQI/G:.UT<\V<OPKU'_OLI/PL8BQULOC
M#,CJ'I<NNOT4O>0O_["?3; HF9AXR<2CA [*:[0JL8C2[Q]@2Z0M7 Y:#W9T
M.,=E+L5C5L4S5KU(,G8PO."S_K#J:"UX(Y6X74$D9IEHKSU S[%&E ;68I$.
MA-X%E,,^/;P:E_J=TCE#OVP,)S3F32W]R$PJC2TRU44L0,<X,#G$X.J5M:OS
MY1<6SHPQ 4%$:(:4Z8_3=M<I&(EQQAY?4]]B;6K_'+2(DO_0A[N7I-0R-B:R
M M5M#4B"L6?/)!Q,E9TNC.73,J1XKM=)"NQ3V<+8C.;&YFO9M<"A;QBB#0B1
M9-(EH*0)1IM=+88P'(V/X_/#1'7B?%.PU %TJ8-8SU%:G>IZ)9N:8WQL]_V7
MUX^MO56*FP(,IQC$,ML]N:_V"6WKK>!$5MYU@S=FM&0YK&,L;ML6XDK:"104
M>G<:>S%-2;M,;V=)[]/:8C._>QS B8QL@NL7HFC:LX*QN^JDK>21![K@Z6R2
M[SO?&/"*?U^0&6T<$%]*Q9S7P]P@Y59T!W5T]#OH,?SH@<=P\C?S1@_NNYM+
M)=YK?X@ GD\DA46!R9P-DSO@<>V!M'D<R FGP+_28GPSWS.EF&4J8^!CTYV:
MH'W]V*3R=7:YA'/V4$H.]^"\,8 ML4&+(>L7(9\TR?TSW=N("*C0_\#@:9G[
M'V+S\#,[1$3\YT/2_YH9^5\1?BSB=G,7DLX7W,[$*?P.SO\C!\XG4\7)V\9%
M1;J1U_SMI]:6Q4;JD[KD^@GUL%/ HX_#?5LP>,055WC1:J%Q26C.\E3L1QGB
M0+=X9L"QNTPB;)9E/4WNA;RUPV42@O/M*;A-]B76G>HBLF?+=<4KK>L+C.H^
M[),3P4FU]VM<BODO:<PL_C$:_"Z')*1L:Z\C]-59MC-O<3XA:\L.Q34U+_><
M9O?URO9%0VM=$Y4Q[)V23:.H%K#2!G4<;N52;K==@]W;9#3TR3;<PO@[9*Z\
M]:5YDIBSZ$D3I^CF1BZIK\!B!)/J:56#_%A&;M%"ON"SEAT![:4<%;9$\8U:
MK#@VALDS%] ]I,N=M6IKM@&$2!0S]Y>A+,787LC:MFKWC&_O+17C"5XZ1;Z4
M,B@7K!LZ:Y-H^WUZ2.KU97TE\<T.KGS5KZ8>B1;@?)2>AF'EEX&7CD<>#HQ=
MO8@NZ=N#H''JWO^X!X,T*4L>6GAIH)HY0S?<=EMO_V]2KM+*7>-ZCH2Y%>?(
M"TZ)H5]>ORY8 L&N<D?RAQ$1!-&]32N!D2S.$^GK#N U,H8,TKNG,F^DF>_B
MP<_O<2E:3FGV_O5&F/^7//LC0J82N??_:/,W;'[\ M[$"25H)MGF#C6&26/#
M[M2P\<OXTS9LAH'K7F8(DNX,W\>!_]1+5>V3K/3*F'M],*Z3"%I&W#\B*_CG
MM\R?*],Q_-I*;7AD1!9/5AQW_8_"P']-H'MV$5=5G-,?#THW+;@D?=OC_QG^
MUIQ"B^& -!:34-SOI;U2W8"K%(EG%)O:@W2=2YYL'(VM2*[BQSI8$Y-](TNV
M*9_R'YR.Z,U$P<VN*F"T#@V6+_+VX/,1T2XVS0K+42V^&]'%_W";^(RYQ-1E
M@I&[6;NH9$P)"G.!)CZIB%+; F,C.YLI3586[SW97.Y=0]RCV*:6*G;YRF9@
MLLDC"LDNXA$'?;.R+RT\ ,U9;D"S142\*O)!W>1?U)*R;'F,UB1&, ,>V5FV
M?K7W(<VYJ5*:VI X=%=P+$I<1"+0.A Q5U?;\.='WUX%+T\?TSD=CRGRZPQF
MU@_B67-+G; 7:O%/.XVM21^LSH.>' +%@XC-7GVW,Z8^:!.26)"MT_F+=:)[
MF'7Y<S>L?/1#]WKC)WM6D#R) ^93K6&]:B#MW!# R 1TC(U^4.55_+=QM*.2
M#-8>+]4Z@AL$8WVB9O$[YL/Q1?2( ]/%^/J9,[T50*$$N"V8[:XGTX4NJ7M*
M5IR#R$T'+\4)*:[@&X-CAJD;@L?@O$<EMV/Y'>_'+,XD%@5UA-/*'V\+.9;4
MN66YV-/BH%7^8IF@(KCFI@:;*1Y;%UYP!O#(EC=R#:7O?2]#B.(O]35ESV]A
M)(8HV0[JW0GL>FINO,)[FP8;HDND;F8+"X%L)2^'#J^V?BP@/:R,W6R\A['O
M2Y7!@0-%;GQ3^+$POT7OP6,?^J/6(6B(L$M"*Z>V@60CE 7V<^G'T]E$.98[
M<B],N\<T4>(>=C0\)9?7:&9AZZM!F)IV@W/IH+@*O_TV.^6)@R,X$@V5%3>N
M2/[SHSNI,28_95@CV:59OXK'*D\D6W\11D2:]@8P!G^(/]E>7;THSZNDGP8O
M'9F]D)ZD*\ (B&>.E4.7"C![[>/O[/4OQ/E3>I!0(@-U2<8#!;,1FOO1*='L
MR&ZGP=4V%_[K;(J;.8BQN-U :W99HYZTD67)RBN;!Q3L$S*1?LOH3(7CRX#\
M0D..P2\3M13>T.#YP5E%*H3&P5X_NL])VI\X/I-(?3_7,\N=MK*SA?-;&YO%
M26\N4;/[\MQ@J(4H_WL?;9LY(?N:M/FB*+.#!MH;"^"/ENW>0?7W-1X0GZ[Y
M:F0+UI6G*5:$Y-K6S[T4J;!7XH:#VBB?4B3,_WJK3KU>C7A+-0.YIW$<24?.
MTK<M'O^X.V7?S8MC>L^'=SEJ!CZ'LIB)9F22#,D/'\@>W=?(<X:#^Y$T$B1C
M3\6/JW'E1_VJST?[BH9'H@;W0+-U?>TWW&D2*QGV*FJ]M6$#AI4H> U:X&D0
MXUC9Z.!V:WITOA[>_ #29JR2(R9Z1S3QETW9MF2LLP_'-6[7C_NI:%]DBUMK
M9\)C$J\'F\4NTZN**MU9E\R&[,<,$ \$I;%BAZ05WU=5HB(W<A/(&<K5V(5S
MFHV;+VGWH36=845@J6(_#EH\IMY-N0 ^N?07;1N2OS9NNLMN0ALYA%3L0GUU
M-^IB[3YH%J9DV8/._7D<2ADUT+_(?ZT"I&-0N=D;Q[-,YC1I6UR&P*BIM0-#
MD.>BQ<*I/5LN(0*]*8PW0.6.5"BT?_HP!/Z*)XKN>*YU$,%-FKWI8Y<_+8@:
M'$DLC+15L[75D+B<>]J&KNOSXHMY34%DR?JCX0;WJ#.MS_[3?D1MGRJ/77H2
M2/?8AAN29OB8OFL*M&@FKVW-XDLK#YJ\]I##+W>SD5>RR9]+/:9QL?7R]V/4
MWF*+\8L!*]C872S;Z37.W/U?Q+UE4)S1TBX*@2#!0X(-#H$0W!V"0[  "1X2
MW(9!!@8G2/#!@UN"AJ"##8,39'"7 09W&31X0D[VON=6G>_NKV[5J3K[[#_]
M[WV7=:_5:W4__50#,L4!)(W,]4#%'V$DWTDF,D7YVL>1L^&?-WM[6!PEQ<'S
M;;E=F,/SG;Y?[5_4%%A)/XXXNS@;*2D\$W?RERJ :#S[-LK=0"(Y#TBP$G@^
M:&.=!W$\(_BPK-?1&YDV?$%$FSD@%-<Z[-+FJ<U>IP<N+!_\S,&![,OIJ1E:
M(J77P!,@RC+7;!8D-\Q].>RD%>"CBG1^IHH_D7M9N0K+N[XR=[;&J!KO%O'&
M]?1[\S*:CIN+H]8<Z'6^E$'G?'GJ(;D9_9"MI]N5M!]2T"Q+L,-.BPE.#BS-
MR&YXU=TB06C,UY1];1YI5T77^?H-NU:):!A,!5?;EM&M92VN"C"\S.;M+M.$
MV4UOD*N,ZM@<+BEK:3"V0<::!@BO\&82I &8#BLQ@I7$YR= QO/^TVO7-PIC
MF4L&E:?S5%UBWK(DV5[G5-^GBL,CK$<!6O%%-H^.W.*&W99&;\WAVS(\.?=E
M^S+  ?_,(;4<LL:5E((>L5>O7RZ,>@JKB#M<L0L1W#-NP/G /M>GOLUQWDNV
M2 7:QOXE2DX>^@4DN?GX\6M"9PVFQ,#8I8</R\!T9Z/^7"'%?%]%P@%>[[QF
M3 ;.Q$HEMJ&-V<:3>W(4]57H(PD1#'S3=\1$WQX/-2T"XZ]@'$[5(K)%6'4[
M&6%J5>DV#RWL<-/(>$@V5Y0^LCY*47X_-[7M;B1<MPR$5&N:+@M,1C>4*[\
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M XI]&8.HX@:87,-OXCM(]<.=4]'O'F9DB]C$13L',V,N?)X+Z7U C1A4.UY
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M@3DOM284/AR XF 6 !QN'B_;*"V>$<4>=\'B*K!OVT3PCVW8*(G[PVXK;%+
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MU#>;:%E6G%,B4V"\TI2KB=D%X;JSO/Q&]3S&_8:>-<U#)G(<:!!&)&2XOH<
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MZ22'[PL%;ERDDR6Y;[A]3$\,(K1R>5Q*-2P(B5:AF2\>CV*=[E!8]U^X,U.
MC'IF^]:62H]W0#;% U)#M*(W;&*,3 -'UCZP0CN10SF&;E-Q])&V_E&XW>]^
MI:-KC?<\#-\GY>S#0KS;A@1$[IW7YVL%"V\Z!.KV?YXV3/#D"='RUI%\RJ(S
M0.<5D7A#IH%I=2CUST;.11^%)L=7W\$K/F%J3!JES*+J5&;>V:U"-YS6ASY!
M5QIPAE!!"9/L-W+Y'PB_2+T-WVMM'.7Z0GA%0EKY+L%:DMK]2 U@<4)XOY@3
M0%8]4"Z"5*X]+(YLX\B;@LW$-"C(9:79Q\PN#Y[!9CF6<>I;!E<>QM\ROFM?
MM)N\]!V8[557&0XP#1YYWY"1D)35RELV#Z8Y6S9[H-,=&(43F/#IL3;W!,&>
M7I^\9 ;";XE0*W4][O22^P]60V.7,YF#9&>S1->V!A:0X,)DUH\ELHVVVI[[
M<S;5\ATKDI:50GE@DRQ/0-ERJ_JL>Z G M%)T;Y/&7'IF=O4W'#V%E9[0IGI
MK,GC,7>4U9:FWB=4H8V?UI,\>8QUI&Y!^]&>YW-HSI-XT8Q&%4J@=8$_&[#V
MKB9&XRJYOO+( Q#IMJD4O4F ^M0B/![(YWZ8=:\XE9E G)GFVM@0T?U$3S:D
MN+9GFRIJ6?4(]Q>O]#%"&LV8TN4 [<F<M<F92HEXX=:[&$IC/EN/"*F,$0.[
M.3!3@Y14NS]\]6[+#]QO.\[LT_;8O/*?Q>"PUQFE94:(J=\#6AQQ&-5*N_M]
M3XI,(TNF[.KCXTH$KBW!^':$<1H,K11X?=O2]?=SH9+X9)]<D?L7RLX_^54\
MZU73BOLVA:C,@$8ME%LV%.D-U9X3F416SGD;:&G$9E-<:YE<R)XA=<F9&83K
MBUA@MZ]A%;)O5 7M#XVK]L']@^4R*H<_MSE'U997^U0$0QS$N=F<U*M+,]1@
MM8XZUC4?6N+?P8V#_.XCWX'UI&&]/#&*R[<')&W\P9J/XP(2I1:!>8;HJ[+J
MO5I4\=5OJ^RI!NH6I&6"\*X=L4*+C5?LH8QX=V=OZFBE$%1MR4AWZ'?&'TCU
M(YV;A%QW2MGB20]VBIV/W,?*/^?P/_^P\G@C9)*^L41B0(-8<*Z(XFGN$9;>
MOJ+/N?)S7ZIBQ#ZK3VU^&D0T8Q488#MXF%44Q@WI+FDC\?D"=/TF9X/?=\^'
M>]2I7+V4?8M:DIRBW,U]%MY)5_^A6O&30/JD+_84=GVV<#!VRZ&O*X+]"&\Q
M600NQ153)Z<R/&C+K? 9?*]73;F^YA*?I]$"VJ(%FS+PQ"V%E\9&L>=&_1SP
M=*7]2$8JQ5-E&,96+LMW8<)Z),55:C,I<A;7/6#/I%NP0V;0E%_P:'#EI<B1
M)J<=9L^V3;2YH#)=5S]?$@O:-R>ZCK4;98FS/:3V8X6Q9>!G?*3=9WA*XZ]V
M)4%7MGE*[8_U!!1U83C*>C78\.J$9QI)#UTTOV8L"&2-C&SEJNH, :<Y2*E,
MB,-/!7<:^O&.D9"T9"QT_EN6&5FIG@/B93;.Q.-,]P+#1IIE7' #9A$:YM+O
MB#V"BLL1U_^D\*Y[PDE0" ;QYI?-<BE_RBV4072@8J$#C/NBC!,B1^@#CL(9
MO)UL8R[_ E3%2+I\+@A,/,#^Z>S-\-Z[Z0>[C;;O4F\')7H=)]#[K()=@6YP
MES[HO:'^-*6V+=P)TJ2*%%'UMP))ATY^O#I>&9M>&>KX_%NFD"/B#Y;*!AQ$
M%QPI-*1)/.R6WCQ'LF *<6.L7+1]H?ST\GV!#\_VTZ:A.G0>5>VBKT2?AE?T
MO#1:P?ZQ&1N=*<&B*ZYDH%4S?U@/JLR*R\ZF804W6.&AWVG;A/H-G29K=.69
M#?,A-O/?;2F_@""H>:_RG<=.LU:)&B5/O7W?&(?D!+ZFQ3M$S15;T+(I 1C"
M-I;/K>G_!46?4NB2G;Y9,>60H69;O'S"R.Z8J,J^<1ZY1KH(J4E4-]1G#MZ2
MDE5ZO5'Y=F2KUB125Q--?!GNMD:35"MR"E0H[AIVO,Y2.&]B^W'"0-%=6_%V
M V%7KUB?:F<K=>%<"VE7U4  W1J^1 H 3?$VYKRL"AZ=,4:O&W,C^72YK"K%
MHG9GDT[Q#!(ZZ+>@K +F1%_C6EJ;3D&=80A]8KZT?)P\A%6CP@ZUR[E)5@[4
MT;V.+<LW\I# V702Y^/>8PT4%QUSM1 #9<_F9E*:D*_::RI.N$5P@.*+*:WU
M/<;NQ6UOOJ"N43?ZI9J?"PK62OJPV.GIP'6T^\X*>YI-_,NYOO=$K+)U\(3P
MX+BK\XZ9-?6)A^!2*=K0J=?&\0VQ:NV\^!%J%E2DOP1Z[GEB.!I:Q%H(4'[I
ME.WW0B+4VJK),Z9A D<LC7\O$17:&0-]SPM)A*37')PW>1W=  DA[6]NR(T,
MF]EB$19^DUNU\:6+M8->"*4?T;F_-CWMX?VYOZ7#5Q^H#BV*3P YBGIT$P;F
M6YRX#L= 1I(3H3?/@G^<O;1;!/K^-8 %&:Y;YL@]O@RK^L#FM.\RF0?=(@"D
M:1M$YM4N>D<RL:?O["8-"_)S)?"72W3:'I6T:%Y'8L/G@>;*.P$T+)8LRB@
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M XL=H..8/%22<5'R%^=XI$!#Y^\$ O:HPJ>WV46EW<C/4ND4#-2MBO:!UV$
M+E>^>6]>!-![<<Z5>V%,3Z28Y0-J&N7ST#?<%YJ^[@HR0*QBEM96B%J9Y,A0
MH8JQ:M;O')OA%9/YK]>_(@S99"XV6P V,0+CZU<B+9!ZD5"-4]A#.TM14G[]
M::\*U5<E^N46UL+ZN74"$GYP2++XF4S0&P#NZ]9\0S>?Z/70(1<AHVU5\AIE
M0IO>KUU'Y^NR.=U#]XDG[<\OPG3,IJ<L[1",<I#D?IL6$7<B7<H!;.#+%N\
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MT!_2B08&%V='K')+DHV*E-'",*+"AEN=+4=O E)NLQR^/E+#9FWV1>549<E
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MI\YY#V[@!&24)ZB13^_Z%S/@95A5^Q&O]7<E%)L14+36/'V@WB0-=+S3'B4
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MOUM]"O&D.)<MAL$PD5>Q^VW%=VZ)&)@!:;UT!LVMQ8:XDU>?O]]JJ1-O[$Q
MO$Q<'ZWECH=)JY8U+J?<56V.8)$021+9D9'RN-MW!7@MLJ3!^BHX/*$^6"F%
MXR>NK)+_Y>)Y>N,VBT+T'-:W/I?W!761RI !I3>-<[E;W1B^>B\F9%R"==(Z
M4%?78Y<$KR<5U(^Z5)^[EQ:\TD9S-[@ATIQF(I034.QT:*\FDO!,"4>Q=)0L
M^@W[@02 0.ZJO/TH1]GGFJ"Z"A1 .T=>G' \DWEUE!?0']:.XWL4 RPO!RB-
ME_!T]83F27K=%(ULWX$;"G_8ZO#IIH_6V/"U _AI:*)W<WX&2N>5LP!?09/L
MWFG;@N5V=.BX78'K)(YAM27B(5'3E<1-7Q4>E:0_A_>]3D()WT6=&6Y.G72[
M:%C6:J ;_!0;5Q04TF^?2OGZ_9;+Y+A5O=+W8.4U?Y:/UED2F\)F3$A/;#<P
MVX&V5KF=S $-.=GKV%HM*7!U4!E.8/GS6/=3.?E-^K18-(Z;CDY^N0I3'IR3
M$=$DBSB[(?KBGJ0O:/C=S_ZWDD*2M8-@,B%5%UEK'&\NG$1@NHC*)8S4P;!.
M2B"\CGOH "34++B+V9$N?=[)KWZ\%B=L.<4ML8BNJFZKKOA*VG(-#'CBQ18F
MFS-E>O)I-R0CSA;9T1GD3*O_H"AN,UZQAIV'C$QBDXMVW8?J.4!E*$,:+%1T
M&QCG(ZJ*I4)"9Y'<F'2FMD[\$KW^7)5O=.-&];3JX'7+675',4'Z=)LB::^)
M+Q\?9+PE#JB2^Y"*W];=WKW[_/I]]PD:XK7Z5=<]C3>?XG3:*NE30)Y3;<K;
M8_4W0WX_7[R('8NJHYQQ?RLB1W$%> ?5O4MN<7LAI(<_L-6C6+TCSV;QG$!Z
MC&E.JW0"Q@#OE>"L=!065I%XBA6KZ-H*H*5/U"<>.V?:Y #.3 /*=9OKS&TS
MMW:K_@0M1MY#%P%C!TN(*K([/*.^_Y5IF_\U[665% P..-\O5[R6]*?*38MH
M7LQI;>?68+=(Z-)C<A  F?-;[W'C$+ZT[3.GK1?CWZX >@:7S)*@*T"Q&^M^
MY?CQP]&DP/*C>K2_VQ__,1W94 WO-;HCH] +"Y=C-XOO=X;_'B:]56@\[<5Z
MD-@_/YH4QOL7U/4O#=I0MJ*_D/^B0<_Z?Z/)1HR-X*@R&[ )(>CN-XN*Y,[6
MR%!,7(UN>UV,/X\] &+/L#\[XJ&36B0Y^(\/H$SS2QJ] @B87O>>N<CVKSDU
M/.WF/)?TGBUW.#)6;= S]P_5,>/(E_4^C+I<6W%?XXO97MGR&VR8]N6_L(B[
M9#8,"TPX:K">W:Q/]BOMN )0EC-> 8S.GN^OR:\ROX_]O3_62LXMXY,85F#N
M?%.G_0$BKBE@@*0C)*.*S>$@>-"V^##GLDA:^^)AYQ4@,>[&UW^7O1SMQO->
MY9ND^R\W/E&<LP'XZ=C+Q)G=MJX_IJX!P8W, 83*,];W]_+CURAJ8OL$)9F_
M:XN>^VEA"$X-5P!844PYSS[92,-@>M:)WH-AJBO 2+CLQ;>L8_E;9'4'$6?%
M"I>EF/\@K-M0LR^[QIO57 "BULX\&A/8K*,Z[5K^AZZOV>7:P!6@$.5/65@N
M!_T+FO>7AM+!&S9_0_]2L=K]XF'>_ZZ3/7@PM8;2.;@T?FU64B=M-U'KQO=Q
M%]\QL[ T&=]-SZA/]O-(9ZN:5=E.(Z-2YF@#>#$^M#6FQSH_$JIV!="M\S\5
M_7 %$$S2AC[]UX64^1=V="+LR7^V!$-;#F1_I;H43/&HP ME8NPIU''3:9)>
MB_D6P:-?[V?*6T^!(0&$W8)YS0OH99GOC?.3K=W7.H'_]U3L_YI\*JBK_C]&
ML2J[8E^\S5L TLZ@O0*,U\2<ZL//[ZQV_V>1V@VH6_8_U\,,O@ 57!K]+AVU
M&8NY_.F*VZ\L/O&^Q5?^/S Z9V_]M3,+_,*)5X"NCJ+_RWG@P+\K/3 ^D_=_
M[JMZP? _[$[MV17@0OF?F:88K@ ?'QO_/YD,><M_&E<^_)%VB?:Z NS#22YA
M?(454)N&-;I_@DK%$M8EH:[_DZB<T@'\M'>?;F^YH5/0Z$[,ZOA!VA^!Y7[_
M>+/:_YIO[([+I=PY[?O]4[@I5KE554&SLLD->1?ZGX52SPR"=S4>D_.,XGD^
MX97B[S9,/T817KQ0XCNX.YF0*ZVP&E+<;=2RJAGO /2,F#B?R'TEX3N=BRWI
M&;K[90RQW0?)X@<R5\@Z597A[/O?JJG%A6]X9(@<9!6:WY=O*Y?H<_'.))6[
MGO6<<O5XG!E4452&JEY/Y'/ER#E@ 'E1'E65ZAHS1.MY8V78EH_$'5F@LVQ1
M/=R(Z*7=E$^.+S>+?RQ$\/S>"'=R%J@<K&^M9%HAXY'ZH,?2"%"!<!3,5L].
M$@?"CTXU8X^>6(H2T)=?5'$^7Z_I,N,GL&:4,_5:9.LV \R*H'0_%U'9&C4I
M&I)?5M.HCP$"T7Y1>(0OF'-#A[;F3XB"=G_*@X,77WYY&OF>%H:8#*AYF,)C
M;#U.D@X_D9R5'U%N0*Z5.F=P=NO&[W]VN_$J)M,N(+(WVK66HYK1W.::Y>82
MYFO%S,V9NQJ_[JBWH\?+ZA0>9[TW^MBR5*J^A(ZK99I3E9O1N/Y!F=7D$0PN
M"U./^H,Q!?/:XMY/R\\HZK&-(,7LWD_]5I#S("XS, +P5,9/E\K6SUD5/[]9
MJDR]2]/-+MC_P$5)1+#E4%Q!"L%CG89>KFP)E*G C/N"T[1\TB(*&8P?[H+.
MI<IB8J9;>CX*XIDV9F3LHJIF._"GGYE.?M3%2C[)%PZ]\Q1NY_<^,G'O?556
MF@?6C(YZ64A'9!-WK]J)RT[][%[I=MYZS&":)/_,S^1[Q;9F"]9N3OQ?O1>Q
MG7@H.XS'B;AL!_"GP88NXG*I7E/2200WY%JTK!P_'LLL+[]\M<ST6Z=E60JY
M&!-1#Q\)=6@@:F[(#MR+:!YHF>AZ&QZL;U]]-+>#:H=6<)*>(5)-A2.Z#;8W
M#EF@U&_19\S[VIL*9!H,6E"+G&XMA+R8]LA;T9*Q1]G5E\0>_+7Y:BL>JK)A
MGR+6=8TA9EBP'U3*LJJ-T.W9+#JMP'X4XCG=8^<B%4 8;,KKV$;E[6N/B$=:
M,E;:-G16KVUBWO;^$DAFU_RAR7/+SCV49G^RHWQSW$Z.M&\K-T/,7^U9&0''
MSVVV>]=NH-4[O909[ZGN7;R)76#Q8RW>V&9J59K4^E:V@#Y1312MY 7&ANN+
MVNN/"$G$RS$IZJCNN=26.[&0?D!>WI6W\$V0A.25]YR<]V6N<O/0 >?@YN@,
MERRVI.=MU4K,H5(D'71D-V-EOBMV';L_CU:_6&-X7:0[CYW='&IY(VIR4Y>9
M)A=NR'O<L;"I[IX=H5\]Z^QL^:=/22 =H2^0VM;M>*<H_I5XD.'8"UK8%\FW
MENX\]U@ISDDZ8F5R'D0UP*)#WV5G8>J+4RL?M-BK4/HU!\ )Y@'K)_T@\MC[
M_NP'NJ5GCURY^3*]6:\ :Q'K\TL%UXLLD7W#,LU!L'LLRZUEZ8R^8-[L<G\5
MWA4[O\*V3M])<B.$UE3A<75J8@\H3*X[;HF1!+ .!E)$XS(4R;[Y<TT,@>VL
MC+WZV(=5_!1T8KJ<)5K77>J%FX,NV60$U&K9EB5G>J3I*@\E0=(CPFK'XXNM
MPS^?QTRG[6=5U>[-^@.=9OT[%^UW,SLRR%MFVT8R:CJZ8T-NS_/U3;"!=780
M5P")N4TI5%#[OCO><6=  C%GF9E,VC]=.9M6M;G1OWH%<+\"I(YC)]>HM)Y$
M8L)$'+\7BIJE2NJ.*6U1ALA?(D".N^ZXOC/?W#O?71U*=>1%>PW(CYL+D3U-
M4MNE/AM),OR=)MY<3)=T/@0DJ:.O.\Y^V^30^(]< C=H=%S\V$;)UK)?!FD%
M'H;W3B27<R;VS59#!YC&DIV!I,N(V"%I6LO847JF"A^,C^ZY4N?84^\&VLFT
MCZ]IY8@>+-05N5B(;QK1:>]'WOH*.>W>,.3)6VRIV>06S"FP+E1&GZ/% <T>
M]]N%Y@/Y=-&VX>7N0R56"\J(MT=)2X*,9R2BELTB@\;]RJ_=B)XF)88/MASL
M44!(/[<7YJNGWI3W!"X;F@:Y\?1]A4VN9>%A@;'?]U(&B%EB'*;7 =1].Y86
M>_:<IA)'XS>]8F3U%E=AI6G[=(S5MDQPN#VJO::,62/%9S!:2RKTE4<HQ)_B
M.N VL=0U*:C#QE G&F8%WM9=M_CE]BC!LOXQ,97L)<GQ)_^;+?,] 82P73FN
M]QI'M5ZJEX<_+[Y57 %29(YB5/QG1EG+P0U[_*DO>%/\_A+PS.RL")Q-91^&
MC%]:#"L'NPC\+?@Z+M,D_7#XU-DG^E7TKRZ=0.4/!2Q(J[HM[ZDV)ZJXHMF$
M]GC%6=NU1-;Q5#-[6.[Z0@'>4J8E7H$/^>A#SYBDA![;=$ O/UG(K++7-X,H
MK8G0R7:T_:379)& 6<Y&L1G*0>8/*Q _8W?\,3B:$D&DE6AN.FTB':QOR>RY
MYI,N1%S71DH.Y)E/C!1'"KUMW)[&[V 6_$\@ZT]/1J4?]-I^*;W?6]#K??+L
M>$NRR.8KZOA,43QU@E R?@ZLP\DH5;1NXNU;J/@:Y.S-2XUV\7M :K\%&HJP
MYJE5M$YBL2N8T^FZ?#L5A )_"SGWH4C_/%6:TELA+;H7DX.XU:N!O@(L-?@=
M^BM< ; N6:B\*\"*X<N87!9PL&ULN1#C#IA;Q*$$_AS@R75*59@8&^Q</-/_
MQ_\(X7(P\D^PPGLH2QS\X\(%SPCOZ1J0XTL0A*1N=2A>RJ]^E@_[G[6%?Q\H
M+'_^'AA)A8,^=;7.ML[FB^H[>1[/>]\UFF7Q*8_%<&J<,>WK"'_\]ME-S3"L
MU6!ZU,Y<5,,^7I[#-6,L9,*)T)K71-+<"0+<A[#/M^9](L%Y<"%(SKO2>UPY
M?#+X"I-*'44/<^,'LX/;SVJY%:#6$6E,"??PGI\E^OA)\ "(I_.=T$W%0P?1
MEUG[;>/8Y"\M#2O9Q\D?;B,N9M\P#2F-,%&-U>]EMM?W0YV9LK=6^6H%VG3
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MV?Z??]*(R5SYG?X>*7X%Z#X],=CLR;0Y=":Z)B8SF3(%'M;O+%4>S+22P %
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M6SN;_PIYSLI8?9=&\/?SP*\J/P.U+877N0*6FG/%<PPBK! N7=$1TE$-Y,V
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M ',3Q/QTSCZ3N*M]Q.>3WMRW,W82$+#]0NC-'4C<-XL#?4;+*+R(O4) 6H^
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MF:&?@48RG(($>J\ <W4U/1$24O=[FKBWM^UM3Y6ZH%> P,>FA5L?KP#@3U<
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MI9[,ID\FW*<WW@!XCOY;3<J/G/QGK(/KL.RAIPFD\L4GW,L-J!+*I4+XX,?
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MK1#WE3A=;4^9@!]1T[G#T-^ACK]M$.O/AL^K)?],KBX<]Z+KJ32D2<6('!9
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M(?_H6[7Y_R/A!@O_)\Q,R_@%\/!? GST_8O28=]LW %IZU#P1M^_@U>0;E\
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MSUYHS0R0XON@L"GLQP[PMKCY@[_Q[%B#%]J6J9V#5^3%>I&\A5Y9813DFJG
MI**+E234+'RLR=A$%J*Z]> C<8F>Z^Y&+E)%JZ8\5RY+EI@,M#]>Q:06A[C&
M.*]]Q.4*%)7C_#1*C#J>3^'#14X[4Z60.4L;N=Y+4PV'9K/7W8QFL"M0&<7]
M);E\\?MYC-XOINN(&191"08>=(A$'5T$%*RT?BZX-6%\Q]%K0ZOS],7;>7:W
MCD<PE!#51,FZQ4W[#14!-:B<6,QF@?3WZNDF^VDOW02&:9V8HJ7,IJGH[9Y4
M@?F%'G.W@[MRK[1/VVUNO.-EV,XL3C<UB[3\(UH&>7GA ^\2:]C4"VA0T; ,
M* $C\N$+&]3T;M>I!NV.K1:/4B$ =%76<V6D1#%E!#?E+=-03)Z]&*^O!%'P
M@(F2*XXRK@31^,?\);"C#(:);;-!X*F_$BV/(W@,Q=60K/3<C&3*\RH0!=L"
M:1T+:FQ0+-Y=$U$G?EY(4$5SI;Y"<N1"[<)?]2>3<%6A(9JR0Y!*S7T(J^Y!
M\4OUDH:V06?7F_,(- INA#?.5C*9 ])(FT%LP.4[:"]_:%W":"1ZRD F"  C
M:T6J[ZB485]>3,:]L.9S/_:)/3USPX%Z]VGLW(1E03!OS\UUO]C=RF%H(5KF
M@>T/+HWP024JM-I:/GS/M<(]_FZ!3:ZI4I9PJ$1 ?!"TW)&<A2R4;WB-]&KY
M0%#\7\MP2?M^A!,P9\Q# @XSKI@+N-P=+])4K.\,6I*Y@TIZ;J  +![HX*]-
M U:X,9N/NW<RQL=WEOA*F+GOHA)'$<UA(T5R#Z(GQ6S*MA+&=%O+9B.*MLX.
M_?_TWMF-G->XVT:2IB-]#X*X+>UC[RLZ<:92,-OS^K9F7,B51.$1XC8+2R[1
M9!XG&LI6%K_O(FP(!JX?C<E0&1ZZ0V-J\R^S?DO\,#3&0P&Z&)SJ!Z/M=AS'
M_Y&9(9TN;^;4;4AU-_ 3E20:!$/9$%DK1KX\>DBL<'!9,,&SZ$'E=;^D%\*E
MA;=U.W^=>1@]I>4<NBS5$>\Z?1P2=)=V3BA\=#I+/-OJ]'*6@.\:Y7#R:&&8
MK,S<>S)D0<\R(.)]2%60CRM*6ES'-&2H4(Q_2*S6U)_=WI5>BMVX5H\2;_JU
M=%5#*R/.!$\S[CG]1ZQ\B."="-5:'-)L>NTO/FJ"4E)O=ZE=-WO6<$Q>**)_
M*'5=0VB<EPK<&^)/_A3^VOE@4;G3\]%*F:Q@5$\&8B1P4M*H71[E@[ S<JM(
MC5 \6N/[8\'>H._(T31#)4!]X*2VH-2"ZQB45A97XNXYF&1WGP:EJ2?IAR-L
M-W#YDW'H9<$:U;5**M.F7MWA\FU'B=.)2Q1O,7CPW6T/9<$[XB@E"<T2W6^Z
ME3DUA0UI2A39?Q+,VRV)7"71'?RIZQ<UUR^QPN=_NXCPYER65D:72,)#E(4Z
M9T@O-R5L($9.]7T+7L$>')_.???X&BAF5;/NIX*3?5@@_Z/O3^0JK.)H:C]9
M[:^&.Y>XM_D6X:AYM($;L[Y-YL!?2:D\[@<$J?7YQ^[-I44SCY^F"<.('XJ9
MSZ@776LP7&!ZE6L/PF-L]PO2[/3GGXFN_K-&3=VKL$($7%4L"U!O-9:<ZJL"
MH+H?_VS[63!:>35I9MS@'Q==6U7>[EZ+F,U.[90?G17J^?"-=P%:6_O[!N\>
M\N74*##?'E^2X6PVD$TG_&A\@YVT)$LN-E >*E<3) _S(AMP23*:/M..O*FY
MGARL='C4K#32KF\=<PNR-V51=].G4?C578CWX04"3W221D,@6\QYHL?:X/O"
MW,?[.;(&V[))/+U5TEP\%[X"  HO1?PDT(^KS(:"UF[QDE4:1EU4ZJZ!K*RK
MD4:=,2P,04@SATB4@%&IN<LWKQD[4K%E%2O1][ML)=*FU9WG/M!TY(3=S*9@
M:L0P"KNA)FP,BTPK0N#GON#"Q8Q*%Y]VB[Y^\,['>=8^ZD%-55C&=I9*WBAW
M^%BLPY*?0NALZ!="T%ZK6J>"S]S,@SE+I0V7+=6BGLBIY(+8=4$;RNGPAJ->
MN\[C 2_]']A^#UDN0Z*^P?8U-D\2,5 ?(AWO,39HN\-^%M^B8X&J^R>:-[1D
M5]C/8P?X7C)\PSB5.[F?$#[\_2!H ZD&KOQUAO_7F1BVQF6*)]>__52\2JSK
MBV3Q2]*$YB5"C4UFK%L!FM2MF[_[.8JIV%1>7=$[53K!J-L0M&@8_JWG5!J3
M%6:!M 5)P._^D[+]H *JG7JY]$8H^*79<7\H7*/>SD14UBR +MT 0H:?CIR>
MXXRN\KL\,ZEE(-GT>-\3"L?+&3F_GE.Y.T'BHT/D2N8%^3H]58#2/6CYCJKM
M5SUQ=AW,MR'Q^MS3N9Q>2)H2=)YHM<W['(Z)B8E)8.YA$8[%T5Q+1EL::6EU
MA(01&]7Z40@^[7P1AW$).$UN+V=%F0YV6\$B]":B-X"=A)I$7C8:A"]PS0:H
MY,.D= ]:$YK#!<]9:678V<T]\ ;Z7Y6+\.?9[E'>- WV$G9V]0=#$-F@?BDA
M\&%TI=M!Z6\S9-ND56@[M7M5.(*W>=S7+H\?_,$[_:^^8"YXT;7Y0"I*/3*U
M".$M.B"S'Q^BJ#CVN/L:K44V\P23>?ZMW\C$)T$"2R5"D1@+#KT;>Y3;\=2C
MR2W&U*:RMYF_\,7#NHKV=-$_]8.(S!XW)JEZ'FWU,T?OG?EYJTS#RG:.]C+8
MRK2WQEA3\/U)B/IS#(B'Q%6G\=M-2K)J')+KF[^\63U*W%ZPT%BZ8H7W#. X
MD;?OKFN+:1OE&Q&[HI'2(]7WA%S9E9U.J91TY&"_0B<I:1E8C*ZKK$7]V8>P
MX [/J"]\K'L(9Q_G9 ^^:>\."8IWOEFH0^N6*74>@*%PPJJ3.@L5>"Q17K<
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MBZ776;V!JT@70[$*KN5W3T5^=E4)#[E1RY @/RCV81)P: P@?Q^%)%-30ZB
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M"R_\M;FO3JP\OPOL<9=)Z\"[NGR.XF[MH[ KCO7V2<85MD%C8O[-S9P.LJ(
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MW 5YJU*LMNNL?$^JTB["4R"63L<E^.K\P@*/-Z?'1[CYEVR,^BKX+$>/JES
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MVQ^UZL>IP=#U&XOR\LLDJ6?M[\C,WQ<$G"TID_QQ4A#1[8V@A4";H?67K;X
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M4 BK!F9Q0A>"&X1C?50<CK1?C>6^'[/Z8Y[W%6^$:MWS1YYLZJZ^2R>1TQO
M@OX'\YR::L:?'$?EAPR> YVW.QZDQ$^H4SE!72WI41S6"/4J92'Q1NG9(:=!
MFYCZYV,?B^D-RVQT]5.&AZ6&^:5B>U&%^L2A+@ 4Z7XOJ:.?CTHHB67T#0;=
MURTOFLR-?5'LNK'=$KWAD;(HCZ:%CJZF/>0%B$VAU6L(A0+HP00OV4ZL"JN
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MT0+S$3FU]0'6^Z\]B'<A"556)_V;?TLT%^.L0[;!^3$,@T\N,'WRT%B'>E!
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M!7$#JS,?)+,UWJ$1JNC]C/]?%I8WYU<HC)V8SI-9O[3',L#^Y$NY(AP/U]R
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MRBY[2ELVMK"Q;'%95UCL:_==(II17ET;RIWV:>0P)@#C0#,]G3=ODFBU"FU
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M;NG^M[=>:[N#='.\!S3AQIS,:\W4J.3<%AW"**MA\_CW[H9I#^EOK/TDH?V
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MFU&T_:TRGSN>,@(]+WX<7T'&,]'B-(%X]BH7!-))$SX?>BIDTQ766?+.-Q[
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M^C:6I!4Y:_XR[2T1%P RY &$>.K%JYUC#*BY%9$R#(=J])2Q.(LK9%R(K@:
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MT+QY>.[F_>#O@RYN6V2X@,_8$D,_.>[E>:&I@&"SX/D,X^L!WPWIP! 2]OP
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M0!AE_":#I\&FL&Y4 DVF@9VA(//P-AX\Q0 P0/Y*?I'137O!YN2[E6%5U_=
M%>(2BD!L@Q37%2=KY-LL3>_^>GLLN$6,Q;,9SNE/"L RON0@-06W7>4M4A(=
MM#AY,5B-&)/>H9%W@H*_B:@KM,TOJH1&KBXSMAA*N*%?FA7N]G.%G_<OA]7D
M(V @+*0Q)0>0>OGZ(&7;._1%B33#KJZEG\YA=6)ERO,V  *\PIJX= VN1=T^
MOI=G<$D-B.X-I. YE$#5]KQQ^]#DB&3I&8L1XVLK>VD0_.S4VLX!;P9,BTM
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M1K+4\=FO_M.FP/^>,/Z>^B]02P$"% ,4    " #)2Y):_<<ZIK8#  !-#@
M$               @ $     >&QO+3(P,C4P-C$P+GAS9%!+ 0(4 Q0    (
M ,E+DEJX80, BP(  &4.   4              "  >0#  !X;&\M,C R-3 V
M,3!?;&%B+GAM;%!+ 0(4 Q0    ( ,E+DEHPH"!J 0,  +X-   4
M      "  :$&  !X;&\M,C R-3 V,3!?<')E+GAM;%!+ 0(4 Q0    ( ,E+
MDEJ!!O,+VS@! *S1#  7              "  =0)  !X;&\M,C R-3 V,3!X
M<')E,31A+FAT;5!+ 0(4 Q0    ( ,E+DEK'_S"O=B$  !4D   <
M      "  >1" 0!X;&\M,C R-3 V,3!X<')E,31A7V$P,#,N:G!G4$L! A0#
M%     @ R4N26NG3J(PP!0  T@4  !P              ( !E&0! 'AL;RTR
M,#(U,#8Q,'AP<F4Q-&%?83 P-"YJ<&=02P$"% ,4    " #)2Y):MI$6=Y^T
M 0#5X $ '0              @ '^:0$ >&QO+3(P,C4P-C$P>'!R93$T85]B
M9S P,2YJ<&=02P$"% ,4    " #)2Y):[988S"8\ 0!<;@$ '0
M    @ '8'@, >&QO+3(P,C4P-C$P>'!R93$T85]B9S P,BYJ<&=02P4&
/  @ "  Q @  .5L$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>xlo-20250610xpre14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="xlo-20250610.xsd" xlink:type="simple"/>
    <context id="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840233</identifier>
        </entity>
        <period>
            <instant>2024-08-03</instant>
        </period>
    </context>
    <context id="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001840233</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="Unit_Divide_USD_shares_c9xUV7cLfUGdKvEEazKsrg">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Standard_USD_OLynBvCv7kGDid3dGGWBgw">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_Standard_pure_99kf4M5Iyk-m5QIB71yB2A">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Narr_3Yutd_6FCkS7NNSivtrbww">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Tc_UcyDYk1GOkKHyXitK5FEvg_2_1">0001840233</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Hidden_DHvk5juwyUegKGfLvHvz8A">PRE 14A</dei:DocumentType>
    <dei:EntityRegistrantName
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Narr_fllLZWSAGEWlK0dYeHzy0Q">XILIO THERAPEUTICS,&#160;INC.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Narr_UsFXXTd2NkqWlxSCFdLGmg">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Tb_DskSvD47Y0uiRboxB3qgdw">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;We grant stock options to our employees and directors on an annual basis. We also grant stock options to individuals upon hire or promotion or for retention or recognition purposes and have also granted restricted stock units for retention and recognition purposes. We currently do not grant stock appreciation rights or similar option-like instruments. During the last fiscal year, neither the board of directors nor the compensation committee took material nonpublic information into account when determining the timing or terms of stock options, nor did we time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;While we do not have any policy or obligation that requires us to grant stock options to employees on specified dates, annual stock option grants to employees are typically approved in December and granted on January 1 of the following year. Stock option awards for new hires are typically approved with a grant date of the first day of the month following commencement of employment. Our annual stock option grants to non-employee directors occur automatically and without the need for any further action by the Board on the first business day following the date of each annual meeting of stockholders.&lt;span style="font-size:12pt;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;&lt;span style="font-size:12pt;visibility:hidden;background:#00ff00;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"&gt;The following table presents information regarding stock options, stock appreciation rights and/or similar option-like instruments granted to our named executive officers in the fiscal year ending December 31, 2024 during any period beginning four business days before the filing of a Form 10-Q or Form 10-K, or the filing or furnishing of a Form 8-K that discloses material nonpublic information (other than a Form 8-K disclosing a material new option award grant under Item 5.02(e)), and ending one business day after the filing or furnishing of such report with the SEC. &lt;/p&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Per-share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grant date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Percentage&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;securities underlying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;exercise price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;fair value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;change in the&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Name&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grant Date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;the award&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;of the award&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;of the award&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;closing market price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;"&gt;Christopher Frankenfield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;August 3, 2024&lt;sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt; 52,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt; $0.8950&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$ 35,578&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;+0.69%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"&gt;Granted in connection with Mr. Frankenfield&#x2019;s promotion to chief financial officer on August 3, 2024.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMethodTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Tb_vmCZwpgXrUOIjsVY0ngGYg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;"&gt;We grant stock options to our employees and directors on an annual basis. We also grant stock options to individuals upon hire or promotion or for retention or recognition purposes and have also granted restricted stock units for retention and recognition purposes. We currently do not grant stock appreciation rights or similar option-like instruments. During the last fiscal year, neither the board of directors nor the compensation committee took material nonpublic information into account when determining the timing or terms of stock options, nor did we time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.&lt;/p&gt;</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgPredtrmndFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Narr_EGvJY_lYZUetveHdGi7DPA">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Tb_2R_ysF0xsEmNIVTNPQRVDA">We currently do not grant stock appreciation rights or similar option-like instruments. During the last fiscal year, neither the board of directors nor the compensation committee took material nonpublic information into account when determining the timing or terms of stock options, nor did we time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Narr_Tn1Cc0NUPk-vVgHXkFp9yg">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:MnpiDiscTimedForCompValFlag
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Narr_sSy4N5x4lUyLLjfTTBBNwg">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:AwardsCloseToMnpiDiscTableTextBlock
      contextRef="Duration_1_1_2024_To_12_31_2024_JHoaJAPmkUKCYszkNIvURw"
      id="Tb_hAUX0GJ5C0SKqdv6vrYECg">&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"&gt;&lt;span style="visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"&gt;&lt;tr style="height:1pt;"&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.42%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.53%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.76%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.99%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;margin:0pt;padding:0pt;"&gt;&lt;div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"&gt;&lt;div style="bottom:0pt;position:absolute;width:100%;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:1pt;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Number of&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Per-share&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grant date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;&#160;&#160;&#160;&#160;&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Percentage&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;securities underlying&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;exercise price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;fair value&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;change in the&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Name&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;Grant Date&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;the award&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;of the award&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;of the award&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#ffffff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;font-weight:bold;visibility:hidden;"&gt;&#x200b;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#ffffff;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;b style="font-weight:bold;"&gt;closing market price&lt;/b&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:24.42%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&lt;span style="font-size:9pt;"&gt;Christopher Frankenfield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:12.82%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;August 3, 2024&lt;sup style="font-size:6.75pt;line-height:100%;top:0pt;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.53%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt; 52,000&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:10.76%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt; $0.8950&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:9.99%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;$ 35,578&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:1.85%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;td style="vertical-align:bottom;white-space:nowrap;width:16.17%;background:#cceeff;margin:0pt;padding:0pt;"&gt;&lt;p style="font-family:'Times New Roman','Times','serif';font-size:9pt;margin:0pt 0pt 0.05pt 0pt;"&gt;+0.69%&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-family:'Times New Roman','Times','serif';font-size:9.0pt;margin-bottom:0pt;min-height:1.19em;position:relative;width:100%;"&gt;&lt;div style="background-color:#000000;height:1pt;position:relative;top:0.6em;width:25.0%;border:none;margin:0 auto 0 0;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:0pt;margin-top:0pt;table-layout:fixed;text-align:justify;width:100%;border:0pt;"&gt;&lt;tr&gt;&lt;td style="font-family:'Times New Roman','Times','serif';font-size:8pt;vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"&gt;(1)&lt;/td&gt;&lt;td style="padding:0pt;"&gt;&lt;span style="font-family:'Times New Roman','Times','serif';font-size:8pt;font-style:normal;font-weight:normal;"&gt;Granted in connection with Mr. Frankenfield&#x2019;s promotion to chief financial officer on August 3, 2024.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:AwardsCloseToMnpiDiscTableTextBlock>
    <ecd:AwardsCloseToMnpiDiscIndName
      contextRef="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg"
      id="Tc_hQMRu1kgrUu6e43ivIYlrg_4_0">Christopher Frankenfield</ecd:AwardsCloseToMnpiDiscIndName>
    <ecd:AwardUndrlygSecuritiesAmt
      contextRef="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg"
      decimals="0"
      id="Tc_6AxgcVLSUUKRxOy_MWSu9w_4_4"
      unitRef="Unit_Standard_pure_99kf4M5Iyk-m5QIB71yB2A">52000</ecd:AwardUndrlygSecuritiesAmt>
    <ecd:AwardExrcPrice
      contextRef="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg"
      decimals="4"
      id="Tc_jbP0kuTRq0awWICrywpDmg_4_6"
      unitRef="Unit_Divide_USD_shares_c9xUV7cLfUGdKvEEazKsrg">0.895</ecd:AwardExrcPrice>
    <ecd:AwardGrantDateFairValue
      contextRef="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg"
      decimals="0"
      id="Tc_Xy0PuzNRik2TqiVSYInDpw_4_8"
      unitRef="Unit_Standard_USD_OLynBvCv7kGDid3dGGWBgw">35578</ecd:AwardGrantDateFairValue>
    <ecd:UndrlygSecurityMktPriceChngPct
      contextRef="As_Of_8_3_2024_YAGY-HKZAUSgN093ikm1Xg"
      decimals="2"
      id="Tc_B59tpbp5_EiSFLsJ7V73Lg_4_10"
      unitRef="Unit_Standard_pure_99kf4M5Iyk-m5QIB71yB2A">0.69</ecd:UndrlygSecurityMktPriceChngPct>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
